|
S WIND-UP CORP - S-1 - 19990129 - DILUTION
DILUTION
The pro forma net tangible book value of the Company as of December 31,
1998, after giving effect to the conversion of the Company's outstanding
preferred stock, was $ or $ per share of Common Stock. Pro forma
net tangible book value per share as of a specific date is determined by
dividing the tangible book value of the Company (total tangible assets less
total liabilities) by the number of outstanding shares of Common Stock at that
date. After giving effect to the sale by the Company of the shares of
Common Stock offered hereby (based upon an assumed initial public offering price
of $ per share and after deducting estimated underwriting discounts and
commissions and estimated offering expenses payable by the Company), the
Company's net tangible book value at December 31, 1998 would have been
$ or $ per share. This represents an immediate increase in net
tangible book value to existing stockholders of $ per share and an immediate
dilution to new public investors of $ per share. The following table
illustrates the per share dilution:
Assumed initial public offering price per share...... $
Pro forma net tangible book value per share as of
December 31, 1998............................... $
Increase in net tangible book value per share
attributable to new public investors............
-------- --------
Pro forma net tangible book value per share after
offering...........................................
--------
Dilution per share to new public investors........... $
========
|
The following table sets forth on a pro forma basis as of December 31, 1998
the difference between the number of shares of Common Stock purchased from the
Company, the total consideration paid, and the average price per share paid by
existing stockholders and new public investors (based upon an assumed initial
public offering price of $ per share before deduction of estimated
underwriting discounts and commissions and offering expenses):
SHARES PURCHASED TOTAL CONSIDERATION
--------------------- ------------------- AVERAGE PRICE
NUMBER PERCENT AMOUNT PERCENT PER SHARE
---------- ------- -------- ------- -------------
Existing 18,669,377 % $ % $
stockholders.........
New public
investors(a).........
---------- ----- -------- -----
Total........ 100.0% $ 100.0%
========== ===== ======== =====
|
If the Underwriters' over-allotment option is exercised in full, the number
of shares held by new investors will increase to , or %, of the total
shares of Common Stock outstanding after the offering.
(a) In the event that Sagent issues additional shares of Common Stock in the
future, purchasers of Common Stock in this offering may experience further
dilution. Options and warrants to purchase 2,313,735 and 235,623 shares of
Common Stock, respectively, at a weighted average exercise price of $3.38
and $3.33 per share, respectively, were outstanding as of December 31, 1998.
To the extent the holders of these options and warrants exercise their
options and warrants, new investors will experience further dilution. See
"Management--Employee Benefit Plans."
19
SELECTED CONSOLIDATED FINANCIAL DATA
The following selected consolidated financial data are qualified by
reference to, and should be read in conjunction with, the Company's Consolidated
Financial Statements and related notes thereto and Management's Discussion and
Analysis of Financial Condition and Results of Operations included elsewhere in
this Prospectus. The selected consolidated balance sheet data as of December 31,
1997 and 1998 and selected consolidated statement of operations data for the
years ended December 31, 1996, 1997 and 1998 have been derived from the audited
consolidated financial statements of the Company and the notes thereto included
elsewhere in this Prospectus. The consolidated balance sheet data as of December
31, 1995 and 1996 and selected consolidated statements of operations data for
the period from April 12, 1995 (inception) through December 31, 1995 have been
derived from the audited consolidated financial statements of the Company not
included herein.
PERIOD FROM APRIL 12, 1995 YEARS ENDED DECEMBER 31,
(INCEPTION) THROUGH ------------------------------
DECEMBER 31, 1995 1996 1997 1998
-------------------------- ------- ------- --------
(IN THOUSANDS, EXCEPT PER SHARE DATA)
STATEMENT OF OPERATIONS DATA:
Revenues, net:
Licenses....................... -- $ 240 $ 5,728 $ 10,459
Services....................... -- 39 1,350 6,584
------- ------- ------- --------
Total revenues, net....... -- 279 7,078 17,043
Cost of revenues:
Licenses....................... -- 120 194 143
Services....................... -- 127 679 4,923
------- ------- ------- --------
Total cost of revenues.... -- 247 873 5,066
------- ------- ------- --------
Gross profit................... -- 32 6,205 11,977
Operating expenses:
Sales and marketing............ $ 198 2,727 5,929 12,037
Research and development....... 469 3,425 4,969 6,013
General and administrative..... 363 1,111 2,215 5,186
Acquired in-process
technology................... -- -- -- 2,425
------- ------- ------- --------
Total operating
expenses................ 1,030 7,263 13,113 25,661
------- ------- ------- --------
Loss from operations........... (1,030) (7,231) (6,908) (13,684)
Other income (expense), net.... 44 192 8 (17)
------- ------- ------- --------
Net loss....................... $ (986) $(7,039) $(6,900) $(13,701)
======= ======= ======= ========
Pro forma net loss per share,
basic and diluted............ $ (0.74)
========
Shares used in calculation of
pro forma net loss per share,
basic and diluted(a)......... 18,495
|
AS OF DECEMBER 31,
-------------------------------------
1995 1996 1997 1998
------ ------ ------ -------
(IN THOUSANDS)
BALANCE SHEET DATA:
Cash and cash equivalents......................... $5,026 $4,575 $3,813 $ 3,093
Working capital................................... 4,901 3,715 2,201 1,122
Total assets...................................... 5,453 6,326 7,185 13,196
Long-term obligations, net of current portion..... 114 544 627 3,346
Total stockholders' equity........................ 5,160 4,649 3,123 1,671
|
(a) See Note 2 of Notes to Consolidated Financial Statements for information
concerning the calculation of shares used in computing pro forma net loss
per share.
20
MANAGEMENT'S DISCUSSION AND ANALYSIS
OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
All statements, trend analysis and other information contained in the
following discussion relative to markets for the Company's products and trends
in revenues, gross margins and anticipated expense levels, as well as other
statements including words such as "anticipate," "believe," "plan," "estimate,"
"expect," "intend" and other similar expressions constitute forward-looking
statements. These forward-looking statements are subject to business and
economic risks and uncertainties, and the Company's actual results of operations
may differ materially from those contained in the forward-looking statements.
Factors that could cause or contribute to such differences include, but are not
limited to, those discussed in "Risk Factors" as well as other risks and
uncertainties referenced in this prospectus.
OVERVIEW
Sagent develops, markets and supports Enterprise Intelligence software
designed to address organizations' rapidly growing information access, analysis
and delivery needs. The Sagent DMS product suite provides end-to-end, fully
integrated data movement, access, analysis and presentation capabilities on all
major database platforms and is specifically designed to deliver information
over the Internet. Sagent also provides Sagent Professional Services, which
include system and application design, implementation and education services, to
facilitate the successful implementation of the Sagent DMS product suite.
Sagent was incorporated in April 1995, commenced operations in June 1995
and began selling the first products of the Sagent DMS product suite during the
fourth quarter of 1996. The Company's revenues increased from $279,000 in 1996,
to $7.1 million in 1997, the first full year of product shipments, and to $17.0
million in 1998. The Company had net losses of $7.0 million, $6.9 million and
$13.7 million in 1996, 1997 and 1998, respectively, and had an accumulated
deficit of approximately $28.6 million as of December 31, 1998. Although the
Company's revenues have grown significantly during these periods, there can be
no assurance that such growth will continue, nor that the Company can achieve or
sustain profitability in the future. The Company intends to continue to invest
significant resources in the development of the Sagent DMS product suite and on
its sales and marketing and general and administrative functions.
21
The Company's revenues are derived from two sources, product license
revenues and service revenues. License revenues are derived from product sales
to end users, resellers, distributors and enterprise application vendors as well
as royalties from enterprise application vendors. License revenues are based
upon the number and capacity of servers on which a product is installed, as well
as on a per user basis. Service revenues are derived from providing consulting
and training, maintenance and support services to end users.
The Company recognizes revenues in accordance with the American Institute
of Certified Public Accountants Statement of Position No. 97-2. License revenues
from sales to end users are recognized upon shipment of the product, if a signed
contract exists, the fee is fixed and determinable and collection is deemed
probable. If an acceptance period is provided, revenue is recognized upon the
earlier of customer acceptance or the expiration of that period. The Company
recognizes royalties as revenues based on an enterprise application vendor's
sell-through of the Company's products. Fees for services are charged separately
from licenses. Service revenues from consulting and training are recognized upon
completion of the work to be performed. Revenues from maintenance and support
agreements which includes product updates are deferred and recognized on a
straight-line basis as service revenues over the term of the related agreement,
which is typically one year.
The Company sells its products outside of the United States through
distributors located in France, Germany, Japan, South Africa and the United
Kingdom. In December 1997, the Company established a subsidiary, Sagent
Technology Japan KK, to address the Asia Pacific market. Revenues from licenses
and services to customers outside the United States were insignificant prior to
1998 and represented approximately $1.4 million in 1998. Historically, as a
result of the relatively small amount of international sales, fluctuations in
foreign currency exchange rates have not had a material effect on the Company's
business, financial condition and operating results. The Company has agreements
with its United Kingdom distributor and the parent company of its French and
German distributors, under each of which the Company has an option to acquire
such distributors. In the event of a change of control of the Company, the
Company could be required to acquire the German distributor. Any such
acquisition may have the effect of diluting existing stockholders, reducing the
Company's available cash for working capital and other purposes, requiring
substantial management attention, increasing annual amortization expense or
imposing costs on the Company associated with integrating the acquired entity.
On February 28, 1998, the Company acquired Talus, Inc. ("Talus"), a
privately held consulting company that has significant experience in the design
and implementation of Enterprise Intelligence applications. At the time of the
acquisition, Talus had a staff of 33 consultants. The total purchase price was
$3.5 million, and the acquisition was recorded under the purchase method of
accounting. In connection with the acquisition, the Company expensed $2.4
million of in-process technology in the quarter ended March 31, 1998. The
determination of the acquired in-process technology allocation was based upon
recently issued guidance by the Securities and Exchange Commission "(SEC)" and
considered such factors as degree of completion, technological uncertainties,
costs incurred and projected costs to complete. In addition, the Company
recorded other intangible assets of $587,000 which are being amortized on a
straight-line basis over the six months to three years following the
acquisition. See Note 7 of Notes to Consolidated Financial Statements.
22
RESULTS OF OPERATIONS
The following table sets forth certain statement of operations data as a
percentage of total revenues for the periods indicated:
YEARS ENDED DECEMBER 31,
--------------------------
1996 1997 1998
-------- ----- -----
Revenues, net:
Licenses.......................................... 86.0% 80.9% 61.4%
Services.......................................... 14.0 19.1 38.6
-------- ----- -----
Total revenues, net............................ 100.0 100.0 100.0
-------- ----- -----
Cost of revenues:
Licenses.......................................... 43.0 2.7 0.8
Services.......................................... 45.5 9.6 28.9
-------- ----- -----
Total cost of revenues......................... 88.5 12.3 29.7
-------- ----- -----
Gross profit........................................ 11.5 87.7 70.3
Operating expenses:
Sales and marketing............................... 977.4 83.8 70.6
Research and development.......................... 1,227.6 70.2 35.3
General and administrative........................ 398.2 31.3 30.4
Acquired in-process technology.................... -- -- 14.2
-------- ----- -----
Total operating expenses....................... 2,603.2 185.3 150.6
-------- ----- -----
Loss from operations................................ (2,591.8) (97.6) (80.3)
Other income (expense), net......................... 68.8 0.1 (0.1)
-------- ----- -----
Net loss............................................ (2,522.9)% (97.5)% (80.4)%
======== ===== =====
|
FISCAL YEARS ENDED DECEMBER 31, 1996, 1997 AND 1998
REVENUES
Total revenues. The Company's revenues were $279,000, $7.1 million and
$17.0 million in 1996, 1997 and 1998, respectively, representing increases of
$6.8 million from 1996 to 1997 and $10.0 million, or 141%, from 1997 to 1998.
The increase from 1997 to 1998 was primarily due to a greater volume of products
sold and a significant increase in services revenues as a result of the
acquisition of Talus. Two of the Company's customers each represented 10.0% of
the Company's revenues in 1997. The Company had no customer that accounted for
more than 10.0% of its revenues in 1996 or 1998.
License revenues. The Company's license revenues were $240,000, $5.7
million and $10.5 million in 1996, 1997 and 1998 respectively, representing
increases of $5.5 million from 1996 to 1997 and $4.7 million, or 83.0%, from
1997 to 1998. The increase from 1996 to 1997 was due to the recognition of a
full year of revenues from license sales in 1997, compared to the recognition of
revenues from license sales during the fourth quarter in 1996. The increase from
1997 to 1998 was primarily due to an increase in license sales of the Sagent DMS
product suite resulting from additions to the Company's direct sales and
marketing staff. The Company anticipates that license revenues, which have
represented a significant portion of the Company's total revenues in 1998, will
continue to represent the substantial majority of its revenues for the
foreseeable future.
Service revenues. Service revenues were $39,000, $1.4 million and $6.6
million in 1996, 1997 and 1998, respectively, representing increases of $1.3
million from 1996 to 1997
23
and $5.2 million, or 388%, from 1997 to 1998. The increase from 1996 to 1997 was
primarily due to the addition of training and consulting services. Such services
generated $778,000 in revenue during 1997. In 1996, no training and consulting
work was performed, and service revenues represented only maintenance and
support fees. The increase in service revenues from 1997 to 1998 was primarily
due to additional growth in training and consulting services as a result of the
Talus acquisition. Such services generated $4.2 million, or a 522% increase, in
service revenues in 1998.
COST OF REVENUES
Cost of licenses. Cost of revenues from license sales consists primarily of
royalties, product packaging, shipping, media and documentation. Cost of
revenues from license sales was $120,000, $194,000 and $143,000 in 1996, 1997
and 1998, respectively, representing 50.0%, 3.0% and 1.0% of license revenue in
the respective periods. The dollar increase from 1996 to 1997 was primarily due
to increased costs for documentation and royalties related to the increased
volume of licenses sold. The dollar decrease from 1997 to 1998 was due to
reductions achieved in per unit packaging costs. The percentage decreases
resulted from spreading these relatively fixed costs over an increased volume of
product licenses sold.
Cost of services. Cost of services consists primarily of personnel costs
and third-party consulting fees associated with providing software maintenance
and support and training and consulting services. Cost of services revenues was
$127,000, $678,000 and $4.9 million, in 1996, 1997 and 1998, respectively,
representing 322%, 50.0% and 75.0% of services revenue in the respective
periods. The dollar increases were primarily due to the increase in the number
of technical support staff, the increase in the number of consultants in 1997
required to support introduction of training and consulting services and the
increase in the number of consultants in 1998 providing consulting services as a
result of the Talus acquisition. The percentage decrease from 1996 to 1997 was
primarily due to the introduction of higher margin consulting services. The
percentage increase from 1997 to 1998 was due to the increased infrastructure
costs associated with supporting the Talus consultant staff.
OPERATING EXPENSES
Sales and marketing. Sales and marketing expenses consist primarily of
salaries, benefits, commissions, bonuses and travel expenses for sales and
marketing personnel as well as marketing programs and other promotion costs.
Sales and marketing expenses were $2.7 million, $5.9 million and $12.0 million
in 1996, 1997 and 1998, respectively, representing 976%, 84.0% and 71.0% of
total revenue in the respective periods. The dollar increases resulted primarily
from a $1.7 million increase in 1997 and a $3.0 million increase in 1998 in
employee-related expenses, principally due to the hiring of additional sales
personnel and to higher commissions paid as a result of Sagent's revenue growth.
In addition, during 1998 expenses related to marketing programs increased $1.7
million as a result of the Company conducting its first user conference,
expanding its advertising campaigns and beginning its Enterprise Intelligence
seminar series. The percentage decreases were attributable to the Company's
increased revenues. The Company believes that as it continues to expand its
direct sales and presales support organization, its third-party partnering
relationships and its indirect channel sales organization on a worldwide basis,
sales and marketing expenses will continue to increase in absolute dollars,
although such expenses may vary as a percentage of total revenues.
24
Research and development. Research and development expenses consist
primarily of personnel and related costs associated with the development of new
products, the enhancement and localization of existing products, quality
assurance and testing. Research and development expenses were $3.4 million, $5.0
million and $6.0 million in 1996, 1997 and 1998, respectively, representing
1,226%, 70.0% and 34.0% of total revenues in the respective periods. The dollar
increases were primarily due to a $1.2 million increase in compensation costs in
1997 resulting from the hiring of additional developers and an $800,000 increase
in contractor costs in 1998 for the localization of the Company's software for
use in Japan. The percentage decreases were attributable to the Company's
increased revenues. The Company anticipates that research and development
expenditures will continue to increase in absolute dollars, although such
expenses may vary as a percentage of total revenues.
General and administrative. General and administrative expenses consist
primarily of personnel costs for the Company's finance, human resources,
information systems and other management departments. General and administrative
expenses were $1.1 million, $2.2 million and $5.2 million for 1996, 1997 and
1998, respectively, representing 398%, 31.0% and 30.0% of total revenues in the
respective periods. The dollar increases were primarily due to employee-related
expenses associated with the addition of staff in senior managerial positions
and professional fees necessary to manage and support the Company's growth. The
percentage decreases were attributable to the Company's increased revenues. In
addition, during 1998, the Company recorded significant legal fees associated
with two litigation matters. One such matter remains pending. See "Risk
Factors--Risks Associated with Intellectual Property" and "Business--Legal
Proceedings."
Income Tax. As of December 31, 1998, the Company had available net
operating loss carryforwards for federal and state income tax purposes of
approximately $20.8 and $17.8 million, respectively, which expire from 2003 to
2018. See Note 14 of Notes to the Financial Statements included elsewhere
herein. The Tax Reform Act of 1986 imposes limitations on the use of net
operating loss carryforwards if certain stock ownership changes have occurred or
could occur in the future.
25
QUARTERLY RESULTS OF OPERATIONS
The following tables set forth certain unaudited consolidated statements of
operations data for the eight quarters ended December 31, 1998, as well as the
percentage of Sagent's revenues represented by each item. These data have been
derived from unaudited interim consolidated financial statements prepared on the
same basis as the audited Consolidated Financial Statements contained herein
and, in the opinion of management, include all adjustments, consisting only of
normal recurring adjustments, considered necessary for a full presentation of
such information when read in conjunction with the Consolidated Financial
Statements and Notes thereto appearing elsewhere in this prospectus.
QUARTERS ENDED
-----------------------------------------------------------------------------------------
MARCH 31, JUNE 30, SEPT. 30, DEC. 31, MARCH 31, JUNE 30, SEPT. 30, DEC. 31,
1997 1997 1997 1997 1998 1998 1998 1998
--------- -------- --------- -------- --------- -------- --------- --------
(IN THOUSANDS)
Revenues, net:
Licenses.......................... $ 777 $ 1,326 $ 1,784 $ 1,842 $ 1,798 $ 2,112 $ 2,932 $ 3,618
Services.......................... 224 159 384 583 1,199 1,568 1,689 2,128
------- ------- ------- ------- ------- ------- ------- -------
Total revenues, net............. 1,001 1,485 2,168 2,425 2,997 3,679 4,621 5,746
Cost of revenues:
Licenses.......................... 30 22 26 116 36 24 61 21
Services.......................... 133 89 105 352 729 1,386 1,467 1,340
------- ------- ------- ------- ------- ------- ------- -------
Total cost of revenues.......... 163 111 130 468 765 1,411 1,529 1,362
------- ------- ------- ------- ------- ------- ------- -------
Gross profit........................ 837 1,374 2,037 1,957 2,231 2,269 3,092 4,384
Operating expenses:
Sales and marketing............... 1,343 1,184 1,494 1,908 2,203 3,007 3,188 3,639
Research and development.......... 1,192 1,122 1,217 1,439 1,516 1,401 1,649 1,447
General and administrative........ 403 540 427 845 1,199 1,321 1,425 1,271
Acquired in-process technology.... -- -- -- -- 2,425 -- -- --
------- ------- ------- ------- ------- ------- ------- -------
Total operating expenses........ 2,939 2,846 3,137 4,191 7,343 5,729 6,261 6,327
------- ------- ------- ------- ------- ------- ------- -------
Loss from operations................ (2,101) (1,472) (1,100) (2,235) (5,111) (3,461) (3,169) (1,943)
Other income(expense), net.......... 4 (24) 10 21 22 32 (26) (45)
------- ------- ------- ------- ------- ------- ------- -------
Net loss............................ $(2,097) $(1,496) $(1,090) $(2,214) $(5,089) $(3,429) $(3,195) $(1,988)
======= ======= ======= ======= ======= ======= ======= =======
|
AS A PERCENTAGE OF TOTAL REVENUES
-----------------------------------------------------------------------------------------
Revenues, net:
Licenses.......................... 77.6% 89.3% 82.3% 76.0% 60.0% 57.4% 63.4% 63.0%
Services.......................... 22.4 10.7 17.7 24.0 40.0 42.6 36.6 37.0
------- ------- ------- ------- ------- ------- ------- -------
Total revenues, net............. 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
------- ------- ------- ------- ------- ------- ------- -------
Cost of revenues:
Licenses.......................... 3.0 1.5 1.2 4.8 1.2 0.7 1.3 0.4
Services.......................... 13.3 6.0 4.8 14.5 24.3 37.7 31.8 23.3
------- ------- ------- ------- ------- ------- ------- -------
Total cost of revenues.......... 16.3 7.5 6.0 19.3 25.5 38.3 33.1 23.7
------- ------- ------- ------- ------- ------- ------- -------
Gross profit........................ 83.7 92.5 94.0 80.7 74.5 61.7 66.9 76.3
Operating expenses:
Sales and marketing............... 134.2 79.7 68.9 78.7 73.5 81.7 69.0 63.3
Research and development.......... 119.2 75.5 56.1 59.3 50.6 38.1 35.7 25.2
General and administrative........ 40.3 36.4 19.7 34.8 40.0 35.9 30.8 21.6
Acquired in-process technology.... -- -- -- -- 80.9 -- -- --
------- ------- ------- ------- ------- ------- ------- -------
Total operating expenses........ 293.7 191.7 144.7 172.9 245.0 155.7 135.5 110.1
------- ------- ------- ------- ------- ------- ------- -------
Loss from operations................ (210.0) (99.1) (50.7) (92.2) (170.6) (94.1) (68.6) (33.8)
Other income(expense), net.......... 0.4 (1.6) 0.4 0.9 0.7 0.9 (0.6) (0.8)
------- ------- ------- ------- ------- ------- ------- -------
Net loss............................ (209.6)% (100.8)% (50.3)% (91.3)% (169.8)% (93.2)% (69.1)% (34.6)%
======= ======= ======= ======= ======= ======= ======= =======
|
26
The Company's operating expenses for the three months ended March 31, 1998
exceeded levels that the Company has historically experienced due primarily to
acquired in-process technology expense recorded in connection with the
acquisition of Talus. In addition, operating expenses for the three months ended
June 30, 1998 exceeded levels that the Company has historically experienced due
to the addition of several sales personnel and increased advertising expenses.
Sagent's quarterly operating results may vary significantly from quarter to
quarter. The timing of the Company's revenues are unpredictable due to several
factors, including the effect of delays in customer orders, the lack of software
order backlog, the potential effect of seasonality as international operations
expand and the degree to which customers engage the Company's professional
services. Additionally the Company cannot predict expenses with significant
certainty given planned expansion of its business. Due to uncertainty
surrounding revenues and expenses, the Company believes that quarter to quarter
comparison of its operating results are not a good indication of future
performance.
LIQUIDITY AND CAPITAL RESOURCES
At December 31, 1998, the Company had cash and cash equivalents totaling
$3.1 million, a decrease of $720,000 from December 31, 1997. Since inception,
the Company has funded its operations primarily through private sales of equity
securities, the use of equipment leases and a bank line of credit. As of
December 31, 1998, the Company had raised approximately $28.6 million, net of
offering costs, from the issuance of preferred stock and the exercise of stock
options, had financed equipment purchases totaling approximately $3.3 million,
and had borrowed $1.7 million under its line of credit with a bank.
Approximately $300,000 of available borrowings remain under the line of credit.
Net cash used in operating activities was $6.3 million, $5.4 million and
$11.0 million in 1996, 1997 and 1998, respectively. For such periods, net cash
used in operating activities was primarily a result of funding ongoing
operations.
The Company's investing activities have primarily consisted of annual
purchases of property and equipment. Capital expenditures, including those under
capital leases, totaled $1.1 million, $1.1 million and $1.2 million in 1996,
1997 and 1998, respectively. Capital leases have been used to finance the
acquisition of property and equipment, primarily computer hardware and software,
and leasehold improvements and furniture associated with the Company's recent
move into a larger facility to accommodate its increasing employee base. In
1998, investing activities included $2.7 million associated with the acquisition
of Talus. The Company anticipates that it will experience an increase in its
capital expenditures and lease commitments consistent with its anticipated
growth in operations, infrastructure and personnel.
The Company's financing activities have primarily included sales of
preferred stock and use of its equipment lease lines. Proceeds from the issuance
of preferred stock totaled $6.5 million, $5.2 million and $10.4 million in 1996,
1997 and 1998 respectively. The proceeds from equipment financing, net of
principal payments, totaled $600,000, $294,000 and $3.4 million in 1996, 1997
and 1998 respectively.
The Company has a line of credit with a bank for $2.0 million, which bears
interest at the lending bank's prime rate. Borrowings are limited to the lesser
of 80.0% of eligible accounts receivable or $2.0 million and are secured by
substantially all of the Company's non-leased assets. The line of credit
contains certain financial restrictions and covenants. At December 31, 1998,
total borrowings available under this line were approximately $300,000. This
credit facility expires in December 2001, and the Company expects to
27
extend or replace such credit facility, although there can be no assurance that
it will be able to do so on terms acceptable to the Company or at all. The
Company was not in compliance with certain financial covenants under its line of
credit as of December 31, 1998, and received a waiver from its lender for
non-compliance prior to December 31, 1998. The Company is currently in
compliance with its financial covenants under such line of credit.
Sagent believes that the net proceeds from the offering, together with
existing sources of liquidity, will be sufficient to meet its working capital
and anticipated capital expenditure requirements for at least the next 12
months. Thereafter, Sagent may require additional funds to support its working
capital requirements or for other purposes, and may seek, even before such time,
to raise additional funds through public or private equity financing or from
other sources. There can be no assurance that additional financing will be
available at all, or that if available, such financing will be obtainable on
terms acceptable to Sagent or that are not dilutive to its stockholders.
RECENT ACCOUNTING PRONOUNCEMENTS
The American Institute of Certified Public Accountants issued Statement of
Position ("SOP") No. 98-1, "Software for Internal Use," which provides guidance
on accounting for the cost of computer software developed or obtained for
internal use. SOP No. 98-1 is effective for financial statements for fiscal
years beginning after December 15, 1998. The Company does not expect that the
adoption of SOP No. 98-1 will have a material effect on its business, financial
condition and operating results.
YEAR 2000 ISSUES
Many currently installed computer systems and software products store dates
using only the last two digits of the calendar year. As a result, such systems
may not be able to distinguish whether "00" means 1900 or 2000, which may cause
system failures or erroneous results. The Company has designed its products to
be capable of handling four digit dates, and therefore the Company believes that
the direct impact of the Year 2000 problem on the Company's products will not be
significant. In addition the Company will continue Year 2000 testing of its
products throughout the calendar year 1999. The Company does not expect
expenditures with respect to ensuring Year 2000 compliance of its internal
systems and software to exceed $50,000. The Company's products operate in
complex network environments and directly or indirectly interact with a number
of other hardware and software systems. Despite preliminary testing the Company
cannot predict all the possible Year 2000 issues arising from the interaction
with older hardware and software systems. If the source of any of these hardware
or software systems do not appropriately interpret the upcoming calendar year
2000, some level of modification or possible replacements of such systems will
be necessary. Known or unknown errors associated with interaction between the
Company's products and other hardware or software systems could result in a
delay or loss of revenue, interruption of service, cancellation of customer
contracts, diversion of development resources, damage to the Company's
reputation, increased service and warranty costs and litigation, any of which
could have a material adverse effect on the business, financial condition and
results of operations of the Company.
28
The Company is currently unable to predict the extent to which the Year
2000 problem will affect its customers, strategic partners or suppliers, or the
extent to which it would be vulnerable to any failure by customers, strategic
partners or suppliers to remediate any Year 2000 issue on a timely basis. The
failure of major customers, partners or suppliers to convert its systems on a
timely basis or to implement a conversion that is compatible with the Company's
systems could have a material adverse effect on the Company's business,
financial condition and operating results.
29
BUSINESS
The following description of the Company's business should be read in
conjunction with the information included elsewhere in this Prospectus. This
description contains certain forward-looking statements that are based largely
on the Company's current expectations and are subject to a number of risks and
uncertainties. Actual results and events could differ significantly from those
discussed in the forward-looking statements as a result of certain of the
factors set forth below and elsewhere in this prospectus.
OVERVIEW
Sagent develops, markets and supports Enterprise Intelligence software
solutions designed to address organizations' rapidly growing information access,
analysis and delivery needs. The Sagent DMS product suite provides end-to-end,
fully integrated data movement, access, analysis and presentation capabilities
on all major database platforms, and is specifically designed to deliver
information over the Internet. The Sagent DMS product suite utilizes a
multi-dimensional data structure known as a Star Schema and advanced dataflow
technology to construct and provide access to data marts capable of handling
some of the most complex and demanding Enterprise Intelligence requirements.
Sagent's Web technology enables the distribution of information throughout the
organization and gives end users the ability to access and analyze data through
common Web browsers. Sagent also offers Sagent Professional Services, which
include system and application design, implementation and education services, to
facilitate the successful implementation of the Sagent DMS product suite.
Sagent's products and services have been adopted in a variety of industries,
including financial services, telecommunications, technology, health care,
retail and others. The Company currently has more than 200 customers worldwide.
Sagent markets its software and services through its direct sales force and
indirect channels, which include enterprise application vendors, resellers and
international distributors.
INDUSTRY BACKGROUND
Today, information about an organization's customers, products and
operations is one of its most important strategic assets. An organization's
ability to maximize revenues and efficiently manage operations increasingly
depends upon its ability to rapidly collect, organize, analyze and distribute
information. In particular, as organizations have begun to pursue more complex
operational strategies, their need for timely information has increased. For
example, businesses engaged in total customer management must synthesize
information regarding past purchases, service history, payment status and sales
contacts. Similarly, businesses engaged in supply chain management must manage
the information exchanged among multiple plants, sales locations, suppliers and
distribution facilities. Furthermore, as businesses continue to streamline their
organizational structures to improve time to market and responsiveness to
rapidly changing market conditions, decision making authority is expected to
become more distributed, thus heightening the need for broader dissemination of
information throughout the enterprise. Most recently, the rapid adoption of the
Internet and the World Wide Web has given organizations the ability to share
information internally and externally on a cost-effective basis and has
dramatically increased the number of people who can receive and access
information.
To meet these challenges, many organizations have purchased and implemented
data warehousing systems and decision support software. These systems were
designed to assist organizations in answering fundamental business questions
such as "Who are our best
30
customers?" or "What are our most profitable products?" Early data warehousing
systems aggregated an organization's enterprise data into a single location and
reorganized it into contextual, business-related terms. The single location has
enabled the use of query tools or other decision support software to explore and
analyze the data. The need for data warehousing and decision support software
has also been driven by the proliferation of online transaction processing
("OLTP") systems. These systems include packaged applications or custom and
semi-custom systems, which automate business processes such as manufacturing
planning, customer support, billing, accounting, human resources and financial
services transactions. While these multiple OLTP systems have provided greater
business efficiency, they have also created massive amounts of new data,
typically maintained in the form of proprietary, complex and incompatible data
models.
The demand for more useful information and the proliferation of new data
sources and data types has led to an active market for data warehousing and
decision support software. International Data Corporation ("IDC") estimates that
the size of the data warehouse market will grow from over $2.8 billion in 1997
to over $8.0 billion in 2001. Forrester Research projects that the decision
support segment of the data warehouse market will grow from $1.1 billion in 1997
to $3.6 billion by 2001.
As corporate data warehouses have grown in size and complexity, the Company
believes that several challenges have prevented organizations from realizing the
promise of data warehousing systems and decision support solutions. The first
challenge has been integration. Traditional solutions have utilized discrete
data warehousing and decision support software purchased from many different
vendors, including separate data extraction tools, data cleansing tools, data
sorting packages, relational database management systems, report writers,
analysis tools and distribution packages. Integrating these point products is
difficult and often limits the capability of the overall solution. The second
challenge has been user scalability. Traditional solutions were designed to
handle a small number of users and were not designed to meet the needs of a
large number of simultaneous users with diverse, individual requirements. The
third challenge has been performance. Discrete data warehousing and decision
support software applications often have difficulty aggregating complex
enterprise data into a single business view of information, which is critical
for processing information requests efficiently. The fourth challenge has been
cost and complexity. Many large data warehousing projects cost several million
dollars and take a year or more to implement.
Most importantly, the emergence of the Internet has challenged the
continued viability of traditional data warehousing and decision support
software as the best approach to enterprise-wide information access, analysis
and delivery. The Internet provides organizations with a low-cost infrastructure
to connect their customers, suppliers, partners and employees directly with the
information they need. Organizations are using the Internet to streamline their
marketing, sales and support processes and offer enhanced customer service
capabilities. Examples of these initiatives include enabling customers to use
the Internet to research product features, order products, check order status
and obtain on-line service and support. Organizations are also using the
Internet to track key business information regarding sales, customers,
suppliers, distributors, assets and resources, and to make that information
widely available to employees when and where they need it. As the number of
Internet users continues to grow, the Company believes that the demand for
Web-based information access, analysis and delivery will increase significantly.
IDC forecasts that total commerce on the Internet will grow from an estimated
$12.4 billion in 1997 to $239.5 billion in 2001, with the business-to-business
component growing from an estimated $7.3 billion to $179.4 billon in the same
period.
31
NEED FOR A NEW SOLUTION
The Company believes that new demands for high performance information
access, analysis and delivery, particularly through the Internet, have stretched
the capabilities of traditional data warehousing and decision support systems.
Many organizations now require a new generation of Enterprise Intelligence
solutions that can leverage Internet technologies and accommodate the rapidly
growing number of internal and external users who need to access
business-critical information. To be most effective, the Company believes that
these solutions should satisfy four critical requirements:
- First, solutions must be capable of accessing and assembling increasing
amounts of data from multiple, disparate and complex sources into a
single business view of information for the end user.
- Second, solutions must be capable of scaling to hundreds and thousands of
concurrent users and delivering information through the bandwidth of many
Internet connections, as well as through new access devices such as
hand-held computers and alphanumeric pagers.
- Third, solutions must deliver information fast enough to meet the demands
of the new business environment, particularly the performance
requirements of e-Business and Internet applications.
- Fourth, solutions should be delivered by a single vendor that can provide
a complete, integrated product and the professional services required to
implement a working, timely solution.
THE SAGENT SOLUTION
Sagent offers a new generation of Enterprise Intelligence software
solutions designed to address organizations' rapidly growing information access,
analysis and delivery needs. The Sagent DMS product suite provides end-to-end,
fully integrated data movement, access, analysis and presentation capabilities
on all major database platforms and is specifically designed to deliver
information over the Internet. The Sagent DMS product suite utilizes a
multi-dimensional data structure known as a Star Schema and advanced dataflow
technology to construct and provide access to data marts capable of handling
some of the most complex and demanding Enterprise Intelligence requirements.
Sagent's data marts, which are data warehouses that contain a subset of specific
corporate data, provide a more detailed, single business view of information
that is focused on the needs of a specific group of users. Sagent's Web
technology enables the distribution of information throughout the organization
and gives end users the ability to access and analyze data through common Web
browsers. Sagent also offers Sagent Professional Services, which include system
and application design, implementation and education services, to facilitate the
successful implementation of the Sagent DMS product suite.
Sagent believes its solution provides the following key benefits:
High Performance Internet Access. The Sagent DMS product suite is designed
to provide customers with the ability to access, analyze and deliver critical
information easily and rapidly over the Web. The Sagent architecture utilizes
Internet based processing capabilities to minimize the bandwidth required for
the delivery of information over the Web and other new access technologies. This
technology significantly reduces the waiting time for Web-page processing and
information delivery, thus increasing user productivity.
32
Single Business View of Information. The Sagent DMS product suite utilizes
a 32-bit application server, a proprietary dataflow model and Star Schema data
structure to create a single business view of information from complex,
disparate data sources. The Company believes this consolidated view of
information allows Sagent users to access and analyze complex data more easily
and rapidly than with traditional solutions. This approach also allows Sagent's
customers to manage the rapidly growing levels of data within their
organizations.
Highly Scalable. Sagent's use of advanced bandwidth management technology,
combined with its core Star Schema data structure, enables the Sagent DMS
product suite to provide Web-based information access and data analysis
capabilities to thousands of users without degrading application performance and
availability.
Low Total Cost of Ownership. The Sagent DMS product suite is designed to
deliver low total cost of ownership by leveraging industry standards such as the
Windows NT operating system and other Microsoft technology, by providing an
integrated product suite to lower implementation time and cost, and by providing
extensive administrative functionality to reduce ongoing systems management
burdens.
STRATEGY
Sagent's objective is to become a leading provider of Enterprise
Intelligence software solutions to address organizations' rapidly growing
information access, analysis and delivery needs.
The following are key elements of the Company's strategy:
Focus on Internet Market Opportunity. The Company believes that the growing
global use of the Internet is driving widespread implementation of new
e-Business applications. These applications depend on the efficient access,
analysis and presentation of enterprise data. By providing a product that
delivers large amounts of highly complex data through the Web to large numbers
of simultaneous users, the Company believes that its products can be a
foundation and enabler of Web-based Enterprise Intelligence and e-Business
applications.
Extend Product Functionality and Technology Leadership. The Company
believes it provides the first fully integrated, end-to-end Enterprise
Intelligence software solution capable of meeting the performance demanded by
the emerging e-Business environment. The Company is currently developing the
next version of the Sagent DMS product suite, which is being designed to
significantly enhance user scalability, and which is currently scheduled for
release in the first half of 1999. The Company plans to add capabilities that
broaden and complement the Sagent DMS product suite, such as data analysis
(including data mining, forecasting and modeling), data visualization, data
sorting, Web querying, extraction of data from SAP applications and information
broadcasting. In addition, the Company may introduce new international versions
of its products and may port its products to additional UNIX platforms as
opportunities arise. Although the Company expects that certain of its new
products will be developed internally, the Company may, based on timing and cost
considerations, acquire technology or products from third parties.
Offer Pre-Built Enterprise Intelligence Applications. The Company believes
there is a large market for pre-built applications that utilize the underlying
analytical capabilities of the Sagent DMS product suite and offer "out of the
box" functionality in targeted vertical markets. To date, the Company has
designed, developed and marketed such applications in conjunction with strategic
partners, including Siebel, Advent Software, Inc. ("Advent")
33
and Automatic Data Processing, Inc. ("ADP"). In the future, Sagent plans to
leverage the vertical and functional knowledge gained through these
relationships and through implementations by its Professional Services Group to
develop other pre-built Enterprise Intelligence applications.
Broaden Distribution and Strategic Relationships. The Company believes that
it can continue to expand its market penetration and build its brand recognition
by aggressively expanding its direct sales force; pursuing strategic
relationships with selected enterprise application vendors, consulting firms,
system integrators and development partners; and expanding its network of
resellers and distributors. To date, the Company has entered into relationships
with companies such as Microsoft Corporation ("Microsoft"), Oracle Corporation
("Oracle"), Siebel, ADP, Advent and USinternetworking, Inc.
("USinternetworking"). The Company also believes that a significant opportunity
exists to sell its products internationally and intends to leverage its existing
distributor relationships in Europe and Japan and expand its direct and indirect
international sales efforts to exploit this opportunity.
Provide High Quality Services to Customers. The Company provides
comprehensive implementation, support and training services to help customers
adopt Sagent products and build customer satisfaction, strong references and
long-term relationships. The Company plans to continue to expand its
professional services capabilities and infrastructure. In addition, Sagent
intends to expand the education and training services it offers to its strategic
partners and resellers to help these companies market Sagent products more
effectively.
Exploit Rapid Growth of Microsoft Windows NT. The Company will continue to
focus its development efforts on the Microsoft Windows NT platform. Sagent
believes Windows NT is rapidly gaining share in the enterprise computing market
due to its ease of maintenance and cost effectiveness. IDC projects that the
installed base of Windows NT-based servers will increase from 1.6 million in
1997 to 5.9 million in 2002. The Company believes that the Sagent DMS product
suite has a competitive advantage in leveraging the growth of the Windows NT
platform because it was designed to optimize Microsoft technology.
PRODUCTS
The Sagent DMS product suite is comprised of software application servers
that handle the core components of an end-to-end solution, as well as end user
analysis applications.
34
[Graphic depiction of the components of the Company's product architecture]
As illustrated above, the Sagent DMS product suite consists of three core
functional areas: Data Load and Management, Data Access and Analysis, and
Administration and Design.
DATA LOAD AND MANAGEMENT
Sagent Data Load Server. The Sagent Data Load Server extracts data from
multiple client/server and mainframe databases, transforms that data into a Star
Schema data structure, and then loads that data into a Sagent data mart. The
server relies upon a 32-bit multithreaded architecture to achieve its high level
of performance.
DATA ACCESS AND ANALYSIS
Sagent Data Access Server. The Sagent Data Access Server delivers the data
loaded into a Sagent data mart to end users. The server is designed to allow
large numbers of users to access and analyze data stored in Star Schema
structures. The server relies upon a 32-bit multithreaded architecture to
achieve its high level of performance.
Sagent WebLink Server. The Sagent WebLink Server is a high performance,
scalable application server that delivers information from the Sagent Data
Access Server, allowing end users to query, analyze and report business
information from a Web browser. The server also provides management capabilities
that maintain the security and availability of Internet connections.
Sagent Statistical Calculator. The Sagent Statistical Calculator adds
advanced statistical analysis capabilities to the Sagent Data Access Server. The
calculator allows organizations to automate statistical analyses of large,
complex data sets, thereby improving the single business view of information
distributed to end users.
Sagent Information Studio. Sagent Information Studio enables users to
access and analyze an organization's information in client/server environments.
Information Studio, as well as WebLink Server, can be integrated with Microsoft
Excel to aid in exporting result sets to spreadsheets for further analysis.
35
The following reporting and analysis products can be integrated with the
Sagent DMS product suite:
Sagent Reports. Sagent Reports allows end users to create, publish and view
graphically rich presentations of corporate information.
Sagent Analysis. Sagent Analysis provides a wide range of analytical
capabilities for business data, such as rankings, deciles, periodic and
exception reporting. The product's drill down analysis capabilities allow users
to view information in either cross-tabular or chart format.
StatView for Sagent. StatView for Sagent provides an end user with the
ability to create, publish and view complex statistical analyses of corporate
data in client/server environments.
ADMINISTRATION AND DESIGN
Sagent Design Studio. Sagent Design Studio provides a visual environment
for describing data and designing the flow of data for both loading and
accessing a data mart. Sagent Design Studio minimizes the requirement that users
have in-depth knowledge of databases, networks and operating systems and allows
them to concentrate on the business purpose of accessing, analyzing and
delivering information.
Sagent Admin. Sagent Admin enables administrators to manage and control one
or more Sagent DMS servers from a single location. In addition, Sagent Admin
manages user security and access privileges.
Sagent Automation. Sagent Automation automates common tasks within the
Sagent DMS product suite, such as data loading, error recovery and quality
assurance. Tasks can be initiated by events such as a pre-determined time of day
or date, reaching disk storage capacity or the availability of new data.
PROFESSIONAL SERVICES AND CUSTOMER SUPPORT
The Sagent Professional Services Group offers an extensive set of
consulting and education services to the Company's customers. The Sagent
Professional Services Group has significant experience in the design and
implementation of Enterprise Intelligence applications using a Star Schema data
architecture. Sagent's customers are able to select an appropriate level of
support for their implementations, including project planning, design and
implementation assistance.
In addition to consulting services, the Sagent Professional Services Group
offers design and product training classes to facilitate customer success in
initial implementations and provide a foundation for expanding the use of Sagent
products in customer organizations. The Sagent Professional Services Group also
offers to third party consultants product certification training, which the
Company believes helps develop market awareness of its product offerings.
CUSTOMERS
The following is a representative list of the Company's customers that have
purchased more than $75,000 in product licenses or services from the Company
since January 1, 1997.
36
ARINC DiaLogos Mashantucket Pequot Tribal
Automated Data Processing Eddie Bauer Nation
AT&T Ernst & Young MCI WorldCom
Barnesandnoble.com Express Scripts/ValueRx Miller Freeman
Bell Communications Research Farm Credit Services NationsBanc
BellSouth Cellular General American NETCOM On-Line
BellSouth Entertainment Transportation Communication Services
CEISS/BC Ministry of Education Hoechst Marion Roussel Nordstrom
CellStar GPU Energy Nycomed
Ceridian J.P. Morgan & Co. PairGain Technologies
City of Santa Clara Jiffy Lube International Pharmaceutical Care Network
Cohn & Wells John Hopkins University Prudential Insurance
Deutsche Financial Services Kaufman & Broad Home Rohm & Haas
Kawasaki Steel Systems R&D The Application Group
|
In 1997, the Company received in excess of 10% of its total revenues from
each of Oracle Corporation and Automated Data Processing.
CASE STUDIES
The following case studies illustrate how certain of the Company's
customers have utilized the Sagent DMS product suite:
PHARMACEUTICAL CARE NETWORK
Pharmaceutical Care Network ("PCN") is a pharmacy benefits management and
healthcare information services company.
Business Challenge. PCN was one of the first pharmacy benefit management
companies to institute on-line, real-time claim processing for a nationwide
network of participating pharmacies. When a plan participant presents a
prescription at a PCN participating pharmacy, the applicable plan guidelines are
referenced on-line instantly, ensuring that a customer pays for appropriate and
eligible prescriptions at the contracted price. PCN wanted to leverage the
information it was gathering through its nationwide network of pharmacies to
improve the level of service across its pharmaceutical care value chain,
including plan members, health care providers and plan sponsors and affiliated
pharmacies. To provide this service, PCN wanted to install an Enterprise
Intelligence solution that would allow customers to access and analyze the vast
amounts patient care information through a Web browser.
Solution. PCN established MedIntelligence, a family of information-based
products for its pharmaceutical care value chain, to screen and review
prescription data, initiate notifications that identify drug therapy problems
and recommend action to improve the quality and cost of patient care. PCN
selected the Sagent DMS product suite as the core of MedIntelligence to
integrate large amounts of disparate information within the PCN network and to
rapidly deliver MedIntelligence products over the Web. The MedIntelligence
products and the Sagent DMS product suite furnishes healthcare providers with
access to a more complete view of patient drug regimens, which reduce the risk
of harmful drug interactions, and provide health care payers and plan
administrators with the ability to monitor pharmacy related plan costs and usage
trends.
CELLSTAR CORPORATION
CellStar Corporation ("CellStar") is an integrated wholesaler and retailer
of wireless handsets and other wireless communication products, with operations
in the U.S., Asia/Pacific, Latin America and the U.K.
37
Business Challenge. CellStar required a solution to provide its global
sales force and key customers access to sales data for analysis and
presentation. In particular Cellstar wanted to provide it's employees with the
ability to monitor sell through, perform customer rankings and identify high
margin products. In addition CellStar wished to provide it's key customers and
vendors with worldwide data on the most popular products by volume to maximize
their revenue opportunity.
Solution. CellStar uses the Sagent DMS to manage and access CellStar data.
The Sagent Analysis desktop module with Sagent's WebLink lets users perform
multidimensional analysis on the data mart to gain sales data information either
from a client/server environment for their internal employees and through a Web
browser for their global sales force, customers and vendors. While the WebLink
facility is used to provide access to data mart information to general users,
Sagent's Information Studio with the analysis module is generally utilized by
internal business analysts. This Enterprise Intelligence solution provides
CellStar's manufacturers and key customers with the ability to analyze sell-
through data so that they can determine which products are selling at acceptable
margins to make better informed channel marketing decisions.
TECHNOLOGY
The Company has invested significant resources in developing leading
technologies and believes that utilizing a Star Schema data architecture and the
Company's advanced dataflow technology to construct and provide access to data
marts gives it a competitive advantage over traditional solutions. The Company
also believes that its technology maximizes the advantages of an Internet based
architecture to provide one of the most scalable solutions currently offered in
the market. The following are the key underlying technologies of the Sagent DMS
product suite:
Dataflow Technology. Sagent's dataflow technology is the foundation for the
Sagent DMS load and access servers. Dataflow technology allows users to rapidly
construct processes that load and access a data mart without writing code. These
services relieve the need for users to have in-depth knowledge of databases,
networks and multithreaded operating systems and allow them to concentrate on
the application they are building. The dataflow engine executes the processes
that are visually designed by the user. The dataflow technology is implemented
using the COM (Component Object Model) standard developed by Microsoft. The
utilization of a modular, language-independent component technology allows
customers and resellers to incorporate new functionality into the product via a
transform software development kit. This same development kit provides the
Company with the ability to add new functionality to the server rapidly and send
it to the customer electronically without requiring a complete upgrade of the
system.
Star Schema Design. The Company has implemented a set of dataflow
components to support the loading and accessing of Star Schemas. Star Schemas
are a database design technique used to provide high performance for ad hoc data
analysis within a relational database by minimizing the number of relations to
process in a query. By combining query generation with the dataflow engine's
processing capability, the Company provides power and speed to users accessing
Star Schema structured data. In addition, the Sagent DMS product suite provides
a set of specialized dataflow components for loading Star Schemas that
significantly lowers the implementation time for the Sagent DMS product suite.
Internet-Based Architecture. The Company has developed an architecture that
utilizes the network of computing tiers that comprise the Web. These tiers
include browsers, Internet servers, data access servers, data load servers and
database servers. The efficient
38
usage of CPU cycles and memory provided by these tiers enables the Sagent DMS
product suite to achieve a high degree of scalability and performance. In
addition, on-demand data delivery minimizes bandwidth usage, improving the rate
at which information is delivered to users.
SALES AND MARKETING
Sales. The Company sells its products and services in North America
primarily through its direct sales and services organization. The Company has
domestic sales offices in California, Colorado, Connecticut, Florida, Georgia,
Massachusetts, New York, Pennsylvania, Texas, Illinois and Virginia. The direct
sales process involves the generation of sales leads through direct mail,
seminars, telemarketing, advertising and the Web. The Company's field sales
force typically conducts demonstrations and presentations of the Company's
products to developers and management at customer sites as part of its direct
sales effort. The time between initial customer contact and an actual sales
order may span six months or more. See "Risk Factors--Our Products Have Lengthy
Sales Cycles."
Within the Company's direct sales group, a separate group targets strategic
partnerships with industry-leading application software providers such as
Siebel, Advent, ADP and Oracle. These vendors embed all or a portion of the
Company's products within their own applications and then sell the integrated
products to their customers. The enterprise application vendor's customer
receives a license to use the Company's products solely in conjunction with the
vendor's application with which Sagent DMS products are integrated. Enterprise
application vendors provide the first level of post-sales support to customers.
The Company also utilizes a limited number of resellers, such as Unisys
Corporation, USinternetworking and Cap Gemini Group, that remarket the Company's
products to their customer base. Resellers are offered discounts on the
Company's products and sell a full use license of the product. The Company's
resellers do not provide post-sales support. The Company's ability to achieve
revenue growth in the future will depend in large part on its success in
expanding its direct sales force and in further establishing and maintaining
relationships with enterprise application vendors and resellers. See "Risk
Factors--We Rely Substantially on Our Channel Partners."
The Company also sells its products internationally through distributors
located in France, Germany, Japan, South Africa and the United Kingdom. These
distributors perform some or all of the following functions: sales and
marketing, systems integration, software development, and ongoing consulting
training and customer support. In exchange for providing such services, the
Company offers its distributors discounts on products. International sales are
subject to certain risks, including, but not limited to, costs of localizing
products for foreign countries, dependence on local vendors, currency
fluctuations and greater difficulty or delay in accounts receivable collection.
See "Risk Factors--Risks Associated with International Operations."
Marketing. The Company has a comprehensive marketing strategy which
includes public relations, user group meetings, programs to work closely with
analysts and other influential third parties, and direct mail campaigns. The
Company also utilizes the Web for advertising campaigns on frequently visited
Web sites including those of its strategic partners. The Company uses its Web
site, www.sagenttech.com, to establish its market presence, generate leads and
extend its program offerings to customers and strategic partners. A key element
of the Company's marketing strategy is to leverage its relationship with Dr.
Ralph Kimball, one of the Company's consultants and strategic partners, by
sponsoring his data mart design courses. The Company has also invested in
building a
39
partner and channel marketing function to recruit, train, support and offer
co-marketing opportunities to technology partners and resellers.
RESEARCH AND PRODUCT DEVELOPMENT
The Company's research and development group is organized by product teams,
which consist of product managers, software engineers, quality assurance
engineers and technical documentation specialists. The teams are encouraged to
maintain consistent architectural standards, engineering practices, quality
goals and documentation standards across a broad product line. The product teams
use a phased development approach that monitors cost, schedule, quality, time,
functionality and customer satisfaction. The Company has established an
executive product steering committee which reviews the progress of individual
product teams at each phase of development. In order to incorporate customer
needs in product releases, the product teams actively solicit requirements from
customers, user groups, professional services, industry analysts and technical
support.
The Company's total expenses for research and development for the year
ended December 31, 1996, 1997 and 1998 were $3.4 million, $5.0 million and $6.0
million respectively. The Company believes that research and development
expenses will continue to increase in the future. To date, the Company's
development efforts have not resulted in any capitalized software development
costs.
The Company has made substantial investments in research and development.
The Company is currently developing the next version of the Sagent DMS product
suite, which is being designed to significantly enhance user scalability, and is
currently scheduled for release in the first half of 1999. The Company plans to
add capabilities that broaden and complement the Sagent DMS product suite, such
as data analysis (including data mining, forecasting and modeling), data
visualization, data sorting, Web querying, extraction of data from SAP
applications and information broadcasting. In addition, the Company may
introduce new international versions of its products and may port its products
to additional UNIX platforms as opportunities arise. Although the Company
expects that certain of its new products will be developed internally, the
Company may, based on timing and cost considerations, acquire technology or
products from third parties.
The Company believes that its future performance will depend in large part
on its ability to maintain and enhance its current product line, develop new
products that achieve market acceptance, maintain technological competitiveness
and meet an expanding range of customer requirements. The Company's inability to
enhance its existing products and develop new ones in a timely and effective
manner, could have a material adverse effect upon the Company's business,
financial condition and operating results. See "Risk Factors--We Depend upon New
Product Development," "--Evolving Technology Standards May Impact Our Products"
and "--Risk of Software Defects and Potential Product Liability."
COMPETITION
The markets for the Company's products are intensely competitive and
subject to rapidly changing technology. The Company competes against providers
of decision support software, data warehousing software, enterprise application
software and e-Business software. The primary bases of competition in this
market include performance, scalability, ease of use, operating platform and
cost of ownership.
The Company's competitors providing traditional decision support software
include Brio Technology, Inc., Business Objects S.A., Cognos Incorporated,
Information Advan-
40
tage, Inc. and MicroStrategy, Inc. The Company's competitors providing data
warehousing software include Ardent Software, Inc., Informatica Corporation,
Information Builders, Oracle, PLATINUM Technology, Inc. and SAS Institute, Inc.
In addition, enterprise application software vendors such as Baan Company N.V.,
J.D. Edwards & Company, PeopleSoft, Incorporated and SAP AG are beginning to
offer decision support and analytical modules, although each tends to support
the analysis of data only from its own operational systems. One or more of these
companies may expand its technologies to support greater Enterprise Intelligence
functionality. The Company may also face competition from vendors of products
and turn-key solutions for e-Business applications that could include Internet
based information functionality.
Many of the Company's competitors have longer operating histories,
significantly greater financial, technical, marketing or other resources, or
greater name recognition than we do. The Company's competitors may be able to
respond more quickly than the Company can to new or emerging technologies and
changes in customer requirements. Competition could seriously harm the Company's
ability to sell additional software and maintenance and support renewals on
terms favorable to the Company. Competitive pressures could reduce the Company's
market share or require it to reduce the price of products, either of which
could materially and adversely affect the Company's business, financial
condition and operating results.
INTELLECTUAL PROPERTY
The Company seeks to protect its software, documentation and other written
materials primarily through a combination of patent, trade secret, trademark and
copyright laws, confidentiality procedures and contractual provisions. For
example, the Company licenses rather than sells its software and requires
licensees to enter into license agreements that impose certain restrictions on
the licensees' ability to utilize the software. In addition, the Company seeks
to avoid disclosure of its trade secrets, by, among other things, requiring
those persons with access to the Company's proprietary information to execute
confidentiality agreements with the Company and restricting access to the
Company's source code.
The Company has two patent applications pending and one patent application
allowed in the United States with respect to certain aspects of its software.
None of these patents have been issued, and there can be no assurance that any
patents will be issued pursuant to these applications or that, if granted, such
patent would survive a legal challenge to its validity or provide significant
protection to the Company. Despite the Company's efforts to protect its
proprietary rights, unauthorized parties may attempt to copy aspects of the
Company's products or obtain and use information that the Company regards as
proprietary. Policing unauthorized use of the Company's products is difficult.
While the Company is unable to determine the extent to which piracy of its
software products exists, software piracy can be expected to be a persistent
problem, particularly in foreign countries where the laws may not protect the
Company's proprietary rights as fully as in the United States. There can be no
assurance that the Company's means of protecting its proprietary rights will be
adequate or that the Company's competitors will not independently develop
similar technology.
From time to time, the Company may be involved in intellectual property
disputes. In May 1998, Acta Technology, Inc. ("Acta") filed suit against the
Company alleging, among other things, copyright infringement, and the Company
filed suit against Acta alleging misappropriation of Company trade secrets.
Other than Acta, the Company has not been notified that the Company's products
infringe the proprietary rights of third
41
parties. However, there can be no assurance that third parties will not claim
infringement by the Company with respect to current or future products. The
Company expects that software product developers will increasingly be subject to
infringement claims as the number of products and competitors in the Company's
industry segment grows and the functionality of products in different industry
segments overlaps. See "--Legal Proceedings" and "Risk Factors--Risks Associated
with Intellectual Property."
The Company relies upon certain software to perform key functions that it
has licensed from Opalis S.A. for its Sagent Automation product. This license
may not continue to be available to the Company on commercially reasonable
terms. The loss of this license could result in delays or reductions of
shipments of the Sagent Automation product until equivalent software could be
developed, identified, licensed and integrated, which could materially adversely
affect the Company's business, financial condition and operating results.
EMPLOYEES
As of December 31, 1998, the Company had a total of 152 employees, of whom
147 were based in the United States and 4 were based internationally. Of the
total, 60 were engaged in sales and marketing, 43 in research and development,
32 in professional services and customer support, and 17 in finance,
administration and corporate operations. The Company's future performance
depends in significant part on its continuing ability to attract, train and
retain highly qualified technical, sales, service, marketing and managerial
personnel. None of the Company's employees is represented by a labor union. The
Company has not experienced any work stoppages and considers its relations with
its employees to be good. See "Risk Factors--We Need to Recruit Additional
Personnel and We Depend on Our Key Personnel."
FACILITIES
The Company's principal offices currently occupy approximately 34,000
square feet in Mountain View, California pursuant to a lease which expires in
October 2003. In addition, the Company also leases executive suites on a
short-term basis for North American offices in Englewood, Colorado; Atlanta,
Georgia; Orlando, Florida; Plantation, Florida; Chicago, Illinois; Wellesley,
Massachusetts; New York, New York; Bala Cynwyd, Pennsylvania; Houston, Texas;
Alexandria, Virginia and Toronto, Ontario. The Company believes that its
facilities are adequate for the next 12 months and that, if required, suitable
additional space will be available on commercially reasonable terms to
accommodate expansion of the Company's operations.
LEGAL PROCEEDINGS
In May 1998, Acta filed suit against the Company alleging copyright
infringement of certain of its software code. In addition, Acta alleged that the
Company committed conversion, fraud and unfair competition. Acta sought a
declaration that it did not misappropriate any of the Company's trade secrets.
Acta also sought injunctive relief, monetary damages, costs and attorneys' fees.
In May 1998, the Company filed suit against Acta and its founders alleging
misappropriation of the Company's trade secrets, breach of contract, violation
of the covenant of good faith and fair dealing, breach of confidence, fraud and
unfair competition. The Company and Acta have agreed to mediate the dispute;
however, this mediation may not be successful. If the dispute is not resolved in
mediation and the parties do not otherwise settle the dispute, the Company could
incur substantial expenses and the attention of the Company's development and
management personnel may
42
be diverted. Litigation of this type is inherently uncertain, especially because
it involves complex technical issues. The Company can give no assurance that it
will prevail in the litigation against Acta or that it will successfully defend
Acta's claim. See "Risk Factors--Risks Associated with Intellectual Property."
43
MANAGEMENT
EXECUTIVE OFFICERS AND DIRECTORS
The executive officers and directors of the Company as of January 29, 1999
are as follows:
NAME AGE POSITION
---- --- --------
Kenneth C. Gardner........................ 48 President, Chief Executive Officer and
Director
John E. Zicker............................ 42 Executive Vice President, Technology,
Chief Technology Officer and Director
W. Virginia Walker........................ 53 Executive Vice President, Finance and
Administration, and Chief Financial
Officer
Thomas M. Lounibos........................ 42 Executive Vice President, Sales and
Marketing
Kenneth C. Holcomb........................ 49 Vice President, Operations
Michael P. Venerable...................... 36 Vice President, Professional Services
Shanda Bahles (a)(b)...................... 43 Director
Richard W. Shapero(a)(b).................. 51 Director
Jeffrey T. Webber......................... 46 Director
Klaus S. Luft(c).......................... 57 Director designee
|
(a) Member of the Audit Committee.
(b) Member of the Compensation Committee.
(c) The Board of Directors has appointed Mr. Luft to the Board of Directors, and
Mr. Luft has agreed to join, effective as of the first meeting of the Board
of Directors following completion of the offering.
Kenneth C. Gardner. Mr. Gardner has been President, Chief Executive Officer
and a director since commencement of operations in June 1995. From March 1994
until March 1995, Mr. Gardner was Vice President of Products at Borland
International, Inc. ("Borland"), which has since changed its name to Inprise
Corporation, an enterprise applications company. From February 1992 until March
1994, Mr. Gardner was President, Chief Executive Officer and a co-founder of
ReportSmith, Inc. ("ReportSmith"), a database report applications company, which
was purchased by Borland in 1994. Mr. Gardner is a director of ObjectSwitch
Corp., Data Sage, Inc. and CommerceOne Inc., which are privately held companies.
Mr. Gardner received his B.S.C. degree in Finance from the University of
Louisville.
John E. Zicker. Mr. Zicker has been Executive Vice President, Technology,
Chief Technology Officer and a director since the Company's commencement of
operations in June 1995. From March 1994 until May 1995, Mr. Zicker was Director
of Client/Server Development at Borland. From February 1992 until March 1994,
Mr. Zicker was Vice President of Technology and a co-founder of ReportSmith. Mr.
Zicker has 13 years experience in software development and image processing at
NASA Ames Research Center, Lawrence Livermore Laboratories and the Stanford
Linear Accelerator Center. Mr. Zicker received his B.S. degree in Electrical
Engineering at the University of California at Davis and his M.S. degree in
Electrical Engineering from the University of Wisconsin at Madison.
W. Virginia Walker. Ms. Walker has been Executive Vice President, Finance
and Administration, and Chief Financial Officer since January 1998. From June
1996 to January 1998, Ms. Walker pursued personal interests. From November 1995
until June 1996, Ms. Walker was Executive Vice President of Finance and
Administration, Chief
44
Financial Officer and Secretary of JTS Corporation, a publicly traded disk drive
manufacturer. From May 1985 until September 1995, Ms. Walker worked at Scios
Nova, Inc., a publicly traded biopharmaceutical company, where she held the
positions of Vice President of Finance and Administration and Chief Financial
Officer. Ms. Walker received her B.S. degree in Business Administration,
Accounting from San Jose State University.
Thomas M. Lounibos. Mr. Lounibos has been Executive Vice President, Sales
and Marketing since January 1999. Mr. Lounibos was the Company's Executive Vice
President, Worldwide Sales, from October 1998 until January 1999 and was the
Company's Vice President, Sales from March 1996 until October 1998. From October
1995 until March 1996, Mr. Lounibos was Vice President of Sales for
ParcPlace-DigiTalk Incorporated ("ParcPlace-DigiTalk"), an object-oriented
programming tools company, and from November 1993 until October 1995 Mr.
Lounibos was Vice President of Sales for DigiTalk, Incorporated, which was
acquired by ParcPlace Incorporated. Prior to joining DigiTalk, Mr. Lounibos
worked for Knowledgeware, Incorporated, a software company, where he served as
Vice President of Sales--Western United States and Vice President of Marketing.
Mr. Lounibos received his B.S. degree in Business Economics from the University
of San Francisco.
Kenneth C. Holcomb. Mr. Holcomb has been Vice President, Operations since
March 1998. From March 1997 until February 1998, Mr. Holcomb was Vice President,
Operations of Pilot Network Services, Inc., a publicly-traded network security
company. From May 1996 until February 1997, Mr. Holcomb was Vice President,
Systems Integration of WorldCom, Inc., a publicly traded telecommunications
company. From January 1996 until May 1996, Mr. Holcomb was Vice President,
Internet Development of MFS Communications Company, Inc., a telecommunications
company. From January 1992 until December 1996, Mr. Holcomb was Senior Vice
President, Customer Service and Operations of MFS Datanet, Inc., and subsidiary
of MFS Communications, Inc. a data communications company. Mr. Holcomb received
his B.A. degree in Business Administration, Finance, from the University of
Notre Dame.
Michael P. Venerable. Mr. Venerable has been Vice President, Sagent
Professional Services since March 1998. In March 1992, Mr. Venerable founded
Talus, a data warehousing consulting firm, and served as its President until
February 1998, when the Company acquired Talus. Mr. Venerable received his B.S.
degree in Criminal Justice from the University of Dayton.
Shanda Bahles. Ms. Bahles has been a director of the Company since May
1995. Since May 1991, Ms. Bahles has been a General Partner of El Dorado
Ventures, a venture capital firm. Ms. Bahles joined El Dorado Ventures as an
associate in June 1987. From 1979 to 1985, Ms Bahles held various engineering,
marketing and management positions with Millennium Systems, Inc., a systems
integration company, and Fortune Systems Corporation, a workstation
manufacturer. Ms. Bahles is a director of Pilot Network Services, Inc., a
publicly traded company, and Women.com Networks, Inc., Poet Holdings, Inc. and
MS2, Inc., which are privately held companies. Ms. Bahles received her B.S.E.E.
and M.B.A. degrees from Stanford University.
Richard W. Shapero. Mr. Shapero has been a director of the Company since
May 1995. Since April 1993, Mr. Shapero has been a General Partner of Crosspoint
Venture Partners, a venture capital firm. From January until June 1992, Mr.
Shapero was Chief Operating Officer of Shiva Corporation, a networking company.
Previously, he was a Vice President of Sun Microsystems, Inc., Senior Director
of Marketing of AST Research, Inc. and held marketing and sales positions at
Informatics General Corporation and UNIVAC's
45
Communications Division. Mr. Shapero is a director of Covad Communications
Group, Inc., a publicly traded company, and Digital Island, Inc., Diamond Lane
Communications Corporation, NetBoost Corporation, Fabrik Communications, Inc.,
ObjectSwitch Corp., Jetstream Communications, Inc., AristaSoft Corporation and
iBeam Broadcasting Corporation, which are privately held companies. Mr. Shapero
received his B.A. degree in English from the University of California at
Berkeley.
Jeffrey T. Webber. Mr. Webber has been a director of the Company since
September 1995. Mr. Webber founded, and since January 1991 has served as
President of, R.B. Webber & Company, Inc., a management consulting firm. From
1987 to January 1991, he was a partner of Edgar, Dunn & Company, a management
consulting firm. Mr. Webber serves as a director of Sybase, Inc., a publicly
traded company, and CommerceOne, Inc., enCommerce, Inc., Persistence Software,
Inc., Spear Technologies, Inc. and Workwise Software, Inc., which are privately
held companies. Mr. Webber received his B.A. degree in American Studies from
Yale University.
Klaus S. Luft. Mr. Luft is the founder and President of MATCH -- Market
Access for Technology Services GmbH, a provider of sales and marketing services
to high technology companies, since February 1994. Mr. Luft is also the founder,
owner and President of ISAR-Vermogensverwaltung GbR mbH ("ISAR"). Since August
1990, Mr. Luft has served as an International Advisor and Vice-Chairman of
Goldman Sachs Europe Limited, an investment bank. From March 1986 to November
1989, Mr. Luft was Chief Executive Officer of Nixdorf Computer AG, a
manufacturer of computer systems in Paderborn, Germany, where he also held
various other executive positions in marketing, manufacturing and finance for
more than 17 years. Mr. Luft is a director of Dell Computer Corporation, a
publicly traded company. Mr. Luft received his German Arbitur in Bruchsal,
Germany.
BOARD OF DIRECTORS AND COMMITTEES
Following the offering, the Company's Board of Directors (the "Board") will
consist of six directors divided into three classes with each class serving for
a term of three years. At each annual meeting of stockholders, directors will be
elected by the holders of the Common Stock to succeed those directors whose
terms are expiring. Mr. Shapero and Ms. Bahles are Class I directors whose terms
will expire in 2000; Mr. Webber is a Class II directors whose terms will expire
in 2001; and Messrs. Gardner and Zicker are Class III directors whose terms will
expire in 2002.
The Board has a Compensation Committee and an Audit Committee. The
Compensation Committee, which is comprised of Ms. Bahles and Mr. Shapero,
administers the Amended 1995 Plan, the 1998 Plan and the 1999 Purchase Plan and
all matters concerning executive compensation. The Audit Committee, which is
comprised of Ms. Bahles and Mr. Shapero, approves the Company's independent
auditors, reviews the results and scope of annual audits and other accounting
related services, and evaluates the Company's internal audit and control
functions. Each of these committees was established in February 1997.
DIRECTOR COMPENSATION
The Company does not pay any compensation to directors for serving in that
capacity, nor does it reimburse directors for expenses incurred in attending
board meetings. The Board has the discretion to grant options to non-employee
directors pursuant to the Director Plan. See "Management--Employee Benefit
Plans--Director Plan."
46
COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION
The Compensation Committee is currently comprised of Ms. Bahles and Mr.
Shapero. Neither of these individuals has at any time been an officer or
employee of the Company. Prior to formation of the Compensation Committee, all
decisions regarding executive compensation were made by the full Board. No
interlocking relationship exists between the Board or Compensation Committee and
the board of directors or compensation committee of any other Company, nor has
any such interlocking relationship existed in the past.
LIMITATION ON LIABILITY AND INDEMNIFICATION MATTERS
The Company's Amended and Restated Certificate of Incorporation (the
"Amended Certificate of Incorporation") limits the liability of directors to the
maximum extent permitted by Delaware law. Delaware law provides that directors
of a corporation shall not be personally liable for monetary damages for breach
of their fiduciary duties as directors, except for liability (1) for any breach
of their duty of loyalty to the corporation or its stockholders, (2) for acts or
omissions not in good faith or that involve intentional misconduct or a knowing
violation of law, (3) for unlawful payments of dividends or unlawful Stock
repurchases or redemptions as provided in Section 174 of the Delaware General
Corporation Law or (4) for any transaction from which the director derived an
improper personal benefit.
The Company's Bylaws provide that the Company shall indemnify its directors
and executive officers and may indemnify its other officers and employees and
agents and other agents to the fullest extent permitted by law. The Company
believes that indemnification under its Bylaws covers at least negligence and
gross negligence on the part of indemnified parties. The Company's Bylaws also
permit the Company to secure insurance on behalf of any officer, director,
employee or other agent for any liability arising out of his or her actions in
such capacity, regardless of whether the Bylaws would permit indemnification.
The Company has entered into agreements to indemnify its directors and
officers, in addition to indemnification provided for in the Company's Bylaws.
These agreements, among other things, indemnify the Company's directors and
officers for certain expenses (including attorneys' fees), judgments, fines and
settlement amounts incurred by any such person in any action or proceeding,
including any action by or in the right of the Company, arising out of such
person's services as a director or officer of the Company, any subsidiary of the
Company or any other Company or enterprise to which the person provides services
at the request of the Company. In addition, the Company intends to obtain
directors' and officers' insurance providing indemnification for certain of the
Company's directors, officers and employees for certain liabilities The Company
believes that these provisions, agreements and insurance are necessary to
attract and retain qualified directors and officers.
At present, there is no pending litigation or proceeding involving any
director, officer, employee or agent of the Company where indemnification will
be required or permitted. The Company is not aware of any threatened litigation
or proceeding that might result in a claim for such indemnification.
EXECUTIVE COMPENSATION
The following table sets forth information concerning the compensation that
the Company paid during the year ended December 31, 1998 to the Company's Chief
Executive Officer and each of the Company's other four most highly compensated
47
executive officers whose salary and bonus exceeded $100,000 during such fiscal
year (collectively, the "Named Officers").
SUMMARY COMPENSATION TABLE
LONG-TERM
COMPENSATION
------------
ANNUAL COMPENSATION SECURITIES
-------------------- UNDERLYING ALL OTHER
NAME AND PRINCIPAL POSITION SALARY($) BONUS($) OPTIONS(#) COMPENSATION(A)
--------------------------- --------- -------- ------------ ---------------
Kenneth C. Gardner................ $225,000 $ 90,000 -- $366
President and Chief Executive
Officer
John E. Zicker.................... 150,000 60,000 -- 120
Executive Vice President,
Technology and Chief Technology
Officer
W. Virginia Walker................ 173,965 69,586 180,000 240
Executive Vice President,
Finance and Administration and
Chief Financial Officer
Thomas M. Lounibos................ 164,590 124,420(b) 90,000 120
Executive Vice President, Sales
and Marketing
Perry S. Mizota(c)................ 140,000 35,000 -- 72
Former Vice President, Marketing
|
(a) Consists of premiums paid on term life insurance.
(b) Consists of commissions calculated based on Company revenues.
(c) Perry S. Mizota resigned from his position as Vice President, Marketing of
the Company effective January 29, 1999.
OPTION GRANTS IN LAST FISCAL YEAR
The following table sets forth each stock option grant to each of the Named
Officers during the fiscal year ended December 31, 1998. No stock appreciation
rights were granted during such fiscal year.
INDIVIDUAL GRANTS(A) POTENTIAL REALIZABLE
------------------------------------------------------ VALUE AT ASSUMED
NUMBER ANNUAL RATES OF STOCK
OF SECURITIES % OF PRICE APPRECIATION FOR
UNDERLYING TOTAL OPTIONS EXERCISE OPTION TERM(C)
OPTIONS GRANTED TO PRICE PER EXPIRATION -----------------------
NAME GRANTED EMPLOYEES SHARE(B) DATE 5% 10%
---- ------------- ------------- --------- ---------- --------- -----------
Kenneth C. Gardner......... -- -- -- -- -- --
John E. Zicker............. -- -- -- -- -- --
W. Virginia Walker......... 180,000 13.12% $2.90 01/20/08 $328,283 $ 831,934
Thomas M. Lounibos......... 90,000 6.56% 7.00 12/28/08 396,204 1,004,058
Perry S. Mizota............ -- -- -- -- -- --
|
(a) All options granted during the fiscal year were granted under the Amended
1995 Plan and the 1998 Plan (collectively, the "Stock Plans"). Each option
becomes exercisable according to a vesting schedule, subject to the
employee's continued employment with the Company. Certain options granted
under the Amended 1995 Plan may be exercised immediately upon grant and
prior to full vesting, subject to the optionee's entering a restricted stock
purchase agreement with the Company
48
with respect to any unvested shares. Under such agreement, the optionee
grants the Company the right to repurchase any unvested shares at their
original purchase price in the event the optionee's employment relationship
with the Company should terminate. The Company's right of repurchase will
lapse and the purchaser will vest in the balance of the shares in a series
of installments in accordance with the original vesting schedule of the
exercised option. The exercise price for all these options may be paid in
cash, check, promissory note, shares of Common Stock, through a cashless
exercise procedure involving same-day sale of the purchased shares or any
combination of such methods. The Board has discretion, subject to plan
limits, to modify the terms of outstanding options and to reprice the
options. The Company granted options to purchase 1,367,400 shares of Common
Stock in the year ended December 31, 1998. Ms. Walker's option was granted
under the Amended 1995 Plan in January 1998. One-forty-eighth of the shares
subject to the option vest on each monthly anniversary of January 5, 1998.
Mr. Lounibos' option was granted in December 1998 under the 1998 Plan.
One-twenty-fourth of the shares subject to the option vest on each monthly
anniversary after July 1, 1999.
(b) The exercise price per share of options granted represented the fair market
value of the underlying shares of Common Stock on the dates the respective
options were granted, as determined by the Board. The Company's Common Stock
was not traded publicly at the time of the option grants to the Named
Officers.
(c) Potential gains are net of the exercise price but before taxes associated
with the exercise. The 5% and 10% assumed annual rates of compounded stock
appreciation based upon the deemed fair market value are mandated by the
rules of the Securities and Exchange Commission and do not represent the
Company's estimate or projection of the future Common Stock price. Actual
gains, if any, on stock option exercises are dependent on the future
financial performance of the Company, overall market conditions and the
option holder's continued employment through the vesting period. This table
does not take into account any appreciation in the deemed fair market value
of the Common Stock from the date of grant to the date of this Prospectus,
other than the columns reflecting assumed rates of appreciation of 5% and
10%.
OPTION EXERCISES AND HOLDINGS
The following table sets forth for each of the Named Officers certain
information concerning the number of shares acquired upon exercise of stock
options in the fiscal year ended December 31, 1998 and the number of shares
subject to both exercisable and unexercisable stock options at December 31,
1998. Also reported are values for "in-the-money" options that represent the
positive spread between the respective exercise prices of outstanding stock
options and the fair market value of the Common Stock as of December 31, 1998,
as determined by the Board.
AGGREGATED OPTION EXERCISES IN LAST FISCAL YEAR AND FISCAL YEAR-END OPTION
VALUES
VALUE OF UNEXERCISED
NUMBER OF UNEXERCISED IN-THE-MONEY OPTIONS
OPTIONS AT DECEMBER 31, AT DECEMBER 31,
SHARES VALUE 1998(A) 1998(A)(B)
ACQUIRED ON REALIZED --------------------------- ---------------------------
NAME EXERCISE(A) ($)(C) EXERCISABLE UNEXERCISABLE EXERCISABLE UNEXERCISABLE
---- -------------- ---------- ----------- ------------- ----------- -------------
Kenneth C. Gardner... -- -- 100,000 -- $450,000 --
John E. Zicker....... -- -- 80,000 -- 360,000 --
W. Virginia Walker... 180,000 -- -- -- -- --
Thomas M. Lounibos... 230,000 $1,244,300 118,255 141,745 624,342 $232,853
Perry S. Mizota...... -- -- 50,000 -- 225,000 --
|
(a) Certain options granted under the Amended 1995 Plan may be exercised
immediately upon grant and prior to full vesting, subject to the optionee's
entering a restricted stock purchase agreement with the Company with respect
to any unvested shares. Under such agreement, the optionee grants the
Company an option to repurchase any unvested shares at their original
purchase price in the event the optionee's employment relationship with the
Company should terminate. The Company's right of
49
repurchase will lapse and the purchaser will vest in the balance of the
shares in a series of installments in accordance with the original vesting
schedule of the exercised options.
(b) Calculated by determining the difference between the fair market value of
the securities underlying the option at December 31, 1998 ($7.00 per share,
as determined by the Board) and the exercise price of the options.
(c) Calculated by determining the difference between the fair market value of
the securities underlying the option on the exercise date and the exercise
price paid for such shares.
EMPLOYMENT AGREEMENTS
The Company requires each of its employees to enter into confidentiality
agreements prohibiting such employee from disclosing any confidential or
proprietary information of the Company. In addition, the agreements generally
provide that upon termination such employee will not work for a competitor and
will not solicit Company customers and employees. At the time of commencement of
employment, the Company's employees also generally sign offer letters specifying
certain basic terms and conditions of employment. In general, employees of the
Company are not subject to written employment agreements. However, in connection
with the Company's acquisition of Talus, Michael Venerable entered into an
employment agreement with the Company. See "Certain Transactions--Acquisition of
Talus, Inc."
EMPLOYEE BENEFIT PLANS
1998 Plan. The 1998 Plan provides for grants to employees of incentive
stock options within the meaning of Section 422 of the Internal Revenue Code of
1986, as amended (the "Internal Revenue Code"), and for grants to employees,
directors and consultants of nonstatutory stock options and stock purchase
rights ("SPRs"). The 1998 Plan was approved initially by the Board and the
stockholders in December 1998. Unless terminated sooner, the 1998 Plan will
terminate automatically in December 2008. A total of 2,440,000 shares of Common
Stock are currently authorized for issuance pursuant to the 1998 Plan, of which
2,221,100 are still available for issuance. The number of shares reserved for
issuance will be subject to an annual increase every May beginning in 2000 equal
to the lesser of 1,500,000 shares of Common Stock, five percent of the
outstanding shares of Common Stock on the date of increase or such lesser number
of shares of Common Stock as approved by the Board. No employee, director or
consultant may be granted in any fiscal year of the Company options to purchase
more than 2,000,000 shares of Common Stock (except in connection with his or her
initial service, in which he or she may be granted options to purchase an
additional 2,000,000 shares). As of December 31, 1998, no shares had been issued
upon the exercise of stock options or stock purchase rights granted under the
1998 Plan, 218,900 shares were subject to outstanding options, and 2,221,100
shares remained available for future grant.
The 1998 Plan may be administered by the Board or a committee of the Board
(the "Committee," and collectively with the Board, the "Administrator"), which
Administrator shall, in the case of options intended to qualify as
"performance-based compensation" within the meaning of Section 162(m) of the
Internal Revenue Code, consist of two or more "outside directors" within the
meaning of Section 162(m) of the Internal Revenue Code. The Administrator has
the power to determine the terms of the options or SPRs granted, including the
exercise price, the number of shares subject to each option or SPR, the
exercisability thereof, and the form of consideration payable upon such
exercise. The Administrator also has the authority to reduce the exercise price
of any option or SPR to the then current fair market value, if the fair market
value of the Common Stock covered
50
by such option or SPR declined since the date of grant. In addition, the Board
has the authority to amend, suspend or terminate the 1998 Plan, provided that no
such action may affect any share of Common Stock previously issued and sold or
any option previously granted under the 1998 Plan.
Unless otherwise determined by the Administrator, options and SPRs granted
under the 1998 Plan are not transferable by the optionee, and each option and
SPR is exercisable during the lifetime of the optionee only by such optionee.
The exercise price for options may be paid in cash, check, promissory note,
shares of Common Stock through a cashless exercise procedure involving same-day
sale of the purchased shares or any combination of such exercise procedures.
Options granted under the 1998 Plan must generally be exercised within 90 days
of the end of optionee's status as an employee, director or consultant of the
Company, or within 12 months after such optionee's termination by death or
disability but in no event later than the expiration of the option's term. In
the case of SPRs, unless the Administrator determines otherwise, the Restricted
Stock Purchase Agreement shall grant the Company a repurchase option exercisable
upon the voluntary or involuntary termination of the purchaser's employment with
the Company for any reason (including death or disability). The purchase price
for shares repurchased pursuant to the Restricted Stock Purchase Agreement shall
be the original price paid by the purchaser and may be paid by cancellation of
any indebtedness of the purchaser to the Company. The repurchase option shall
lapse at a rate determined by the Administrator. The exercise price of all
incentive stock options granted under the 1998 Plan must be at least equal to
the fair market value of the Common Stock on the date of grant. The exercise
price of nonstatutory stock options and SPRs granted under the 1998 Plan is
determined by the Administrator, but with respect to nonstatutory stock options
intended to qualify as "performance-based compensation" within the meaning of
Section 162(m) of the Internal Revenue Code, the exercise price must at least be
equal to the fair market value of the Common Stock on the date of grant. With
respect to any participant who owns stock possessing more than 10% of the voting
power of all classes of the Company's outstanding capital stock, the exercise
price of any incentive stock option granted must equal at least 110% of the fair
market value on the grant date and the term of such incentive stock option must
not exceed five years. The term of all other options granted under the 1998 Plan
may not exceed 10 years.
The 1998 Plan provides that in the event of a proposed dissolution or
liquidation of the Company, the Administrator will notify each optionee of such
proposed transaction. The Administrator in its discretion may provide for an
optionee to have the right to exercise his or her option until 10 days prior to
such transaction, including shares as to which the option would not otherwise be
exercisable. In addition, the Administrator may provide that any Company
repurchase option applicable to any shares purchased upon exercise of an option
or SPR shall lapse as to all such shares, provided the proposed dissolution or
liquidation takes place at the time and in the manner contemplated. To the
extent it has not been previously exercised, an option or SPR will terminate
immediately prior to the consummation of such proposed action.
The 1998 Plan provides that in the event of a merger of the Company with or
into another corporation or a sale of substantially all of the Company's assets,
each option must be assumed or an equivalent option substituted by the successor
corporation (or its parent or subsidiary). If the outstanding options are not
assumed or an equivalent option is not substituted, the optionee will fully vest
in and have the right to exercise the option or SPR as to all of the optioned
stock, including shares which would not otherwise have been vested or
exercisable. In the event that an option or SPR becomes exercisable in full in
the
51
event of a merger or sale of assets, the Administrator will notify each optionee
and the option or SPR will be fully exercisable for a period of fifteen (15)
days from the date of such notice. The option or SPR will terminate upon the
expiration of such period.
Amended 1995 Plan. The Amended 1995 Plan provides grants to employees of
incentive stock options within the meaning of Section 422 of the Internal
Revenue Code, and for grants to employees, directors and consultants of
nonstatutory stock options and SPRs. The original plan was approved initially by
the Board and the stockholders in May 1995. The Amended 1995 Plan was approved
by the Board in July 1998 and the stockholders in September 1998. A total of
3,276,000 shares of Common Stock were authorized for issuance pursuant to the
Amended 1995 Plan. As of December 31, 1998, 1,214,443 shares had been issued
upon the exercise of stock options or stock purchase rights granted under the
Amended 1995 Plan and 2,056,580 shares were subject to outstanding options, and
no shares remain available for future grant. The terms of the Amended 1995 Plan
are substantially similar to those of the 1998 Plan. The Board terminated the
Amended 1995 Plan as to new option grants in December 1998.
Director Plan. The Board has the discretion to grant options to
non-employee directors pursuant to the Director Plan. The Director Plan was
adopted by the Board in January 1999, and is subject to stockholder approval,
but it will in no event become effective until the date of this offering. The
Director Plan has a term of 10 years, unless terminated sooner by the Board. A
total of 150,000 shares of Common Stock have been reserved for issuance under
the Director Plan.
The Board has the authority to determine the terms of the options granted
including the exercise price, number of shares subject to each option,
exercisability thereof and form of consideration payable upon such exercise.
Options outstanding at the end of an optionee's tenure as a director may be
exercised only to the extent exercisable at the time of such cessation of
service as a director. No option granted under the Director Plan is transferable
by the optionee other than by will or the laws of descent and distribution, and
each option is exercisable, during the lifetime of the optionee, only by such
optionee. In the event of a merger of the Company or the sale of substantially
all of the assets of the Company, each outstanding option will become fully
vested and exercisable for all of the option shares, unless such outstanding
option are assumed or substituted by the successor corporation (or its parent or
subsidiary). In the event either outstanding options are assumed or an
equivalent option substituted by the successor corporation, each outstanding
option will continue to become exercisable in accordance with its original
exercise schedule. If an outstanding option is assumed or substituted and the
optionee's status as a director or as a director of the successor corporation
terminates other than upon a voluntary resignation by the optionee, then the
option will become immediately vested exercisable for all of the option shares.
1999 Purchase Plan. The 1999 Purchase Plan was adopted by the Board in
January 1999 and will be submitted the stockholders in February 1999. A total of
450,000 shares of Common Stock has been reserved for issuance under the 1999
Purchase Plan. The number of shares reserved under the 1999 Purchase Plan will
be subject to an annual increase every January equal to the lesser of the number
of shares optioned during the prior year or a lesser amount determined by the
Board. The 1999 Purchase Plan, which is intended to qualify under Section 423 of
the Internal Revenue Code, will be implemented with an initial offering period
commencing on the date on which the Securities and Exchange Commission declares
the Company's Registration Statement effective and ending on or about October
31, 1999. Subsequent offering periods shall each have a six-month duration
52
commencing on the first trading day on or after May 1 and November 1 of each
year. The 1999 Purchase Plan is administered by the Board or by a committee
appointed by the Board. Employees are eligible to participate if they are
customarily employed by the Company or any participating subsidiary for at least
20 hours per week and more than five months in any calendar year. The 1999
Purchase Plan permits eligible employees to purchase Common Stock through
payroll deductions of up to 20% of an employee's compensation (excluding
commissions, overtime and other bonuses and incentive compensation), subject to
the limitations of Section 423(b)(8) of the Internal Revenue Code. The price of
stock purchased under the 1999 Purchase Plan is 85% of the lower of the fair
market value of the Common Stock at the beginning or end of each offering period
or at the end of the offering period. Employees may end their participation at
any time during an offering period, and they will be refunded their payroll
deductions to date. Participation ends automatically upon termination of
employment with the Company.
Rights granted under the 1999 Purchase Plan are not transferable by a
participant other than by will, the laws of descent and distribution, or as
otherwise provided under the 1999 Purchase Plan. The 1999 Purchase Plan provides
that, in the event of a merger of the Company with or into another corporation
or a sale of substantially all of the Company's assets, each option shall be
assumed or an equivalent plan substituted by the successor corporation. If the
successor corporation refuses to assume or substitute for the option, the
offering period then in progress shall be shortened so that employees' rights to
purchase stock under the 1999 Purchase Plan are exercised prior to the merger or
sale of assets. The 1999 Purchase Plan will terminate in February 2009. The
Board has the authority to amend or terminate the 1999 Purchase Plan, except
that no such action may adversely affect any outstanding rights to purchase
stock under the 1999 Purchase Plan.
401(k) Plan. The Company maintains in a tax-qualified employee savings and
retirement plan (the "Company 401(k) Plan") which covers all of the Company's
employees who are at least 21 years of age. Pursuant to the Company 401(k) Plan,
eligible employees may defer up to 25% of their pre-tax earnings, subject to the
limitation under Section 415 of the Internal Revenue Code and Internal Revenue
Service's annual contribution limit. The Company 401(k) Plan permits additional
discretionary matching contributions by the Company on behalf of all
participants in the in such a percentage amount as may be determined annually by
the Board. To date, the Company has made no such matching contributions. The
Company 401(k) Plan is intended to qualify under Section 401 of the Internal
Revenue Code, so that contributions by employees or by the Company to the
Company 401(k) Plan, and income earned on plan contributions, are not taxable to
employees until withdrawn from the Company 401(k) Plan, and so that
contributions by the Company, if any, will be deductible by the Company when
made. The trustee under the Company 401(k) Plan invests the assets of the
Company 401(k) Plan at the direction of each participant in any of a number of
investment options.
53
CERTAIN TRANSACTIONS
EQUITY INVESTMENT TRANSACTIONS
In July, August and September 1996, the Company sold an aggregate of
2,615,680 shares of its Series C Preferred Stock ("Series C Preferred") at a
price per share of $2.50. In August and September 1997 and January 1998, the
Company sold an aggregate of 1,572,327 shares of its Series D Preferred Stock
("Series D Preferred") at a price per share of $3.18. In February and March
1998, the Company sold an aggregate of 1,895,370 shares of its Series E
Preferred Stock ("Series E Preferred") at a price per share of $5.40.
Simultaneously with the consummation of this offering, all shares of preferred
stock will be converted into shares of Common Stock. Listed below are those
directors, executive officers and stockholders who beneficially own five percent
or more of the Company's securities who participated in such financings. The
Company believes that the shares issued in these transactions were sold at the
then fair market value and that the terms of these transactions were no less
favorable than the Company could have obtained from unaffiliated third parties.
SERIES C SERIES D SERIES E AGGREGATE CASH
STOCKHOLDER PREFERRED PREFERRED PREFERRED CONSIDERATION
----------- --------- --------- --------- --------------
Entities affiliated with Crosspoint 531,708 411,130 925,926 $7,636,664
Venture Partners(a)...................
Entities affiliated with El Dorado 531,708 411,130 485,185 5,256,662
Ventures(b)...........................
Greylock Equity Limited Partnership..... 480,584 371,599 437,963 4,748,145
Entities affiliated with U.S. Venture 1,040,000 150,405 -- 3,078,288
Partners(c)...........................
Jeffrey T. Webber....................... 6,000(d) 58,262(e) 46,296(f) 450,272
Thomas M. Lounibos...................... -- 45,785 -- 145,596
|
(a) Includes shares purchased by Crosspoint Venture Partners LS 1993, Crosspoint
1993 Entrepreneurs Fund and Crosspoint Venture Partners LS 1997. Each of
these funds has five general partners, each of whom shares voting and
investment power over the shares held by such funds. Richard W. Shapero, a
director of the Company, is a general partner of each of these entities. Mr.
Shapero disclaims beneficial ownership of the shares held by these funds,
except to the extent of his proportionate interest therein.
(b) Includes shares purchased by El Dorado Ventures III, L.P. and El Dorado
Technology IV, L.P. Each of these funds has four general partners, each of
whom shares voting and investment power over the shares held by such funds.
Shanda Bahles, a director of the Company, is a general partner of each of
these entities. Ms. Bahles disclaims beneficial ownership of the shares held
by these funds, except to the extent of her proportionate interest therein.
(c) Includes shares purchased by U.S. Venture Partners IV, L.P., Second Ventures
II, L.P., U.S.V.P. Entrepreneur Partners II, L.P. and 2180 Associates Fund.
Presidio Management Group IV, L.P. ("Presidio"), which is the general
partner of each of these entities, has five general partners, each of whom
shares voting and investment power over the shares held by Presidio.
(d) Includes (1) 4,000 shares held by Mr. Webber directly and (2) 2,000 shares
held by Mr. Webber's wife. Mr. Webber is a director of the Company.
(e) Includes (1) 51,973 shares held by The Entrepreneurs' Fund, L.P., whose
General Partner is BW Management LLC, of which Mr. Webber is one of the
managing directors, (2) 1,572 shares held by Mr. Webber's wife, (3) 1,572
shares held by Mr. Webber directly and (4) 3,145 shares held by the First
Trust Corporation fbo Jeffrey T. Webber, which is Mr. Webber's IRA account.
Mr. Webber is a director of the Company. Mr. Webber disclaims beneficial
ownership of the shares held by The Entrepreneurs' Fund, L.P., except to the
extent of his proportionate interest therein.
54
(f) Includes (1) 39,352 shares held by The Entrepreneurs' Fund, L.P. and (2)
6,944 shares held by RBW Investments, LLC, of which Mr. Webber is the
Managing Director. Mr. Webber disclaims beneficial ownership of the shares
held by The Entrepreneurs' Fund, L.P. and RBW Investments, LLC, except to
the extent of his proportionate interest therein.
RESTRICTED STOCK PURCHASE AGREEMENTS
In February 1998, Ms. Walker, the Company's Executive Vice President,
Finance and Administration, and Chief Financial Officer, exercised two options
to purchase an aggregate of 180,000 shares of Common Stock and entered into
Notices of Early Exercise and Restricted Stock Purchase Agreements with respect
to such exercises. Ms. Walker paid the $2.90 exercise price per share for such
shares by delivery of a series of three year full-recourse promissory notes
bearing interest at the rate of 5.47% per annum. The notes are secured by the
shares of Common Stock purchased by Ms. Walker. As of December 31, 1998,
$548,499 in unpaid principal and interest was outstanding in the aggregate under
the notes.
ACQUISITION OF TALUS, INC.
In February 1998, the Company and Talus entered into an Agreement and Plan
of Reorganization whereby the Company acquired Talus for total consideration of
$1,170,000 in cash and 259,258 shares of Series E Preferred Stock. Michael P.
Venerable, the Company's Vice President, Professional Services, was Talus'
President at the time of the acquisition. Mr. Venerable received $571,051 in
cash and 109,919 shares of Series E Preferred as consideration for his shares of
Talus. In addition, in connection with the acquisition, Mr. Venerable entered
into an employment agreement (the "Venerable Agreement") with the Company.
Pursuant to the Venerable Agreement, Mr. Venerable received a salary of $123,000
and a bonus based upon performance milestones. The Company also granted Mr.
Venerable an option to purchase 150,000 shares of Common Stock at an exercise
price of $4.30 per share. Twenty percent of the shares subject to the option
vested on the first anniversary of the date of the Venerable Agreement, 20% will
vest on the second anniversary and 60% will vest on the third anniversary. In
the event of a Change of Control (as defined in the Venerable Agreement) of the
Company, the option will accelerate and become immediately exercisable if such
options are not assumed. If Mr. Venerable's options are assumed and he is
terminated for any reason other than for Cause (as defined in the Venerable
Agreement) or if he voluntarily terminates his employment for Good Reason (as
defined in the Venerable Agreement), after the Change of Control, the unvested
portion of the option will accelerate and become immediately exercisable. If Mr.
Venerable's employment is terminated for Cause or if he resigns for any reason
other than Good Reason, he has agreed not to engage in a Restricted Business (as
defined in the Venerable Agreement) or solicit any of the Company's employees
for three years.
EXECUTIVE CHANGE OF CONTROL POLICY
The Board has adopted an Executive Change of Control Policy (the "Policy")
applicable to key executives of the Company. The Policy provides that options
granted to key executives ("Key Executive Options") will be assumed upon a
Change of Control of the Company (as defined in the Policy). Furthermore, if a
key executive remains an employee at the time of the Change of Control, the
vesting of that individual's Key Executive Options will accelerate, and the
Company's right to repurchase will lapse, as to 50% of the unvested portion of
such options. If a key executive is terminated for any
55
reason other than for Cause (as defined in the Policy) or terminates employment
for Good Reason (as defined in the Policy) during the one-year period after the
date of the Change of Control, then the remaining unvested portion of such Key
Executive Options will accelerate and become immediately exerciseable, and the
Company's right to repurchase the applicable portion of such shares will lapse.
TRANSACTIONS WITH ISAR
Klaus S. Luft, has agreed to join the Board as of the first meeting of the
Board following completion of the offering, is a general partner of ISAR. The
Company has entered into an agreement (the "ISAR Agreement") with ISAR, pursuant
to which ISAR established a German company, Magnolia II Vermogensverwaltung GmbH
("Magnolia"), to distribute and support the Company's products in Germany,
Austria and Switzerland (the "Territory"). The Company has entered into an
agreement with Magnolia pursuant to which Magnolia has the exclusive right
(other than with respect to value added resellers who have been or will be
granted worldwide distribution rights) to distribute the Company's products in
the Territory. Magnolia has agreed to pay the Company royalties on sales and
maintenance of the Company's products. The Company has a call option to acquire
Magnolia with cash, registrable securities or a combination of cash and
registrable securities, with the acquisition price determined according to the
date of the acquisition and Magnolia's revenues.
In May 1998, the Company and ISAR entered into a Common Stock Purchase
Agreement pursuant to which ISAR purchased 28,000 shares of the Company's Common
Stock for an aggregate purchase price of $120,960. In May 1998, the Company
granted ISAR a Warrant to purchase 22,000 shares of the Company's Common Stock
at an exercise price of $5.40 per share. Mr. Luft disclaims beneficial ownership
of the shares and Warrant held by ISAR except to the extent of his proportionate
interest therein.
OTHER TRANSACTIONS
The Company has entered into an Indemnification Agreement with each of its
executive officers and directors.
The Company has granted options to certain of its executive officers. See
"Management--Option Grants in Last Fiscal Year."
Holders of Preferred Stock are entitled to certain registration rights with
respect to the Common Stock issued or issuable upon conversion thereof. See
"Description of Capital Stock--Registration Rights."
The Company believes that all related-party transactions described above
were on terms no less favorable than could have been otherwise obtained from
unrelated third parties. All future transactions between the Company and its
principal officers, directors and affiliates will be approved by a majority of
the independent and disinterested members of the Board and will be on terms no
less favorable that could be obtained from unrelated third parties.
56
PRINCIPAL STOCKHOLDERS
The following table sets forth certain information with respect to
beneficial ownership of the Common Stock as of December 31, 1998 and as adjusted
to reflect the sale of Common Stock offered hereby, conversion of all
outstanding shares of Preferred Stock into shares of Common Stock upon
completion of this offering and the exercise of outstanding warrants which
expire or are required to be exercised upon completion of this offering for (1)
each person who is known by the Company to beneficially own more than five
percent of the Common Stock, (2) each of the Company's directors, (3) each of
the Named Officers and (4) all directors and executive officers as a group.
Unless otherwise indicated, the principal address of each of the stockholders
below is c/o Sagent Technology, Inc., 800 W. El Camino Real, Suite 300, Mountain
View, California 94040.
PERCENTAGE
OWNED(A)(B)
SHARES OWNED -------------------
PRIOR TO THE BEFORE AFTER
OFFERING(A) OFFERING OFFERING
------------ -------- --------
5% STOCKHOLDERS:
Entities affiliated with Crosspoint Venture
Partners(c).............................. 4,179,876 22.4% %
Entities affiliated with El Dorado
Ventures(d).............................. 3,739,135 20.0
Greylock Equity Limited Partnership(e)...... 3,379,034 18.1
Entities affiliated with U.S. Venture
Partners(f).............................. 1,190,405 6.4
DIRECTORS AND OFFICERS:
Kenneth C. Gardner(g)....................... 1,200,000 6.4
Jeffrey T. Webber(h)........................ 334,940 1.8
John E. Zicker(i)........................... 968,000 5.2
W. Virginia Walker(j)....................... 180,000 *
Perry S. Mizota(k).......................... 320,000 1.7
Thomas M. Lounibos(l)....................... 434,040 2.3
Richard W. Shapero(c)....................... 4,179,876 22.4
Shanda Bahles(d)............................ 3,739,135 20.0
All directors and officers as a group
(10 persons)(m).......................... 11,712,420 60.8
|
* Represents less than one percent of the total
(a) Assumes no exercise of the Underwriter's over-allotment option. Except
pursuant to applicable community property laws or as indicated in the
footnotes to this table, to the Company's knowledge, each stockholder
identified in the table possesses sole voting and investment power with
respect to all shares of Common Stock shown as beneficially owned by such
stockholder.
(b) Percent of the outstanding shares of Common Stock, based on 18,669,377
shares outstanding as of December 31, 1998, treating as outstanding all
shares of Common Stock issuable on exercise of options exercisable within
60 days of December 31, 1998 held by the particular beneficial owner and
that are included in the first column.
(c) Principal address is The Pioneer Hotel Building, 2925 Woodside Road,
Woodside, CA 94062. Number of shares includes (1) 3,155,547 shares held by
Crosspoint Venture Partners LS 1993; (2) 925,926 shares held by Crosspoint
Venture Partners LS 1997; and (3) 98,403 shares held by Crosspoint 1993
Entrepreneurs Fund. Crosspoint Venture Partners has five general partners.
Each of these general partners shares voting and investment power over the
shares held by Crosspoint Venture Partners. Richard W. Shapero, a director
of the Company, is a general partner of Crosspoint Venture Partners. Mr.
Shapero disclaims beneficial ownership of the shares held by such entities
except to the extent of his proportionate pecuniary interest therein.
57
(d) Principal address is 2400 Sand Hill Road, Suite 100, Menlo Park, CA 94025.
Number of shares includes (1) 3,172,773 shares held by El Dorado Ventures
III L.P.; (2) 478,658 shares held by El Dorado Ventures IV, L.P.; (3)
81,177 shares held by El Dorado Technology IV, L.P.; and (4) 6,527 shares
held by El Dorado Technology '98, L.P. El Dorado Ventures has four general
partners. Each of these general partners shares voting and investment power
over the shares held by El Dorado Ventures. Shanda Bahles, a director of
the Company, is a general partner of El Dorado Ventures. Ms. Bahles
disclaims beneficial ownership of the shares held by such entities except
to the extent of her proportionate pecuniary interest therein.
(e) Principal address is 755 Page Mill Road, Suite A-100, Palo Alto, CA 94304.
(f) Principal address is 2180 Sand Hill Road, Suite 300, Menlo Park, CA 94025.
Number of shares includes (1) 1,026,129 shares held by U.S. Venture
Partners IV, L.P.; (2) 124,993 shares held by Second Ventures II, L.P.; (3)
35,712 shares held by U.S.V.P. Entrepreneur Partners II, L.P.; and (4)
3,571 shares held by 2180 Associates Fund.
(g) Includes (1) 925,000 shares registered in the name of Kenneth C. Gardner
and Patricia T. Gardner, Trustees of the Gardner Family Trust u/d/t dated
September 6, 1996; (2) 100,000 shares registered in the name of Delaware
Charter Guarantee & Trust Co., Trustee fbo Kenneth C. Gardner, IRA; (3)
75,000 shares registered in the name of trusts; and (4) an option, granted
to Kenneth C. Gardner, to purchase 100,000 shares exercisable within 60
days of December 31, 1998.
(h) Includes (1) 207,692 shares registered in the name of Jeffrey T. Webber;
(2) 91,325 shares registered in the name of The Entrepreneurs' Fund, L.P.;
(3) 32,778 shares registered in the name of Mr. Webber's wife; and (4)
3,145 shares registered in the name of First Trust Corporation fbo Jeffrey
T. Webber.
(i) Includes (1) 788,000 shares registered in the name of John E. Zicker; (2)
100,000 shares registered in the name of Delaware Charter Guarantee & Trust
Co., Trustee fbo John E. Zicker, IRA; and (3) an option, granted to John E.
Zicker, to purchase 80,000 shares, exercisable within 60 days of December
31, 1998.
(j) Includes 138,750 shares which are subject to a repurchase option held by
the Company as of December 31, 1998.
(k) Includes an option to purchase 50,000 shares, exercisable within 60 days of
December 31, 1998.
(l) Includes (1) an option to purchase an aggregate of 158,255 shares
exercisable within 60 days of December 31, 1998 and (2) 45,575 shares which
are subject to a repurchase option held by the Company as of December 31,
1998.
(m) Includes the directors and officers as listed and (1) an option, granted to
Kenneth C. Holcomb, to purchase 46,510 shares, exercisable within 60 days
of December 31, 1998; (2) 109,919 shares registered in the name of Michael
P. Venerable; (3) an option, granted to Mr. Venerable, to purchase 150,000
shares, exercisable within 60 days of December 31, 1998; (4) 28,000 shares
registered in the name of ISAR; and (5) a warrant, granted to ISAR, to
purchase 22,000 shares, exercisable within 60 days of December 31, 1998.
58
DESCRIPTION OF CAPITAL STOCK
Upon the closing of this offering, the authorized capital stock of the
Company will consist of 70,000,000 shares of Common Stock, $0.001 par value, and
5,000,000 shares of Preferred Stock, $0.001 par value.
The following summary of certain provisions of the Common Stock and
Preferred Stock does not purport to be complete and is subject to, and qualified
in its entirety by, the provisions of the Amended Certificate of Incorporation,
which is included as an exhibit to the Registration Statement of which this
Prospectus is a part, and by the provisions of applicable law.
COMMON STOCK
After giving effect to the conversion of all previously outstanding
preferred stock into shares of Common Stock, as of December 31, 1998, there were
18,669,377 shares of Common Stock outstanding held of record by approximately
144 stockholders. There will be shares of Common Stock
outstanding (assuming no exercise of the Underwriters' over-allotment option and
no exercise of certain outstanding options or warrants) after giving effect to
the sale of Common Stock in the offering.
The holders of Common Stock are entitled to one vote for each share held of
record on all matters submitted to a vote of stockholders. Subject to
preferences that may be applicable to any outstanding shares of Preferred Stock,
the holders of Common Stock are entitled to receive ratably such dividends, if
any, as may be declared by the Board out of funds legally available for the
payment of dividends. See "Dividend Policy." In the event of a liquidation,
dissolution or winding up of the Company, the holders of Common Stock are
entitled to share ratably in all assets remaining after payment of liabilities
and liquidation preferences of any outstanding shares of Preferred Stock.
Holders of Common Stock have no preemptive rights or rights to convert their
Common Stock into any other securities. There are no redemption or sinking fund
provisions applicable to the Common Stock. All outstanding shares of Common
Stock are fully paid and non-assessable, and the shares of Common Stock to be
issued in the offering will be fully paid and non-assessable.
PREFERRED STOCK
Pursuant to the Amended Certificate of Incorporation the Board has the
authority, without further action by the stockholders, to issue up to 5,000,000
shares of Preferred Stock in one or more series and to fix the designations,
powers, preferences, privileges and relative participating, optional or special
rights and the qualifications, limitations or restrictions thereof, including
dividend rights, conversion rights, voting rights, terms of redemption and
liquidation preferences, any or all of which may be greater than the rights of
the Common Stock. The Board, without stockholder approval, can issue Preferred
Stock with voting, conversion or other rights that could adversely affect the
voting power and other rights of the holders of Common Stock. Preferred Stock
could thus be issued quickly with terms calculated to delay or prevent a change
in control of the Company or make removal of management more difficult.
Additionally, the issuance of Preferred Stock may have the effect of decreasing
the market price of the Common Stock, and may adversely affect the voting and
other rights of the holders of Common Stock. At present, there are no shares of
Preferred Stock outstanding, and the Company has no plans to issue any Preferred
Stock.
59
COMMON STOCK WARRANTS
Upon completion of the offering, the Company will have three warrants
outstanding to purchase an aggregate of 18,306 shares of Common Stock,
exerciseable as follows: (1) 5,539 shares at an exercise price of $6.50 per
share; (2) 9,433 shares at an exercise price of $3.18 per share; and (3) 3,334
shares at an exercise price of $5.40 per share. These warrants expire 10 years
from the date of execution or five years from the effective date of the
offering, whichever is later.
REGISTRATION RIGHTS
Upon completion of the offering, the holders of an aggregate of
approximately 14,800,000 shares of Common Stock will be entitled to certain
rights with respect to the registration of such shares under the Securities Act.
Under the terms of certain registration rights agreements, if the Company
proposes to register any of its securities under the Securities Act of 1933, as
amended (the "Securities Act"), either for its own account or for the account of
other security holders exercising registration rights, such holders are entitled
to notice of such registration and are entitled to include shares of Common
Stock in the registration. The rights are subject to certain conditions and
limitations, among them the right of the underwriters of an offering subject to
the registration to limit the number of shares included in such registration.
Holders of these rights may also require the Company to file a registration
statement under the Securities Act at its expense with respect to their shares
of Common Stock, and the Company is required to use its best efforts to effect
such registration, subject to certain conditions and limitations. Furthermore,
such holders may require the Company to file additional registration statements
on Form S-3, subject to certain conditions and limitations.
DELAWARE ANTI-TAKEOVER LAW AND CERTAIN CHARTER AND BYLAWS PROVISIONS
Delaware Anti-Takeover Statute. The Company is subject to Section 203 of
the Delaware General Corporation Law ("Section 203"), which, subject to certain
exceptions, prohibits a Delaware corporation from engaging in any business
combination with any interested stockholder for a period of three years
following the date that such stockholder became an interested stockholder,
unless: (1) prior to such date, the board of directors of the corporation
approved either the business combination or the transaction that resulted in the
stockholder becoming an interested stockholder; (2) upon consummation of the
transaction that resulted in the stockholder becoming an interested stockholder,
the interested stockholder owned at least 85% of the voting stock of the
corporation outstanding at the time the transaction commenced, excluding for
purposes of determining the number of shares outstanding those shares owned (A)
by persons who are directors and officers and (B) by employee stock plans in
which employee participants do not have the right to determine confidentially
whether shares held subject to the plan will be tendered in a tender or exchange
offer; or (3) on or subsequent to such date, the business combination is
approved by the board of directors and authorized at an annual or special
meeting of stockholders, and not by written consent, by the affirmative vote of
at least 66 2/3% of the outstanding voting stock that is not owned by the
interested stockholder.
Section 203 defines business combination to include: (1) any merger or
consolidation involving the corporation and the interested stockholder; (2) any
sale, transfer, pledge or other disposition of 10% or more of the assets of the
corporation involving the interested stockholder; (3) subject to certain
exceptions, any transaction that results in the issuance or transfer by the
corporation of any stock of the corporation to the interested stockholder;
60
(4) any transaction involving the corporation that has the effect of increasing
the proportionate share of the stock of any class or series of the corporation
beneficially owned by the interested stockholder; or (5) the receipt by the
interested stockholder of the benefit of any loans, advances, guarantees,
pledges or other financial benefits provided by or through the corporation. In
general, Section 203 defines an interested stockholder as any entity or person
beneficially owning 15% or more of the outstanding voting stock of the
corporation and any entity or person affiliated with or controlling or
controlled by such entity or person.
Amended Certificate of Incorporation. In February 1999, the Company
submitted to its stockholders for approval the Amended Certificate of
Incorporation, to provide: (1) for the authorization of the Board to issue,
without further action by the stockholders, up to 5,000,000 shares of Preferred
Stock in one or more series and to fix the rights, preferences, privileges and
restrictions thereof; (2) that any action required or permitted to be taken by
stockholders of the Company must be effected at a duly called annual or special
meeting of the stockholders and may not be effected by a consent in writing; (3)
for a classified Board; (4) that vacancies on the Board, including newly created
directorships, can be filled only be a majority of the directors then in office;
(5) that directors of the Company may be removed only for cause, and (6) for the
elimination of cumulative voting effective upon such time as the Company ceases
to be subject to Section 2115 of the California Corporations Code.
Bylaws. In January 1999, the Board approved certain amendments to the
Bylaws to provide that special meetings of stockholders of the Company may be
called only by the Chairman of the Board, the President of the Company or the
Board.
These provisions are intended to enhance the likelihood of continuity and
stability in the composition of the Board and in the policies formulated by the
Board and to discourage certain types transactions that may involve an actual or
threatened change of control of the Company. These provisions also are designed
to reduce the vulnerability of the Company to an unsolicited proposal for a
takeover of the Company that does not contemplate the acquisition of all of its
outstanding shares or an unsolicited proposal for the restructuring or sale of
all or part of the Company. Such provisions, however, could discourage potential
acquisition proposals and could delay or prevent a change in control of the
Company. Such provisions may also have the effect of preventing changes in the
management of Sagent.
TRANSFER AGENT AND REGISTRAR
The transfer agent and registrar for the Company's Common Stock is
. 's address is , and its
telephone number is .
LISTING
The Company has applied to list its Common Stock on the Nasdaq National
Market under the trading symbol "SGNT". The Company has not applied to list its
Common Stock on any other exchange or quotation system.
61
SHARES ELIGIBLE FOR FUTURE SALE
Prior to this offering, there has been no market for the Common Stock.
Future sales of substantial amounts of Common Stock in the public market could
adversely affect the prevailing market price from time to time. Furthermore,
because only a limited number of shares will be available for sale shortly after
this offering, because of certain contractual and legal restrictions on resale
(as described below), sales of substantial amounts of Common Stock in the public
market after the restrictions lapse could adversely affect the prevailing market
price and the Company's ability to raise equity capital in the future.
Upon completion of the offering, the Company will have outstanding an
aggregate of shares of Common Stock, assuming no exercise of the
Underwriters' over-allotment option and no exercise of outstanding options or
outstanding warrants after December 31, 1998. Of these outstanding shares, the
18,669,377 shares sold in the offering will be freely tradeable without
restriction or further registration under the Securities Act, unless purchased
by "affiliates" of the Company as that term is defined in Rule 144 under the
Securities Act. The remaining shares of Common Stock outstanding
upon completion of the offering and held by existing stockholders will be
"restricted securities," as that term is defined in Rule 144 under the
Securities Act ("Restricted Shares"). Restricted Shares may be sold in the
public market only if registered or if they qualify for an exemption from
registration under Rules 144, 144(k) or 701 promulgated under the Securities
Act, which rules are summarized below, or another exemption therefrom. Sales of
the Restricted Shares in the public market, or the availability of such shares
for sale, could adversely affect the market price of the Common Stock.
All officers, directors and certain other holders of Common Stock have
entered into contractual "lock-up" agreements providing that they will not
offer, sell, contract to sell or grant any option to purchase or otherwise
dispose of shares of Common Stock owned by them or that could be purchased by
them through the exercise of options for a period of 180 days after the date of
this prospectus without the prior written consent of Donaldson, Lufkin &
Jenrette Securities Corporation. As a result of these contractual restrictions,
notwithstanding possible earlier eligibility for sale under the provisions of
Rules 144, 144(k) and 701, additional shares will be available for sale in the
public market as follows: (1) no shares of Common Stock will be eligible for
sale as of the effective date of this offering, (2) no additional shares will be
eligible for sale beginning 90 days after the effective date of this offering,
and (3) 18,404,766 additional shares will be eligible for sale beginning 180
days after the effective date of this offering, subject in some cases to certain
volume limitations. Of the 264,611 remaining Restricted Shares, (1) 236,611
shares are subject to a repurchase option of the Company in the event of
termination of employment and (2) 28,000 shares will not be eligible for sale
pursuant to Rule 144 until the expiration of a one-year holding period in
December 1999.
In general, under Rule 144 as currently in effect, beginning 90 days after
the date of this Prospectus, a person (or persons whose shares are aggregated)
who has beneficially owned Restricted Shares for at least one year, including
persons who may be deemed to be "affiliates" of the Company, would be entitled
to sell within any three-month period a number of shares that does not exceed
the greater of: (1) one percent of the number of shares of Common Stock then
outstanding (which will equal approximately shares
immediately after this offering) or (2) the average weekly trading volume of the
Common Stock as reported through the Nasdaq National Market during the four
calendar weeks preceding the filing of a Form 144 with respect to such sale.
Sales under Rule 144 are also subject to certain manner of sale provisions and
notice
62
requirements and to the availability of current public information about the
Company. Under Rule 144(k), a person who is not deemed to have been an affiliate
of the Company at any time during the 90 days preceding a sale, and who has
beneficially owned for at least two years the Restricted Shares proposed to be
sold (including the holding period of any prior owner except an affiliate), is
entitled to sell such shares without complying with the manner of sale, public
information, volume limitation or notice provisions of Rule 144.
Subject to certain limitations on the aggregate offering price of a
transaction and certain other conditions, Rule 701 permits resales of shares
issued prior to the date an issuer becomes subject to the reporting requirements
of the Securities Exchange Act of 1934, as amended (the "Exchange Act"),
pursuant to certain compensatory benefit plans and contracts. Such resales may
be made commencing 90 days after the issuer becomes subject to the reporting
requirements of the Exchange Act, in reliance upon Rule 144 but, in certain
cases, without compliance with certain restrictions, including the holding
period requirements. In addition, the Securities and Exchange Commission has
indicated that Rule 701 will apply to typical stock options granted by an issuer
before it becomes subject to the reporting requirements of the Exchange Act,
along with the shares acquired upon exercise of such options, including
exercises after the date the issuer becomes so subject. Securities issued in
reliance on Rule 701 are restricted securities and, subject to the contractual
restrictions described above, beginning 90 days after the date of this
Prospectus, may be sold by persons other than affiliates subject only to the
manner of sale provisions of Rule 144, and by affiliates under Rule 144 without
compliance with its one-year minimum holding period requirement.
The Company has agreed not to sell or otherwise dispose of any shares of
Common Stock or any securities convertible into or exercisable or exchangeable
for Common Stock, or enter into any swap or similar agreement that transfers, in
whole or in part, the economic risk of ownership of the Common Stock, for a
period of 180 days after the date of this Prospectus, without the prior written
consent of Donaldson, Lufkin & Jenrette Securities Corporation, subject to
certain limited exceptions.
The Company intends to file a registration statement under the Securities
Act covering the shares of Common Stock subject to outstanding options or
reserved for issuance under the Amended 1995 Plan, 1998 Plan, 1999 Purchase Plan
and the Director Plan. Such registration statement is expected to be filed as
early as the effectiveness of the registration statement covering the shares of
Common Stock offered in this offering and will automatically become effective
upon filing. Accordingly, shares registered under such registration statement
will, subject to Rule 144 volume limitations applicable to affiliates and the
expiration of a 180-day lockup period, be available for sale in the open market,
except to the extent that such shares are subject to vesting restrictions with
the Company or the contractual restrictions described above.
63
UNDERWRITING
Subject to the terms and subject to conditions contained in an Underwriting
Agreement dated , 1999 (the "Underwriting
Agreement"), the underwriters named below (the "Underwriters"), who are
represented by Donaldson, Lufkin & Jenrette Securities Corporation, Hambrecht &
Quist LLC and Piper Jaffray Inc. (the "Representatives"), have severally agreed
to purchase from the Company the respective number of shares of Common Stock set
forth opposite their names below:
NUMBER OF
UNDERWRITERS: SHARES
------------- ---------
Donaldson, Lufkin & Jenrette Securities Corporation.........
Hambrecht & Quist LLC.......................................
Piper Jaffray Inc. .........................................
-------
Total.............................................
=======
|
The Underwriting Agreement provides that the obligations of the several
Underwriters to purchase and accept delivery of the shares of Common Stock
offered hereby are subject to approval by their counsel of certain legal matters
and to certain other conditions. The Underwriters are obligated to purchase and
accept delivery of all the shares of Common Stock offered hereby (other than
those shares covered by the over-allotment option described below) if any are
purchased.
The Underwriters initially propose to offer the shares of Common Stock in
part directly to the public at the initial public offering price set forth on
the cover page of this prospectus and in part to certain dealers (including the
Underwriters) at such price less a concession not in excess of $ per share.
The Underwriters may allow, and such dealers may re-allow, to certain other
dealers a concession not in excess of $ per share. After the initial
offering of the Common Stock, the public offering price and other selling terms
may be changed by the Representatives at any time without notice. The
Underwriters do not intend to confirm sales to any accounts over which they
exercise discretionary authority.
DLJdirect Inc., an affiliate of Donaldson, Lufkin & Jenrette Securities
Corporation and a member of the selling group, is facilitating the distribution
of the shares sold in the offering over the Internet. The Underwriters have
agreed to allocate a limited number of shares to DLJdirect Inc. for sale to its
brokerage account holders.
Sagent has granted to the Underwriters an option, exercisable for 30 days
after the date of this prospectus, to purchase, from time to time, in whole or
in part, up to an aggregate of additional shares of Common
Stock at the initial public offering price less underwriting discounts and
commission. The Underwriters may exercise such option solely to cover
over-allotments, if any, made in connection with the offering. To the extent
that the Underwriters exercise such option, each Underwriter will become
obligated, subject
64
to certain conditions, to purchase its pro rata portion of such additional
shares based on such Underwriters' percentage underwriting commitment as
indicated in the above table.
Sagent has agreed to indemnify the Underwriters against certain
liabilities, including liabilities under the Securities Act, or to contribute to
payments that the Underwriters may be required to make in respect thereof.
Each of Sagent, its executive officers, directors, stockholders and option
holders has agreed, subject to certain exceptions, not to (1) offer, pledge,
sell, contract to sell, sell any option or contract to purchase, purchase any
option or contract to sell, grant any option, right or warrant to purchase or
otherwise transfer or dispose of, directly or indirectly, any shares of Common
Stock or any securities convertible into or exercisable or exchangeable for
Common Stock or (2) enter into any swap or other arrangement that transfers all
or a portion of the economic consequences associated with the ownership of any
Common Stock (regardless of whether any of the transactions described in clause
(1) or (2) is to be settled by the delivery of Common Stock, or such other
securities, in cash or otherwise) for a period of 180 days after the date of
this prospectus without the prior written consent of Donaldson, Lufkin &
Jenrette Securities Corporation. In addition, during such 180-day period, Sagent
has also agreed not to file any registration statement with respect to, and each
of its executive officers, directors and certain stockholders of Sagent has
agreed not to make any demand for, or exercise any right with respect to, the
registration of any shares of Common Stock or any securities convertible into or
exercisable or exchangeable for Common Stock without the prior written consent
of Donaldson, Lufkin & Jenrette Securities Corporation.
Prior to the offering, there has been no established trading market for the
Common Stock. The initial public offering price of the shares of Common Stock
offered hereby will be determined by negotiation among Sagent and the
Representatives. The factors to be considered in determining the initial public
offering price include the history of and the prospects for the industry in
which Sagent competes, the past and present operations of Sagent, the historical
results of operations of Sagent, the prospects for future earnings of Sagent,
the recent market prices of securities of generally comparable companies, and
the general condition of the securities markets at the time of the offering.
Other than in the United States, no action has been taken by Sagent or the
Underwriters that would permit a public offering of the shares of Common Stock
offered hereby in any jurisdiction where action for that purpose is required.
The shares of Common Stock offered hereby may not be offered or sold, directly
or indirectly, nor may this prospectus or any other offering material or
advertisements in connection with the offer and sale of any such shares of
Common Stock be distributed or published in any jurisdiction, except under
circumstances that will result in compliance with the applicable rules and
regulations of such jurisdiction. Persons into whose possession this prospectus
comes are advised to inform themselves about and observe any restrictions
relating to the offering and the distribution of this prospectus. This
prospectus does not constitute an offer to sell or a solicitation of an offer to
buy any shares of Common Stock offered hereby in any jurisdiction in which such
an offer or a solicitation is unlawful.
In connection with the offering, the Underwriters may engage in
transactions that stabilize, maintain or otherwise affect the price of the
Common Stock. Specifically, the Underwriters may over-allot the offering,
creating a syndicate short position. The Underwriters may bid for and stabilize
the price of the Common Stock. In addition, the underwriting syndicate may
reclaim selling concessions from syndicate members and selected dealers if they
repurchase previously distributed Common Stock in syndicate
65
covering transactions, in stabilizing transactions or otherwise. These
activities may stabilize or maintain the market price of the Common Stock above
independent market levels. The Underwriters are not required to engage in these
activities, and may end any of these activities at any time.
LEGAL MATTERS
Certain legal matters with respect to the legality of the issuance of the
shares of Common Stock offered hereby will be passed upon for the Company by
Wilson Sonsini Goodrich & Rosati, Professional Corporation, Palo Alto,
California. Arthur F. Schneiderman, a member of Wilson Sonsini Goodrich &
Rosati, is Secretary of the Company. Mr. Schneiderman and investment
partnerships, of which certain members of Wilson Sonsini Goodrich & Rosati are
general partners, beneficially own an aggregate of 180,445 shares of the
Company's Common Stock. Certain legal matters in connection with this offering
will be passed upon for the Underwriters by Brobeck Phleger & Harrison LLP, Palo
Alto, California.
EXPERTS
The consolidated balance sheets as of December 31, 1998 and 1997 and the
consolidated statements of operations, stockholders' equity and cash flows for
each of the three years in the period ended December 31, 1998 for Sagent
Technology, Inc. included in this Prospectus and Registration Statement, have
been included herein in reliance on the report of PricewaterhouseCoopers LLP,
independent accountants, given upon the authority of such firm as experts in
accounting and auditing.
The balance sheets as of December 31, 1997 and 1996 and the statements of
operations and retained earnings and cash flows for the two years in the period
ended December 31, 1997 for Talus, Incorporated included in this Prospectus and
Registration Statement, have been included herein in reliance on the report of
PricewaterhouseCoopers LLP, independent accountants, given upon the authority of
such firm as experts in accounting and auditing.
66
AVAILABLE INFORMATION
We have filed with the SEC, Washington, D.C. 20549, under the Securities
Act a registration statement on Form S-1 relating to the Common Stock offered
hereby. This prospectus does not contain all of the information set forth in the
registration statement and the exhibits and schedules thereto. For further
information with respect to Sagent and the shares we are offering pursuant to
this prospectus you should refer to the registration statement, including the
exhibits and schedules thereto. Statements contained in this prospectus as to
the contents of any contract, agreement or other document referred to are not
necessarily complete, and you should refer to the copy of such contract or other
document filed as an exhibit to the registration statement or such other
document. You may inspect a copy of the registration statement without charge at
the Public Reference Section of the SEC at Room 1024, 450 Fifth Street, N.W.,
Washington, D.C. 20549 or at the SEC's regional offices at 5670 Wilshire
Boulevard, 11th Floor, Los Angeles, California 90036. The SEC maintains an
Internet site that contains reports, proxy and information statements and other
information regarding registrants that file electronically with the SEC. The
SEC's World Wide Web address is www.sec.gov.
Sagent intends to furnish holders of the Common Stock with annual reports
containing, among other information, audited financial statements certified by
an independent public accounting firm and quarterly reports containing unaudited
condensed financial information for the first three quarters of each fiscal
year. Sagent intends to furnish such other reports as it may determine or as may
be required by law.
67
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
PAGE
----
SAGENT TECHNOLOGY, INC.
Report of Independent Accountants........................... F-2
Consolidated Balance Sheets as of December 31, 1997 and
1998...................................................... F-3
Consolidated Statements of Operations for the years ended
December 31, 1996, 1997 and 1998.......................... F-4
Consolidated Statements of Stockholders' Equity as of
December 31, 1997
and 1998.................................................. F-5
Consolidated Statements of Cash Flows for the years ended
December 31, 1996, 1997 and 1998.......................... F-6
Consolidated Notes to Financial Statements.................. F-7
TALUS, INCORPORATED
Report of Independent Accountants........................... F-24
Balance Sheets as of December 31, 1996 and 1997............. F-25
Statements of Operations and Retained Earnings for the years
ended December 31, 1996 and 1997.......................... F-26
Statements of Cash Flows for the years ended December 31,
1996 and 1997............................................. F-27
Notes to Financial Statements............................... F-28
Pro Forma Consolidated Financial Statements (unaudited)..... F-33
Pro Forma Consolidated Statements of Operations for the year
ended December 31, 1998 (unaudited)....................... F-34
Notes to Pro Forma Consolidated Financial Statements
(unaudited)............................................... F-35
|
F-1
REPORT OF INDEPENDENT ACCOUNTANTS
To the Stockholders and Board of Directors of
Sagent Technology, Inc.:
In our opinion, the accompanying consolidated balance sheets and the
related statements of operations and stockholders' equity and cash flows present
fairly, in all material respects, the financial position of Sagent Technology,
Inc. and its subsidiaries at December 31, 1997 and 1998, and the results of
their operations and their cash flows for each of the three years in the period
ended December 31, 1998, in conformity with generally accepted accounting
principles. These financial statements are the responsibility of the Company's
management; our responsibility is to express an opinion on these financial
statements based on our audits. We conducted our audits of these statements in
accordance with generally accepted auditing standards which require that we plan
and perform the audit to obtain reasonable assurance about whether the financial
statements are free of material misstatement. An audit includes examining, on a
test basis, evidence supporting the amounts and disclosures in the financial
statements, assessing the accounting principles used and significant estimates
made by management, and evaluating the overall financial statement presentation.
We believe that our audits provide a reasonable basis for the opinion expressed
above.
PricewaterhouseCoopers LLP
San Jose, California
January 27, 1999
F-2
SAGENT TECHNOLOGY, INC.
CONSOLIDATED BALANCE SHEETS
(IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)
ASSETS
PRO FORMA
STOCKHOLDERS'
EQUITY
DECEMBER 31, DECEMBER 31,
------------------- -------------
1997 1998 1998
-------- -------- -------------
CURRENT ASSETS:
Cash and cash equivalents.................... $ 3,813 $ 3,093
Accounts receivable, net of allowance for
doubtful accounts of $450 in 1997 and $508
in 1998................................... 1,603 5,376
Prepaid assets............................... 220 832
-------- --------
Total current assets...................... 5,636 9,301
Property and equipment, net.................. 1,396 3,044
Other assets................................. 153 851
-------- --------
Total assets.............................. $ 7,185 $ 13,196
======== ========
LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES:
Accounts payable............................. $ 512 $ 1,478
Accrued liabilities.......................... 1,383 4,216
Deferred revenue............................. 1,077 1,304
Current portion of capital lease
obligations............................... 463 1,181
-------- --------
Total current liabilities................. 3,435 8,179
Long-term portion of capital lease
obligations............................... 627 3,346
-------- --------
Total liabilities......................... 4,062 11,525
-------- --------
Commitments and contingencies (Note 5)
STOCKHOLDERS' EQUITY:
Convertible preferred stock, par value $.001
per share:
Authorized: 13,056 shares in 1997 and 15,556
in 1998;
Issued and outstanding: 12,390 shares in 1997
and 14,544 shares in 1998 and no pro forma
shares (unaudited)........................ 12 15 --
(Liquidation value of $29,554 at December 31,
1998)
Common Stock, par value $.001 per share:
Authorized: 20,000 shares in 1997 and 25,000
shares in 1998;
Issued and outstanding: 3,249 shares in 1997,
4,125 shares in 1998 and 18,495 pro forma
shares (unaudited)........................ 3 4 19
Additional paid-in capital................... 18,033 30,699 30,699
Notes receivable from stockholder............ (522) (522)
Cumulative translation adjustment............ 101 101
Accumulated deficit.......................... (14,925) (28,626) (28,626)
-------- -------- --------
Total stockholders' equity................ 3,123 1,671 $ 1,671
-------- -------- --------
Total liabilities and stockholders'
equity.................................. $ 7,185 $ 13,196
======== ========
|
The accompanying notes are an integral part of these consolidated financial
statements.
F-3
SAGENT TECHNOLOGY, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)
FOR THE YEARS ENDED DECEMBER 31,
---------------------------------
1996 1997 1998
-------- -------- ---------
REVENUES, NET:
Licenses...................................... $ 240 $ 5,728 $ 10,459
Services...................................... 39 1,350 6,584
------- ------- --------
Total revenues, net........................ 279 7,078 17,043
------- ------- --------
COST OF REVENUES:
Licenses...................................... 120 194 143
Services...................................... 127 679 4,923
------- ------- --------
Total cost of revenues..................... 247 873 5,066
------- ------- --------
Gross profit.................................... 32 6,205 11,977
------- ------- --------
OPERATING EXPENSES:
Sales and marketing........................... 2,727 5,929 12,037
Research and development...................... 3,425 4,969 6,013
General and administrative.................... 1,111 2,215 5,186
Acquired in-process technology (Note 7)....... 2,425
------- ------- --------
Total operating expenses................... 7,263 13,113 25,661
------- ------- --------
Loss from operations............................ (7,231) (6,908) (13,684)
Interest expense................................ (65) (191) (207)
Other income.................................... 257 199 190
------- ------- --------
Net loss........................................ $(7,039) $(6,900) $(13,701)
======= ======= ========
Historical basic and diluted net loss per
share......................................... $ (2.67) $ (2.41) $ (3.47)
======= ======= ========
Number of shares used in calculation of
historical basic and diluted net loss per
share......................................... 2,637 2,860 3,951
Pro forma net loss per share, basic and diluted
(unaudited)................................... $ (0.74)
========
Shares used in computing pro forma net loss per
share, basic and diluted (unaudited).......... 18,495
|
The accompanying notes are an integral part of these consolidated financial
statements.
F-4
SAGENT TECHNOLOGY, INC.
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
(IN THOUSANDS, EXCEPT PER SHARE DATA)
CONVERTIBLE
PREFERRED STOCK COMMON STOCK ADDITIONAL CUMULATIVE STOCKHOLDERS
--------------- --------------- PAID-IN TRANSLATION NOTE ACCUMULATED
SHARES AMOUNT SHARES AMOUNT CAPITAL ADJUSTMENT RECEIVABLE DEFICIT
------ ------ ------ ------ ---------- ----------- ------------ -----------
BALANCES, DECEMBER 31, 1995............. 8,122 $ 8 2,625 $2 $ 6,136 $ $ $ (986)
Issuance of Common Stock at $.09
per share........................... 13 1
Issuance of Series C Preferred Stock
at $2.50 per share for cash, net of
issuance costs of $16,483........... 2,616 3 6,525
Repurchase of Common Stock at $.045
per share........................... (18) (1)
Stock options exercised............... 14 1
Net loss.............................. (7,039)
------ --- ----- -- ------- ---- ----- --------
BALANCES, DECEMBER 31, 1996............. 10,738 11 2,634 2 12,662 -- -- (8,025)
Issuance of Series C Preferred Stock
at $2.50 per share for cash......... 79 198
Issuance of Series D Preferred Stock
at $3.18 per share for cash, net of
issuance costs of $14,856........... 1,573 1 4,983
Stock options exercised............... 615 1 67
Issuance of Series C Preferred Stock
warrant............................. 23
Issuance of Common Stock warrant...... 100
Net loss.............................. (6,900)
------ --- ----- -- ------- ---- ----- --------
BALANCES, DECEMBER 31, 1997............. 12,390 12 3,249 3 18,033 -- -- (14,925)
Issuance of Series D Preferred Stock
at $3.18 per share for cash, net of
issuance costs of $12,924........... 45 132
Issuance of Series E Preferred Stock
at $5.40 per share for cash, net of
issuance costs of $7,821............ 2,155 3 11,625
Stock options exercised............... 715 1 235
Repurchase of Series C Preferred Stock
at $2.50 per share.................. (40) (100)
Repurchase of Series D Preferred Stock
at $3.18 per share.................. (6) (18)
Repurchase of Common Stock............ (57) (20)
Issuance of Series E Preferred Stock
warrant............................. 18
Issuance of Common Stock warrants..... 96
Exercise of Common Stock options at
$5.50 per share..................... 10 55
Cumulative translation adjustment..... 101
Issuance of notes receivable for
Common Stock........................ 180 522 (522)
Exercise of stock purchase right...... 28 121
Net loss.............................. (13,701)
------ --- ----- -- ------- ---- ----- --------
BALANCES, DECEMBER 31, 1998............. 14,544 $15 4,125 $4 $30,699 $101 $(522) $(28,626)
====== === ===== == ======= ==== ===== ========
STOCKHOLDERS'
EQUITY
-------------
BALANCES, DECEMBER 31, 1995............. $ 5,160
Issuance of Common Stock at $.09
per share........................... 1
Issuance of Series C Preferred Stock
at $2.50 per share for cash, net of
issuance costs of $16,483........... 6,527
Repurchase of Common Stock at $.045
per share........................... (1)
Stock options exercised............... 1
Net loss.............................. (7,039)
--------
BALANCES, DECEMBER 31, 1996............. 4,649
Issuance of Series C Preferred Stock
at $2.50 per share for cash......... 198
Issuance of Series D Preferred Stock
at $3.18 per share for cash, net of
issuance costs of $14,856........... 4,984
Stock options exercised............... 68
Issuance of Series C Preferred Stock
warrant............................. 23
Issuance of Common Stock warrant...... 100
Net loss.............................. (6,899)
--------
BALANCES, DECEMBER 31, 1997............. 3,123
Issuance of Series D Preferred Stock
at $3.18 per share for cash, net of
issuance costs of $12,924........... 132
Issuance of Series E Preferred Stock
at $5.40 per share for cash, net of
issuance costs of $7,821............ 11,628
Stock options exercised............... 236
Repurchase of Series C Preferred Stock
at $2.50 per share.................. (100)
Repurchase of Series D Preferred Stock
at $3.18 per share.................. (18)
Repurchase of Common Stock............ (20)
Issuance of Series E Preferred Stock
warrant............................. 18
Issuance of Common Stock warrants..... 96
Exercise of Common Stock options at
$5.50 per share..................... 55
Cumulative translation adjustment..... 101
Issuance of notes receivable for
Common Stock........................ --
Exercise of stock purchase right...... 121
Net loss.............................. (13,701)
--------
BALANCES, DECEMBER 31, 1998............. $ 1,671
========
|
The accompanying notes are an integral part of these consolidated financial
statements.
F-5
SAGENT TECHNOLOGY, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(IN THOUSANDS)
YEARS ENDED
DECEMBER 31,
------------------------------
1996 1997 1998
------- ------- --------
CASH FLOWS FROM OPERATIONS:
Net loss.......................................... $(7,039) $(6,900) $(13,701)
Adjustments to reconcile net loss to net cash used
in operating activities:
Acquired in-process technology............... -- -- 2,425
Depreciation and amortization................ 268 835 1,445
Fair value of stock warrants issued.......... 123 114
Change in operating assets and liabilities,
net of acquisition:
Accounts receivable..................... (152) (1,451) (3,773)
Prepaid assets.......................... (67) (99) (550)
Other assets............................ (105) 16 (1,011)
Accounts payable........................ 513 (72) 966
Accrued liabilities..................... 221 1,136 2,833
Deferred revenue........................ 51 1,027 227
------- ------- --------
Net cash used in operating activities............... (6,310) (5,385) (11,025)
------- ------- --------
CASH FLOWS FROM INVESTING ACTIVITIES:
Maturity of restricted investments................ 26 150 --
Purchase of restricted investments................ (150) --
Purchase of property and equipment................ (1,143) (1,072) (2,696)
Acquisition of Talus, Incorporated................ -- -- (1,170)
------- ------- --------
Net cash used in investing activities............... (1,267) (922) (3,866)
------- ------- --------
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from capital lease financings............ 738 650 4,103
Payments of principal under capital lease
obligations.................................... (139) (356) (666)
Proceeds from issuance of Preferred Stock, net of
issuance costs................................. 6,527 5,183 10,360
Repurchase of Common Stock........................ (1) -- (20)
Repurchase of Preferred Stock..................... -- -- (118)
Proceeds from issuance of Common Stock............ 2 68 411
------- ------- --------
Net cash provided by financing activities........... 7,127 5,545 14,070
Effect of exchange rate changes in cash........ -- -- 101
------- ------- --------
Net decrease in cash and cash equivalents........... (450) (762) (720)
Cash and cash equivalents, beginning of year........ 5,025 4,575 3,813
------- ------- --------
Cash and cash equivalents, end of year.............. $ 4,575 $ 3,813 $ 3,093
======= ======= ========
Supplemental disclosure of cash flow information:
Cash payments for interest........................ $ 65 $ 184 $ 191
Supplemental non-cash financing activities:
Issuance of Preferred Stock warrants.............. -- 23 18
Issuance of Common Stock warrants................. -- 100 96
Issuance of Common Stock for notes and interest
receivable..................................... -- -- 522
Liabilities assumed in connection with acquisition
of Talus, Incorporated:
Fair value of assets acquired..................... 3,526
Cash paid......................................... (1,170)
Preferred Stock issued............................ (1,400)
--------
Liabilities assumed............................ $ 956
========
|
The accompanying notes are an integral part of these consolidated financial
statements.
F-6
SAGENT TECHNOLOGY, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(IN THOUSANDS, EXCEPT PER SHARE DATA)
1. FORMATION AND BUSINESS OF THE COMPANY
Sagent Technology, Inc. (the "Company") develops, markets and supports
software designed to address organizations' information access, analysis, and
delivery needs.
The Company was incorporated under the laws of the State of California in
April 1995 under the name of Savant Software, Inc. In June 1995, the Company
changed its name to Sagent Technology, Inc. The Company was reincorporated under
the laws of the State of Delaware in September 1998.
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
PRINCIPLES OF CONSOLIDATION
The consolidated financial statements include the accounts of Sagent
Technology, Inc. and its wholly-owned subsidiaries, Sagent Technology Japan KK
and Sagent Technology (Canada), Inc. All significant intercompany accounts and
transactions have been eliminated.
USE OF ESTIMATES
The preparation of financial statements in conformity with generally
accepted accounting principles requires management to make estimates and
assumptions that affect the reported amounts of assets and liabilities and
disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during the
reporting period. Actual results could differ from those estimates.
FOREIGN CURRENCY TRANSLATION
The functional currency of the Company's subsidiaries is the local
currency. Accordingly, the Company applies the current rate method to translate
the subsidiaries' financial statements into U.S. dollars. Translation
adjustments are included as a separate component of stockholders' equity in the
accompanying consolidated financial statements.
CASH AND CASH EQUIVALENTS
The Company considers all highly liquid investments with an original or
remaining maturity of three months or less at the time of purchase to be cash
equivalents.
BUSINESS RISK AND CONCENTRATION OF CREDIT RISK
The Company operates in one segment and its revenue is attributable to the
sale of one product line and related maintenance, consulting and training
services. The Company's future success will depend upon its ability to continue
to improve its product and to develop new products to meet diverse and evolving
customer demands.
Financial instruments which potentially subject the Company to
concentrations of credit risk consist primarily of temporary cash investments
(including money market accounts). The Company places its temporary cash
investments with two major financial institutions. The Company maintains
allowances for potential credit losses and such losses to date have been within
management's expectations. There were no customers with
F-7
SAGENT TECHNOLOGY, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
(IN THOUSANDS, EXCEPT PER SHARE DATA)
balances due to the Company in excess of 10% of aggregate accounts receivable at
December 31, 1998.
FAIR VALUE OF FINANCIAL INSTRUMENTS
Carrying amounts of certain of the Company's financial instruments,
including cash and cash equivalents, accounts receivable, accounts payable,
accrued expenses and other liabilities, approximate fair value due to their
short maturities. Based upon borrowing rates currently available to the Company
for loans with similar terms, the carrying value of capital lease obligations
approximates fair value.
PROPERTY AND EQUIPMENT
Property and equipment are stated at cost and depreciated on a
straight-line basis over the estimated useful lives of the related assets,
generally two to five years. Leased assets are amortized on a straight-line
basis over the lesser of the estimated useful life or the lease term. Gains and
losses upon asset disposal are taken into income in the year of disposition.
REVENUE RECOGNITION
The Company's revenues are derived from two sources, product license
revenues and service revenues. License revenues are derived from product sales
to end users, resellers and distributors and enterprise application vendors as
well as royalties from enterprise application vendors. License revenues are
based upon the number and capacity of servers on which a product is installed,
as well as on a per user basis. Service revenues are derived from providing
consulting and training, maintenance and support services to end users.
The Company recognizes revenues in accordance with the American Institute
of Certified Public Accountants Statement of Position No. 97-2. License revenues
from sales to end users are recognized upon shipment of the product, if a signed
contract exists, the fee is fixed and determinable and collection is deemed
probable. If an acceptance period is provided, revenue is recognized upon the
earlier of customer acceptance or the expiration of that period. The Company
recognizes royalty as revenues based on an enterprise application vendor's
sell-through of the Company's products. Fees for services are charged separately
from licenses. Service revenues from consulting and training are recognized upon
completion of the work to be performed. Revenues from maintenance and support
agreements which includes product updates are deferred and recognized on a
straight-line basis as service revenues over the term of the related agreement,
which is typically one year.
The Company performs ongoing credit evaluations of its customers' financial
condition and does not require collateral. The Company maintains allowances for
potential credit losses and the amount of such losses have been within
management's expectations.
ADVERTISING
The Company expenses advertising costs as incurred. Advertising costs
amounted to $137, $50, and $532 for 1996, 1997 and 1998, respectively.
F-8
SAGENT TECHNOLOGY, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
(IN THOUSANDS, EXCEPT PER SHARE DATA)
INCOME TAXES
The Company accounts for income taxes in accordance with Financial
Accounting Standards Board ("FASB") Statement of Financial Accounting Standards
("SFAS") No. 109, "Accounting for Income Taxes." This statement prescribes the
use of the liability method whereby deferred tax assets and liabilities are
determined based on the differences between financial reporting and tax bases of
assets and liabilities and measured at tax rates that will be in effect when the
differences are expected to reverse. Valuation allowances are established when
necessary to reduce deferred tax assets where it is more likely than not the
deferred tax asset will not be realized.
STOCK-BASED COMPENSATION
In 1997, the Company adopted the disclosure provisions of SFAS No. 123,
"Accounting for Stock-based Compensation." The Company has elected to continue
accounting for stock-based compensation issued to employees using Accounting
Principles Board ("APB") Opinion No. 25, "Accounting for Stock Issued to
Employees," and, accordingly, pro forma disclosures required under SFAS No. 123
have been presented (See Note 9). Under APB No. 25 ("APB No. 25"), compensation
expense is based on the difference, if any, on the date of the grant, between
the fair value of the Company's Common Stock and the exercise price.
Additionally, pursuant to SFAS No. 123, stock issued to non-employees is
accounted for at the fair value of the equity instruments issued, or at the fair
value of the consideration received, whichever is more reliably measurable.
RESEARCH AND DEVELOPMENT EXPENSES
Costs related to research, design and development of products are charged
to research and development expense as incurred. Software development costs are
capitalized beginning when a product's technological feasibility has been
established and ending when a product is available for general release to
customers. To date, completing a working model of the Company's products and
general release have substantially coincided. As a result, the Company has not
capitalized any software development costs.
RECLASSIFICATION
The Company has reclassified the presentation of certain prior year
information to conform to the current year presentation. These changes had no
effect on previously reported financial position or results of operations.
NET LOSS PER SHARE AND PRO FORMA NET LOSS PER SHARE
The Company computes net loss per share in accordance with SFAS No. 128,
"Earnings per Share," ("SFAS No. 128") and The Securities and Exchange
Commission ("SEC") Staff Accounting Bulletin No. 98 ("SAB 98"). Under the
provisions of SFAS No. 128 and SAB 98, basic net loss per share is computed by
dividing the net loss available to common stockholders for the period by the
weighted average number of common shares outstanding during the period. Diluted
net loss per share is computed by dividing the net loss for the period by the
weighted average number of common and common equivalent shares outstanding
during the period. Options, warrants and Convert-
F-9
SAGENT TECHNOLOGY, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
(IN THOUSANDS, EXCEPT PER SHARE DATA)
ible Preferred Stock were not included in the computation of diluted net loss
per share because the effect would be antidilutive.
Pro forma net loss per share has been computed as described above and also
gives effect, even if antidilutive, to common equivalent shares from Preferred
Stock that will automatically convert upon the closing of the Company's initial
public offering (using the as-if-converted method). If the offering contemplated
by this Prospectus is consummated, all of the convertible preferred stock
outstanding, as of the closing date will automatically be converted into an
aggregate of approximately 14,544 shares of Common Stock based on the shares of
Convertible Preferred Stock outstanding at December 31, 1998. Unaudited pro
forma stockholders' equity at December 31, 1998, as adjusted for the conversion
of Preferred Stock, is disclosed on the balance sheet.
A reconciliation of shares used in the calculation of historical and pro
forma basic and diluted net loss per share follows:
YEARS ENDED DECEMBER 31,
------------------------------
1996 1997 1998
------- ------- --------
HISTORICAL NET LOSS PER SHARE, BASIC AND
DILUTED:
Net loss................................. $(7,039) $(6,900) $(13,701)
======= ======= ========
Shares used in computing net loss per
share, basic and diluted.............. 2,637 2,860 3,951
======= ======= ========
Net loss per share, basic and diluted.... $ (2.67) $ (2.41) $ (3.47)
======= ======= ========
Antidilutive securities including
options, warrants and preferred stock
not included in historical net loss
per share calculations................ 12,006 14,350 17,055
======= ======= ========
PRO FORMA NET LOSS PER SHARE:
Net loss................................. $(13,701)
========
Shares used in computing net loss per
share, basic and diluted.............. 3,951
Adjustment to reflect assumed conversion
of convertible preferred stock........ 14,544
--------
Shares used in computing pro forma net
loss per share, basic and diluted..... 18,495
========
Pro forma net loss per share, basic and
diluted............................... $ (0.74)
========
|
RECENT ACCOUNTING PRONOUNCEMENTS
The American Institute of Certified Public Accountants ("AICPA") issued SOP
No. 98-1, "Software for Internal Use," which provides guidance on accounting for
the cost of computer software developed or obtained for internal use. SOP No.
98-1 is effective for financial statements for fiscal years beginning after
December 15, 1998. The Company does not expect that the adoption of SOP No. 98-1
will have a material impact on its financial statements.
F-10
SAGENT TECHNOLOGY, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
(IN THOUSANDS, EXCEPT PER SHARE DATA)
In June 1997, the FASB issued SFAS No. 130, "Reporting Comprehensive
Income." SFAS No. 130 is effective for fiscal years beginning after December 15,
1997. There was no difference between the Company's net loss and its total
comprehensive loss for the years ended December 31, 1996 and 1997. The only
component of comprehensive income for the year ended December 31, 1998 related
to a cumulative translation adjustment and amounted to $101.
During June 1997, the FASB issued SFAS No. 131, "Disclosures About Segments
of an Enterprise and Related Information." SFAS No. 131 replaces SFAS No. 14,
"Financial Reporting for Segments of a Business Enterprise" and changes the way
the public companies report segment information. SFAS No. 131 is effective for
fiscal years beginning after December 15, 1997 and has been adopted by the
Company for the year ending December 31, 1998. The Company markets and sells its
services primarily in North America and operates in one business segment.
In April 1998, the AICPA issued SOP 98-5 "Reporting on the Costs of
Start-Up Activities." This standard requires companies to expense the costs of
start-up activities and organization costs as incurred. In general, SOP 98-5 is
effective for fiscal years beginning after December 15, 1998. The Company
believes the adoption of SOP 98-5 will not have a material impact on its results
of operations.
3. PROPERTY AND EQUIPMENT
Property and equipment consist of the following:
AS OF DECEMBER 31,
--------------------
1997 1998
------- -------
Office equipment................................. $ 612 $ 2,166
Computer software and equipment.................. 1,847 2,996
Leasehold improvements........................... 73 83
------- -------
2,532 5,245
Less accumulated depreciation and amortization... (1,136) (2,201)
------- -------
$ 1,396 $ 3,044
======= =======
|
Property and equipment under capital leases consist of the following:
AS OF DECEMBER 31,
-------------------
1997 1998
------- --------
Computer equipment.................................. $1,594 $ 2,208
Office equipment.................................... 447 1,527
------ -------
2,041 3,735
Less accumulated amortization....................... (811) (1,662)
------ -------
$1,230 $ 2,073
====== =======
|
F-11
SAGENT TECHNOLOGY, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
(IN THOUSANDS, EXCEPT PER SHARE DATA)
4. ACCRUED LIABILITIES
Accrued liabilities consists of the following:
AS OF DECEMBER 31,
------------------
1997 1998
------- -------
Accrued employee compensation........................ $ 530 $1,198
Sales returns and allowances......................... -- 830
Accrued taxes........................................ -- 622
Accrued other........................................ 853 1,566
------ ------
$1,383 $4,216
====== ======
|
5. COMMITMENTS AND CONTINGENCIES
The Company has entered into an equipment line of credit with a leasing
company and a bank. See Note 6 of Notes to Consolidated Financial Statements.
The capital lease obligations, which expire through January 2002 are
collateralized by the related assets. Under the terms of the capital lease
obligations, the Company is responsible for taxes, insurance and maintenance
costs. The Company also leases various facilities under noncancelable operating
leases expiring through August 2003. Future minimum lease payments under these
leases at December 31, 1998, are as follows:
OPERATING CAPITAL
LEASES LEASES
----------- -------
1999............................................... $1,771 $1,404
2000............................................... 1,623 2,831
2001............................................... 1,491 628
2002............................................... 1,536 8
2003............................................... 1,312 --
------ ------
Total minimum lease payments....................... $7,733 4,871
======
Less amount representing interest.................. (344)
------
Present value of minimum lease payments............ 4,527
Current portion.................................... 1,181
------
$3,346
======
|
Rent expense for the years ended December 31, 1996, 1997, and 1998 was
$241, $606, and $1,112, respectively.
In May 1998, Acta Technology, Inc. ("Acta") filed suit in the United States
District Court, Northern District of California (the "Federal Litigation")
against the Company, and in June 1998, Acta filed an amended complaint. Acta
alleged, among other things, that the Company committed copyright infringement
of certain of its software code. In addition Acta alleged that the Company
committed conversion, fraud and unfair competition. Acta sought a declaration
that it did not misappropriate any trade secrets of the Company, injunctive
relief, monetary damages, costs and attorneys' fees. The Company intends to
vigorously contest Acta's claims in the Federal Litigation.
F-12
SAGENT TECHNOLOGY, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
(IN THOUSANDS, EXCEPT PER SHARE DATA)
In May 1998, the Company filed suit against Acta and its founders (the
"Defendants") in Superior Court of California, Santa Clara County (the "State
Litigation"). The Company alleged that the Defendants misappropriated certain of
the Company's trade secrets. In addition, the Company alleged breach of
contract, violation of the covenant of good faith and fair dealing, breach of
confidence, fraud and unfair competition. The Company is seeking injunctive
relief and monetary damages, including costs and reasonable costs and reasonable
attorneys' fees.
Both the Federal and State Litigation are currently pending. Although the
Company does not believe such litigation will have a material impact on the
Company, litigation, regardless of its outcome, could result in substantial cost
and diversion of resources of the Company. On December 8, 1998, the parties
stipulated in the State Litigation to enter into mediation, which has been
scheduled for February 3, 1999, and which will address both the Federal and
State Litigation.
6. LINE OF CREDIT
During 1997, the Company entered into a loan and security agreement with a
bank under which the Company can borrow up to an aggregate amount of $4.8
million. The agreement is used to finance various leased assets and (see also
Note 3) includes a revolving line of credit (revolving line) for up to $2
million and an equipment line of credit (equipment line) for up to $2.8 million.
Both lines are collateralized by all assets of the Company, including
receivables, equipment and intellectual property.
The revolving line consists of advances against eligible accounts
receivable in an aggregate amount not to exceed the lesser of, the committed
revolving line or the borrowing base, less any outstanding letters of credit.
Advances against the revolving line bear interest at the bank's prime rate
(7.75% at December 31, 1998) and are due no later than January 15, 2000. During
1998 advances totaled $1.75 million.
The equipment line consists of advances for the acquisition of equipment
through May 5, 1999. Each advance bears interest at the bank's prime rate (7.75%
at December 31, 1998) and is due in 36 monthly principal and interest payments.
The equipment line matures on May 7, 2002.
Under these agreements, the Company is required to comply with certain
covenants, among which are minimum quick ratios, debt to net worth ratios,
tangible net worth ratios and profitability. As of December 31, 1998, the
Company was not in compliance with certain of these covenants. Subsequent to
December 31, 1998, the loan and security agreement was amended to waive the
aforementioned covenant violations through the period ending December 31, 1998.
7. ACQUISITION OF BUSINESS
In February 1998, the Company acquired Talus, Incorporated for cash of
approximately $1.2 million, 259 shares of preferred stock amounting to $1.4
million and the assumption of certain liabilities for an aggregate purchase
price of $3.526 million. The Company accounted for the acquisition under the
purchase method and, accordingly, the
F-13
SAGENT TECHNOLOGY, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
(IN THOUSANDS, EXCEPT PER SHARE DATA)
purchase price was allocated to the fair value of tangible and intangible assets
acquired and liabilities assumed.
The Company has allocated approximately $2.4 million of the purchase price
to acquired in-process technology. The determination of the acquired in-process
technology allocation was based upon recently issued guidance issued by the SEC
to the AICPA SEC Regulations Committee and considered such factors as degree of
completion, technological uncertainties, costs incurred and projected costs to
complete. The value assigned to the acquired workforce was based on replacement
cost. The allocation of the purchase price resulted in additional intangible
assets (primarily non-compete agreements and the value of an acquired workplace)
of $587, which as been capitalized and is being amortized on a straight line
basis over six-months to three years. Amortization expense for the year ended
December 31, 1998 was $102.
As of the date of acquisition, the Talus development project consisted of
ongoing research and development efforts on decision support applications for
manufacturing, food service and hospitality, and high technology. Based on
management's estimates, the remaining research and development efforts relating
to the completion of the technology were expected to continue into 2000.
Accordingly, the cost to complete the inprocess technology was estimated based
on the number of man months required to reach technological feasibility for the
technology, the type of professional and engineering staff involved in the
completion process and their fully burdened months' salaries. Management
estimated the direct costs to achieve technological feasibility to be
approximately $1,800.
The preliminary allocation of the Company's aggregate purchase price to the
tangible and identifiable intangible assets acquired and liabilities assumed in
connection with this acquisition were based primarily on estimates by
independent appraisers of fair values. The allocation is summarized below:
TALUS
Acquired in-process technology....................... $2,425
Current assets....................................... 494
Other intangibles.................................... 587
Other assets......................................... 11
Goodwill............................................. 9
------
Total purchase price....................... $3,526
======
|
The excess of the purchase price over the fair value of the net tangibles
and identifiable intangible assets acquired has been recorded as goodwill, which
is being amortized on a straight-line basis over a period of three year.
8. CONVERTIBLE PREFERRED STOCK
Holders of Series A, B, C, D and E Preferred Stock are entitled to
preferential noncumulative dividends at the rate of $.04, $.07, $.20, $.25 and
$.43 per share, respectively, if and when declared by the Board of Directors. No
dividends have been declared as of December 31, 1998. The holders of Series A,
B, C, D and E shares Preferred Stock have liquidation preferences of $0.45,
$0.90, $2.50, $3.18 and $5.40 per share, respectively, plus an amount equal to
all declared but unpaid dividends. In the event
F-14
SAGENT TECHNOLOGY, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
(IN THOUSANDS, EXCEPT PER SHARE DATA)
of liquidation, if the assets of the Company are insufficient to pay the
entirety of such amounts to the preferred stockholders, the assets shall be
distributed ratably among the preferred stockholders in proportion to their
preferential amounts. Preferred stockholders are entitled to one vote for each
share of Common Stock into which their Preferred Stock is convertible. After
payment to the preferred stockholders of the full preferential amounts specified
above, the remaining assets will be distributed ratably among the holders of the
Common Stock.
At the option of the holder, and at any time after the date of issuance of
such share, each share of Series A, B, C, D and E Preferred Stock is convertible
on a one-for-one basis into shares of the Company Common Stock subject to
adjustment for stock splits and certain dilutive issuances of securities. The
shares will automatically convert into Common Stock upon the closing of an
underwritten public offering of Common Stock under the Securities Act of 1933,
as amended, with minimum proceeds of $10 million. As of December 31, 1998, the
Company has reserved 14,544 shares of its Common Stock in the event of
conversion of all Preferred Stock.
All preferred shareholders have a right to first refusal to purchase any
new securities issued by the Company in proportion to the shares they currently
hold as a percentage of the total shares the Company has outstanding. The
holders of Preferred Stock have certain registration rights.
At December 31, 1998, Preferred Stock consists of the following:
COMMON
SHARES STOCK
SHARES ISSUED AND RESERVED FOR LIQUIDATION
SERIES AUTHORIZED OUTSTANDING PROCEEDS (NET) CONVERSION VALUE
------ ---------- ----------- -------------- ------------ -----------
A.................. 2,800 2,567 $ 1,138 $ 2,567 $ 1,155
B.................. 5,656 5,555 4,981 5,555 5,000
C.................. 2,800 2,655 6,625 2,655 6,637
D.................. 1,800 1,612 5,100 1,612 5,127
E.................. 2,500 2,155 11,627 2,155 11,635
------ ------ ------- ------- -------
15,556 14,544 $29,471 $14,544 $29,554
====== ====== ======= ======= =======
|
9. RESTRICTED STOCK PURCHASE AGREEMENT:
The Company has sold shares of its Common Stock to founders and employees
of the Company under agreements which provide for repurchase of the shares by
the Company at the stock's original purchase price upon termination of
employment of such persons. The Company's right to repurchase shares generally
lapses as to 1/48 of the total shares on the date of purchase and 1/48 on the
first day of each subsequent month thereafter until the founder or employee is
fully vested. At December 31, 1998, 335 shares of Common Stock were subject to
repurchase.
10. STOCK OPTION PLAN:
Under the 1995 Stock Option Plan (the "1995 Plan"), the Company initially
reserved 1,200 shares of Common Stock for issuance to employees, officers,
directors and
F-15
SAGENT TECHNOLOGY, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
(IN THOUSANDS, EXCEPT PER SHARE DATA)
consultants of the Company. The Company amended the 1995 Plan in 1996, 1997 and
1998 to increase the number of shares reserved under the 1995 Plan to, in the
aggregate, 1,800 shares, 2,800 shares and 3,276 shares, respectively.
Under the terms of the 1995 Plan, incentive stock options may be granted at
prices not lower than fair market value at the date of grant, while nonqualified
options may be granted at prices not lower than 85% of fair market value at the
date of grant, each as determined by the Board of Directors. However, if an
employee or other person who, at the time of the grant of such stock option,
owns stock representing more than 10% of the voting power of all classes of
stock in the Company, the exercise price may be no less than 110% of the fair
market value per share on the date of grant. Options granted under the 1995 Plan
are exercisable immediately, conditioned upon the optionee entering into a
restricted stock purchase agreement, and generally vest to the extent of 25% of
the shares granted 12 months from the vesting commencement date and the
remainder to the extent of 1/48 of the options granted each month thereafter,
such that all options granted will be vested four years from the vesting
commencement date. Options granted expire 10 years from the date of grant.
In December 1998, the Board of Directors approved the 1998 Stock Option
Plan (the "1998 Plan") which authorized 2,440 shares of the Common Stock as
available for issuance to employees, officers, directors and consultants of the
Company.
Under the terms of the 1998 Plan, incentive options may be granted at
prices not lower than fair market value at the date of grant, while nonqualified
options may be granted at prices as determined by the Administrator at the date
of grant. However, if an employee or other person who, at the time of the grant
of such stock option, owns stock representing more than 10% of the voting power
of all classes of stock in the Company, the exercise price may be no less than
110% of the fair market value per share on the date of grant. In the case of
nonqualified options intended to qualify as performance-based compensation, the
exercise price shall be no less than 100% of fair market value on the date of
grant.
Options granted under the 1998 Plan are generally exercisable one year
after the vesting commencement date. Upon exercise of an option, the optionee
shall enter into a restricted stock purchase agreement. Options generally vest
to the extent of 25% of the shares granted 12 months from the vesting
commencement date and the remainder to the extent of 1/48 of the shares granted
each month thereafter, such that all options granted will be vested four years
from the vesting commencement date. Options generally expire 10 years from the
date of grant.
Upon adoption of the 1998 Plan, the Board of Directors approved the
cessation of grants under the 1995 Plan and determined that all shares of Common
Stock then reserved under the 1995 Plan for the future grant of stock options
were no longer reserved for issuance.
At December 31, 1998, 1,158 shares were no longer subject to repurchase. Of
the stock options exercised, 879 shares were no longer subject to repurchase.
F-16
SAGENT TECHNOLOGY, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
(IN THOUSANDS, EXCEPT PER SHARE DATA)
The following table summarizes activity under the Company's stock option
plans for the years ended December 31, 1996, 1997 and 1998:
WEIGHTED
AGGREGATE AVERAGE
NUMBER OF EXERCISE PRICE EXERCISE EXERCISE
SHARES PER SHARE PRICE PRICE
--------- -------------- --------- --------
Options outstanding at January 1,
1996............................... 625 $0.05 - $ 0.09 $ 35 $0.06
Options granted under the 1995
Plan............................ 558 0.09 - $ 0.25 72 0.13
Options canceled under the 1995
Plan............................ (13) 0.09 - $ 0.25 (2) 0.13
Options exercised under the 1995
Plan............................ (14) 0.05 (1) 0.05
----- ------------- ------- -----
Options outstanding at December 31,
1996............................... 1,156 0.05 - $ 0.25 104 0.09
Options granted under the 1995
Plan............................ 1,280 0.25 - $2.80 2,309 1.80
Options canceled under the 1995
Plan............................ (146) 0.09 - $2.50 (32) 0.22
Options exercised under the 1995
Plan............................ (535) 0.05 - $ .50 (47) 0.09
----- ------------- ------- -----
Options outstanding at December 31,
1997............................... 1,755 0.05 - $2.80 2,334 1.33
Options granted under the 1995
Plan............................ 1,148 2.90 - $6.50 5,094 4.43
Options granted under the 1998
Plan............................ 219 7.00 1,532 7.00
Options canceled under the 1995
Plan............................ (182) 0.09 - $5.50 (418) 2.30
Options exercised under the 1995
Plan............................ (665) 0.05 - $5.50 (737) 1.11
----- ------------- ------- -----
Options outstanding at December 31,
1998............................... 2,275 $0.05 - $7.00 $ 7,805 $3.43
===== ============= ======= =====
|
At December 31, 1997 and 1998, 496 shares and 2,221 shares, respectively,
remained available for issuance.
The following table summarizes information with respect to stock options
outstanding at December 31, 1998:
OPTIONS OUTSTANDING
------------------------------------- OPTIONS EXERCISABLE
WEIGHTED ----------------------
AVERAGE WEIGHTED WEIGHTED
NUMBER REMAINING AVERAGE NUMBER AVERAGE
RANGE OF OF SHARES CONTRACTUAL EXERCISE OF SHARES EXERCISE
EXERCISE PRICE OUTSTANDING LIFE (YEARS) PRICE EXERCISABLE PRICE
-------------- ----------- ------------ -------- ----------- --------
$.045 - $ .09 259 7.01 $ 0.07 259 $ 0.07
.25 - .50 112 7.87 0.27 112 0.27
2.00 - 4.60 1,448 8.96 3.34 1,448 3.34
5.50 - 7.00 456 9.85 6.42 237 5.89
----- -----
.045 - 7.00 2,275 2,056
===== =====
|
The following information concerning the Company's stock option plans is
provided in accordance with SFAS No. 123. The Company accounts for such plans in
accordance with APB No. 25, "Accounting for Stock Issued to Employees."
F-17
SAGENT TECHNOLOGY, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
(IN THOUSANDS, EXCEPT PER SHARE DATA)
The fair value of each option grant has been estimated on the date of grant
using the minimum value method with the following weighted average assumptions
used for grants:
YEARS ENDED DECEMBER 31,
------------------------------
1997 1998
------------- -------------
Risk-free interest rate................. 5.31% - 6.54% 5.14% - 5.94%
Expected life........................... 4 years 4 years
Dividends............................... -- --
|
The weighted average fair value per option granted in 1996, 1997 and 1998
was $0.15, $1.50 and $4.94, respectively.
The following pro forma net loss and net loss per share information has
been prepared as if the Company had followed the provisions of SFAS No. 123:
YEARS ENDED DECEMBER 31,
------------------------------
1996 1997 1998
------- ------- --------
Net loss
As reported........................... $(7,039) $(6,900) $(13,701)
Pro forma............................. (7,042) (6,940) (13,999)
Basic and diluted net loss per share
As reported........................... (2.67) (2.41) (3.47)
Pro forma............................. (2.67) (2.43) (3.54)
|
11. NON-PLAN STOCK OPTIONS:
During 1996, the Company granted options to purchase 268,255 shares to an
officer of the Company outside of the 1995 Stock Option Plan. These options are
exercisable at $.09 per share and vest at the rate of 1/48 per month over a
four-year period. In addition, these options have certain accelerated vesting
requirements in the event of a change of control in the Company, as defined in
the option grant agreement.
At December 31, 1998 and 1997, 38,255 and 268,255 shares of Common Stock,
respectively, were reserved for the exercise of non-plan stock options.
At December 31, 1998, the non-plan stock options exercised 45,575 shares
are subject to repurchase.
F-18
SAGENT TECHNOLOGY, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
(IN THOUSANDS, EXCEPT PER SHARE DATA)
The following table summarizes activity under the non-plan stock options
for the years ended December 31, 1996, 1997 and 1998:
WEIGHTED
EXERCISE AGGREGATE AVERAGE
NUMBER OF PRICE EXERCISE EXERCISE
SHARES PER SHARE PRICE PRICE
--------- --------- --------- --------
Options outstanding at January 1,
1996............................... -- -- -- --
Options granted.................... 268 $0.09 $ 24 $0.09
---- ----- ---- -----
Options outstanding and exercisable
at December 31, 1996............... 268 0.09 24 0.09
---- ----- ---- -----
Options outstanding and exercisable
at December 31, 1997............... 268 0.09 24 0.09
Options exercised.................. (230) 0.09 (21) 0.09
---- ----- ---- -----
Options outstanding and exercisable
at December 31, 1998............... 38 $0.09 $ 3 $0.09
==== ===== ==== =====
|
At December 31, 1998, the remaining contractual life of these options was
7.18 years.
The Company accounts for the fair value of its non-plan stock option grants
under the non-stock plan in accordance with APB 25. Accordingly, no compensation
expense has been recognized for the non-plan stock options.
The fair value of the options is estimated using the minimum value option
pricing method allowable for non-public companies and using the following
assumptions; dividend yield of 0%, volatility of 0%, risk-free interest rate of
6.45% at the date of grant, and an expected term of four years.
12. STOCKHOLDER NOTES RECEIVABLE
Stockholder notes receivable represents amounts due from a stockholder in
exchange for the issuance of Common Stock together with interest. The notes bear
interest at a rate of 5.47% and are due February 1, 2001 but may be repaid
earlier. The notes are collateralized by a pledge of a portion of the underlying
Common Stock issued.
13. WARRANTS
In connection with equipment leasing activity under a master lease
agreement with a leasing company, the Company has issued warrants to the leasing
company to purchase up to 42 shares of Series A Preferred Stock at a price of
$.45 per share, 61 shares of Series B Preferred Stock at a price of $.90 per
share and 22 shares of Series C Preferred Stock at a price of $2.50 per share.
Each warrant has a seven year life and can be exercised at any time prior to
expiration, except that the warrants will immediately expire on the effective
date of an initial public offering if not exercised. The estimate fair value of
these warrants of $22 has been recorded as debt issuance costs.
In connection with a reseller and technology license agreement with another
software company, the Company issued a warrant to purchase up to 70 shares of
the Company's Common Stock. The warrant can be exercised at any time prior to
expiration. The exercise
F-19
SAGENT TECHNOLOGY, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
(IN THOUSANDS, EXCEPT PER SHARE DATA)
price will be equal to $7.20 per share. The warrant expires on December 22,
2002. The estimate fair value of the warrant of $100 has been recorded as cost
of sales.
The Company issued warrants to purchase Common and Preferred Stock to
establish and increase a line of credit with a financial institution. Each
warrant can be exercised at any time prior to expiration. At December 31, 1998
such warrants were as follows.
SHARES OF EXERCISE
COMMON PRICE
STOCK PER SHARE EXPIRATION DATE
--------- --------- ---------------------------
Series D Preferred Stock... 93 $3.18 Later of July 16, 2007 or
five years after the
closing of an initial
public offering
Series E Preferred Stock... 3 5.40 Later of May 7, 2008 or
five years after the
closing of an initial
public offering
Common Stock............... 6 6.50 Later of September 30, 2008
or five years after the
closing of an initial
public offering
|
The estimate fair value of these warrants of $54 has been recorded as debt
issuance costs. In 1998, in connection with a joint venture to conduct business
in a foreign country, the Company issued a warrant to purchase 22 shares of
Common Stock at a price of $5.40 per share. The warrant is immediately
exercisable and expires on the later of May 21, 2003, the closing of a business
combination or the closing of the Company's initial public offering. The
estimate fair value of the warrant of $60 has been recorded as general and
administrative expense.
The estimated fair value of these warrants have been determined based on a
Black Scholes fair value model.
14. INCOME TAXES
The Company's effective tax rate differs from the U.S. Federal statutory
tax rate as follows:
YEARS ENDED DECEMBER 31,
-----------------------------
1996 1997 1998
------- ------- -------
Tax benefit at statutory rate................ $(2,393) $(2,346) $(4,652)
State taxes, net of federal benefit.......... -- -- (744)
Nonrecognition of tax benefits............... 2,481 2,554 5,885
Tax credits.................................. (100) (240) (420)
Other........................................ 12 32 (69)
------- ------- -------
$ -- $ -- $ --
======= ======= =======
|
F-20
SAGENT TECHNOLOGY, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
(IN THOUSANDS, EXCEPT PER SHARE DATA)
Deferred tax assets (liabilities) are comprised of the following:
AS OF DECEMBER 31,
1997 1998
------- --------
Deferred tax assets and liabilities:
Net operating loss carry forwards............... $ 4,083 $ 7,588
Capitalized research and development costs...... 958 1,796
Research and development credit................. 516 1,080
Depreciation and amortization................... 73 68
Other........................................... 460 1,457
------- --------
6,090 11,989
Valuation allowance............................... (6,090) (11,989)
------- --------
$ -- $ --
======= ========
|
Due to the uncertainty surrounding the realization of the deferred tax
asset in future tax returns, the Company has placed a valuation allowance
against its net deferred tax assets. The valuation allowance increased by $2,139
and $5,899 during 1997 and 1998, respectively.
The difference between the statutory rate of approximately 40% (34% federal
and 6% state, net of federal benefits) and the tax benefit of zero recorded by
the Company is primarily due to the Company's full valuation allowance against
its net deferred tax assets.
At December 31, 1998, the Company had available net operating loss
carryforwards for federal and state income tax purposes of approximately $20,775
and $17,819, respectively. These carryforwards expire from 2003 to 2018.
Although a significant portion of the state net operating loss expire in 2003.
At December 31, 1998, the Company also had available research and development
credit carryforwards for federal and state income tax purposes of approximately
$741 and $514 respectively. These carryforwards expire from 2010 to 2013.
For federal and state tax purposes, a portion of the Company's net
operating loss carryforwards may be subject to certain limitation on annual
utilization in case of a change in ownership, as defined by federal and state
tax law.
15. EMPLOYEE BENEFIT PLANS
Sagent maintains a Profit Sharing Salary Deferral 401(k) plan for all of
its employees. This plan allows eligible employees to defer up to 15%, but no
greater than the stated limitation in any plan year, of their pretax
compensation in certain investments at the discretion of the employee. Under the
Plan, the Company is not required to and has not made a contribution to the Plan
for 1996, 1997 or 1998.
Sagent Professional Services maintained a separate Profit Sharing Salary
Deferral 401(k) plan for eligible employees until January 1, 1999. This Plan
allowed eligible employees to defer up to 15%, but no greater than the stated
limitation in any plan year, of their pretax compensation in certain investments
at the discretion of the employee. Under the Plan the Company was required to
make matching contributions to the Plan. The Company could elect to make
additional contributions on the basis of (a) a percentage of
F-21
SAGENT TECHNOLOGY, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
(IN THOUSANDS, EXCEPT PER SHARE DATA)
the employee deferral and (b) profit sharing. Costs related to matching
contributions amounted to $0, $50 and $51 for 1996, 1997 and 1998, respectively.
Effective January 1, 1999, all employees, including those formerly covered
by the Profit Sharing Salary Deferral 401(k) plan of Sagent Professional Group,
will be included in the Profit Sharing Salary Deferral 401(k) plan of Sagent
Technology, Inc.
16. SUBSEQUENT EVENTS
In January 1999, the Board of Directors adopted the Director Plan, subject
to stockholder approval, which allows the Company to grant up to 150 shares of
Common Stock to non-employee directors. The exercise price of any option granted
under the Director Plan will be equal to the fair market value per share of
Common Stock on the date of grant. Each option granted will have a term of ten
years and the shares subject to the option will become exercisable in four equal
annual installments subject to the optionee's completion of each year of Board
service.
The 1999 Purchase Plan was adopted by the Board of Directors in January
1999, subject to stockholder approval, a total of 450 shares of common stock has
been reserved for issuance under the 1999 Purchase Plan. The number of shares
reserved will be subject to an annual increase every January equal to the lesser
of the number of shares optioned during the prior year or lesser amount
determined by the Board of Directors. The 1999 Purchase Plan permits eligible
employees to purchase Common Stock through payroll deductions at a price equal
to 85% of the lower of the fair market value of the common stock at the
beginning or end of each six-month offering period.
Upon the closing of the Company's initial public offering the authorized
capital stock will be 70,000 shares of Common Stock, $0.001 par value, and 5,000
shares of Preferred Stock, $0.001 par value.
F-22
TALUS, INCORPORATED
INDEX TO FINANCIAL STATEMENTS
PAGE(S)
-------
Report of Independent Accountants........................... F-24
Balance Sheets.............................................. F-25
Statements of Operations and Retained Earnings.............. F-26
Statements of Cash Flows.................................... F-27
Notes to Financial Statements............................... F-28
|
F-23
REPORT OF INDEPENDENT ACCOUNTANTS
To the Board of Directors of Sagent Technology, Inc.
and Talus, Incorporated Stockholders:
We have audited the accompanying balance sheets of Talus, Incorporated
(formerly known as InCASE Corporation) as of December 31, 1996 and 1997, and the
related statements of operations and retained earnings and cash flows for each
of the two years in the period ended December 31, 1997. These financial
statements are the responsibility of the Company's management. Our
responsibility is to express an opinion on these financial statements based on
our audits.
We conducted our audits in accordance with generally accepted auditing
standards. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material
misstatement. An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements. An audit also includes
assessing the accounting principles used and significant estimates made by
management, as well as evaluating the overall financial statement presentation.
We believe that our audits provide a reasonable basis for our opinion.
In our opinion, the financial statements referred to above present fairly,
in all material respects, the financial position of Talus, Incorporated as of
December 31, 1996 and 1997, and the results of operations and its cash flows for
each of the two years in the period ended December 31, 1997 in conformity with
generally accepted accounting principles.
PricewaterhouseCoopers LLP
McLean, VA
February 20, 1998
F-24
TALUS, INCORPORATED
BALANCE SHEETS
(IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)
YEARS ENDED
DECEMBER 31,
------------
1996 1997
---- ----
ASSETS
CURRENT ASSETS:
Cash...................................................... $ 13 $ 1
Accounts receivable, net.................................. 511 361
Prepaid expenses.......................................... 7 35
---- ----
Total current assets................................. 531 397
Property and equipment, net............................... 111 76
Deposits and other noncurrent assets...................... 19 8
---- ----
Total assets......................................... $661 $481
==== ====
LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES:
Borrowings under line of credit........................... $299 $ 90
Note payable.............................................. -- 90
Accounts payable and accrued expenses..................... 97 63
Accrued vacation.......................................... 41 36
Accrued retirement contributions.......................... 49 50
Due to stockholders....................................... 17 --
---- ----
Total current liabilities............................ 503 329
Accrued bonus to stockholders.......................... 105 105
---- ----
Total liabilities.................................... 608 434
---- ----
Commitments (Note 5)
STOCKHOLDERS' EQUITY
Common Stock; par value $.01 per share; authorized 200
shares; issued and outstanding 102 shares.............. 1 1
Additional paid-in capital................................ 4 4
Retained earnings......................................... 48 42
---- ----
Total stockholders' equity........................... 53 47
---- ----
Total liabilities and stockholders' equity........... $661 $481
==== ====
|
The accompanying notes are an integral part of these financial statements.
F-25
TALUS, INCORPORATED
STATEMENTS OF OPERATIONS AND RETAINED EARNINGS
(IN THOUSANDS)
YEARS ENDED
DECEMBER 31,
----------------
1996 1997
------ ------
Gross revenue............................................... $2,667 $2,830
OPERATING EXPENSES:
Cost of goods sold..................................... 1,238 1,178
Sales and marketing.................................... 161 140
Research and development............................... 573 627
General and administrative............................. 686 857
------ ------
Operating income............................................ 9 28
------ ------
OTHER INCOME (EXPENSE):
Interest expense....................................... (22) (30)
Loss on investment..................................... (2) --
Loss on disposal of property and equipment............. -- (4)
Net loss.................................................... (15) (6)
Retained earnings, beginning of year........................ 63 48
------ ------
Retained earnings, end of year.............................. $ 48 $ 42
====== ======
|
The accompanying notes are an integral part of these financial statements.
F-26
TALUS, INCORPORATED
STATEMENTS OF CASH FLOWS
(IN THOUSANDS)
YEARS ENDED
DECEMBER 31,
1996 1997
------ -----
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss.................................................. $ (15) $ (6)
Adjustments to reconcile net losses to net cash provided
by (used in) operating activities:
Depreciation and amortization.......................... 43 40
Provision for doubtful accounts and writeoff of
uncollectible accounts............................... 40 41
Loss on sale of property and equipment................. -- 4
Changes in operating assets and liabilities:
Accounts receivable.................................. (176) 109
Prepaid expenses..................................... (10) (28)
Deposits............................................. (14) 10
Accounts payable and accrued expenses................ -- (34)
Accrued vacation..................................... -- 1
Accrued retirement contributions..................... 7 (4)
Accrued stockholders bonus........................... (45) --
------ -----
Net cash provided by (used in) operating activities......... (170) 133
------ -----
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property and equipment....................... (12) (9)
Sales of property and equipment........................... -- 1
------ -----
Net cash used in investing activities....................... (12) (8)
------ -----
CASH FLOWS FROM FINANCING ACTIVITIES:
Borrowings under line of credit........................... 1,112 769
Repayments on line of credit.............................. (940) (978)
Proceeds from issuance of stockholder note................ 17 --
Repayment of stockholder note............................. -- (17)
Proceeds from note payable................................ -- 100
Repayments of note payable................................ -- (11)
Distributions to stockholders............................. -- --
------ -----
Net cash (used in) provided by financing activities......... 189 (137)
------ -----
Net increase (decrease) in cash............................. 7 (12)
Cash at beginning of year................................... 6 13
------ -----
Cash at end of year......................................... $ 13 $ 1
====== =====
Supplemental disclosure of cash flow information:
Cash paid for interest.................................... $ 21 $ 30
Write-off of investment received in exchange for
services............................................... 2 --
|
The accompanying notes are an integral part of these financial statements.
F-27
TALUS, INCORPORATED
NOTES TO FINANCIAL STATEMENTS
(IN THOUSANDS)
1. DESCRIPTION OF BUSINESS
Talus, Incorporated (previously known as InCASE Corporation) was formed to
provide advanced information technology services to both governmental and
commercial customers. Talus, Incorporated (the "Company") was incorporated in
Virginia in 1992 and is owned by two stockholders. The primary activities of the
Company consist of software engineering and data warehousing consulting.
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
BASIS OF ACCOUNTING
These financial statements have been prepared on the accrual basis of
accounting in accordance with generally accepted accounting principles.
ACCOUNTS RECEIVABLE
Accounts receivable include amounts billed and unbilled costs and fees
recoverable under contracts. Included in unbilled costs and fees at December 31,
1997 and 1996 are amounts currently billable in accordance with specified
contract terms. Of the stated amounts, $224 and $331 were billed by December 31,
1997 and 1996, respectively.
PROPERTY AND EQUIPMENT
Property and equipment are recorded at cost and depreciated using the
straight-line method over the estimated useful lives of the respective assets as
follows:
DESCRIPTION YEARS
----------- -----
Furniture and fixtures...................................... 7
Software.................................................... 3
Office equipment............................................ 5
|
Expenditures for repairs and maintenance are charged to expense as
incurred. The costs of major improvements are capitalized and depreciated over
their estimated useful lives. The cost and related accumulated depreciation of
property and equipment are removed from the accounts upon disposition and any
resulting gain or loss is reflected in operations at that time.
REVENUE RECOGNITION
The Company's revenue is derived primarily from time and materials
contracts. Revenue on time and material contracts is recognized based on actual
hours performed at the contracted hourly rate plus the costs of any direct
materials provided.
INCOME TAXES
The Company has elected to be treated as an "S" Corporation under the
Internal Revenue Code. Accordingly, the income or loss of the Company is taxable
to the stockholders and the Company is not liable for federal and state income
taxes.
F-28
TALUS, INCORPORATED
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
(IN THOUSANDS)
MAJOR CUSTOMERS
During 1997 and 1996, the Company's revenue was primarily derived from
three major customers, each of which contributed more than 10% of total
revenues. These customers accounted for 55% and 48% of gross revenue for 1997
and 1996, respectively. As of December 31, 1997 and 1996, these customers had
accounts receivable balances totalling $147 and $140, respectively.
ACCOUNTING ESTIMATES
The preparation of financial statements in conformity with generally
accepted accounting principles requires management to make estimates and
assumptions that affect the reported amounts of assets and liabilities and
disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during the
reporting period. Actual results could differ from those estimates.
EMPLOYEE BONUSES
The Company adopted a bonus plan in 1994 which provided that 83% of the
Company's income before bonuses be allocated to a bonus pool. Of this amount,
40% was allocated to employee performance, 40% to sales performance and 20% to
the two stockholders of the Company. In 1994 the two stockholders earned $63 in
sales performance bonuses (approximately 50% of the total sales performance
bonuses) and $25 in direct stockholder bonuses, and in 1995 they earned $17 in
direct stockholder bonuses. The two stockholders have agreed to defer collection
of these bonuses, totaling $105, until Talus is able to operate with less debt.
It is not anticipated that these bonuses will be paid during 1998.
3. ACCOUNTS RECEIVABLE
AS OF
DECEMBER 31,
------------
1996 1997
---- ----
Billed and unbilled receivables......................... $537 $389
Allowance for doubtful accounts......................... (26) (28)
---- ----
Accounts receivable, net................................ $511 $361
==== ====
|
F-29
TALUS, INCORPORATED
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
(IN THOUSANDS)
4. PROPERTY AND EQUIPMENT
Property and equipment consisted of the following:
AS OF
DECEMBER 31,
------------
1996 1997
---- ----
Furniture and fixtures.................................. $ 33 $ 23
Computers and equipment................................. 158 163
Computer software....................................... 22 27
---- ----
213 213
Less accumulated depreciation........................... 102 137
---- ----
Property and equipment, net............................. $111 $ 76
==== ====
|
Depreciation expense for the years ended December 31, 1997 and 1996 was $40
and $42, respectively.
5. COMMITMENTS
LEASE OBLIGATIONS
The Company leases its office space and various equipment under
noncancelable operating leases with original terms in excess of the year. Future
minimum payments on noncancelable operating leases were as follows at December
31, 1997:
1998.................................................... $120
1999.................................................... 113
2000.................................................... 85
----
Total......................................... $318
====
|
Rental expense was $116 and $126 for the years ended December 31, 1997 and
1996, respectively.
6. LINE OF CREDIT AND NOTE PAYABLE
In March 1995, the Company entered into a revolving credit facility
agreement with maximum borrowings of $150 subject to certain borrowing base
restrictions which matured on March 24, 1996. Interest was at the prime rate
plus 1 1/2% per annum, (a total of 10.15% at December 31, 1995). Borrowings were
collateralized by the Company's eligible accounts receivable. The Company's two
principal stockholders and one other member of management were guarantors on the
Loan Agreement.
In March 1996, the Company entered a credit facility agreement with maximum
borrowing of $300 subject to certain borrowing base restrictions. Interest was
at the prime rate plus 1 1/2% per annum, (a total of 9.75% at December 31,
1996). In April 1997, the agreement was amended to decrease the maximum
borrowings to $200, amended to increase the interest rate to prime rate plus 2%
per annum (a total of 10.5% at December 31, 1997), and extended through May
1998.
F-30
TALUS, INCORPORATED
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
(IN THOUSANDS)
In July 1997, Talus entered into a term loan agreement with the same
financial institution of $100 due July 24, 2001. Interest is at the prime rate
plus 2% per annum, (a total of 10.5% at December 31, 1997).
These agreements contain certain restrictive terms and covenants, the most
restrictive of which requires the Company to maintain a specified liabilities to
tangible net worth ratio. The Company was not in compliance with this
restrictive covenant as of December 31, 1997. Accordingly, the entire balance of
the note payable as of December 31, 1997 has been classified as current.
Borrowings are collateralized by the Company's eligible accounts receivable. The
Company's two principal stockholders and one other member of management are
guarantors on the Loan Agreement.
In 1996, majority stockholders loaned the Company $17 bearing interest at
10%. The loans were repaid during 1997.
7. RETIREMENT PLAN
In 1995, the Company established a qualified salary reduction simplified
employee pension plan (SARSEP) for all eligible employees. The Company was
required to contribute 3% of eligible salaries to the SARSEP each year. Because
of restrictions imposed by the Internal Revenue Code, the 3% contribution for
the highly compensated employees could not be made to the SARSEP. Accordingly,
the Company adopted a policy that any amount that could not be funded to the
SARSEP due to these restrictions would be paid directly to those highly
compensated employees as additional compensation. As of December 31, 1996, six
employees were deemed to be highly compensated. The compensation provided for
such employees was $17. The total Company contributions for 1996 for all
eligible employees, as defined by the Internal Revenue Code, were $32. The
SARSEP was terminated during 1997.
During 1997 the Company established a 401(k) plan for the benefit of all
eligible employees. Employees may make contributions to the plan, subject to
certain limitations contained in the Internal Revenue Code. The Company matches
up to 50% of the first 6% of compensation deferred under the plan. Employees
vest 50% in the employer contributions after one year and 100% after two years
of employment at the Company. Employer contributions to the plan were $50 for
the year ended December 31, 1997.
8. COMMON STOCK, ADDITIONAL PAID-IN CAPITAL AND STOCK OPTIONS
At the Company's inception in 1992, 25 shares of common stock with $.10 par
value per share were authorized and 10 shares were issued. In 1996, the Articles
of Incorporation were amended to authorize 200 shares of common stock with a
$.01 par value per share. A stock split was effective in 1996 increasing the
number of issued and outstanding shares to 102.
A stock option plan, which was adopted in 1996, provides for the granting
of stock options to employees. The agreements provide the participants an option
to purchase shares of the Company's stock generally based on certain time
vesting requirements. On June 21, 1996, the Company granted 7 options with an
exercise price of $1.00 per share.
F-31
TALUS, INCORPORATED
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
(IN THOUSANDS)
On May 31, 1997, the Company granted 11 options with an exercise price of $4.77
per share. As of December 1997, options for 7 shares are exercisable.
The effects of applying SFAS NO. 123 are immaterial as the application of
SFAS NO. 123 would not result in a significant difference from reported net
loss. Accordingly, the following disclosures are omitted: (1) pro forma net
income, (2) weighted-average grant date fair value of options granted during the
year and (3) description of method and assumptions used to estimate fair value
of options.
9. SUBSEQUENT EVENTS
The Company is currently negotiating a merger agreement with Sagent
Technology, Inc.
F-32
SAGENT TECHNOLOGY, INC.
PRO FORMA CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
The following financial statements present the Sagent Technology, Inc.
("Sagent") Pro Forma Consolidated Statements of Operations for the year ended
December 31, 1998.
The Company's acquisition of Talus, Incorporated ("Talus") has been
accounted for under the "purchase" method of accounting, which requires the
purchase price to be allocated to the acquired assets and liabilities of Talus
on the basis of their estimated fair values as of the date of acquisition. The
following pro forma consolidated statements of operations for the year ended
December 31, 1998 give effect to the acquisition of Talus as if it occurred on
January 1, 1998, and include adjustments directly attributable to the
acquisition of Talus and expected to have a continuing impact on the combined
company (collectively, the "Pro Forma Financial Statements").
The pro forma information is based on historical financial statements. The
pro forma results of operations for the year ended December 31, 1998 includes
the results of operations of Talus from January 1, 1998 to February 28, 1998.
The assumptions give effect to the business combination with Talus under the
purchase method of accounting. The information has been prepared in accordance
with the rules and regulations of the Commission and is provided for comparative
purposes only. The pro forma information does not purport to be indicative of
the results that actually would have occurred had the combination been effected
at the beginning of the periods presented.
F-33
SAGENT TECHNOLOGY, INC.
PRO FORMA CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED)
(IN THOUSANDS, EXCEPT PER SHARE DATA)
FOR THE YEAR ENDED DECEMBER 31, 1998
------------------------------------------------
PURCHASE PRO FORMA
SAGENT TALUS ADJUSTMENTS CONSOLIDATED
-------- -------- ----------- ------------
Total revenues, net....................... $ 17,043 $ 452 $ -- $ 17,495
Cost of revenues.......................... 5,066 167 (102) 5,131
-------- -------- -------- --------
Gross profit.............................. 11,977 285 102 12,364
Sales and marketing....................... 12,037 383 12,420
Research and development.................. 6,013 283 6,296
General and administrative................ 5,186 342 5,528
Acquired in-process technology............ 2,425 (2,425) --
-------- -------- -------- --------
Total operating expense......... 25,661 1,008 (2,425) 24,244
-------- -------- -------- --------
Loss from operations...................... (13,684) (723) (2,527) (11,880)
Interest expense.......................... (207) (207)
Other income.............................. 190 190
-------- -------- -------- --------
Net loss........................ $(13,701) $ (723) $ (2,527) $(11,897)
======== ======== ======== ========
Pro forma net loss per share.............. $ (0.74) $ (.64)
======== ========
Weighted average shares used in
computation of pro forma net loss per
share................................... 18,495 18,495
======== ========
|
See accompanying notes.
F-34
SAGENT TECHNOLOGY, INC.
NOTES TO PRO FORMA
CONSOLIDATED FINANCIAL STATEMENTS
(IN THOUSANDS)
1. BASIS OF PRESENTATION
On February 28, 1998, the Company acquired Talus, a privately held
consulting company that has experience in the design and implementation of
enterprise intelligence applications.
The unaudited pro forma information presented is not necessarily indicative
of future consolidated results of operations of Sagent or the consolidated
results of operations that would have resulted had the acquisition taken place
on January 1, 1998. The unaudited pro forma consolidated statements of
operations for the year ended December 31, 1998 reflect the effects of the
acquisition, assuming the related events occurred as of January 1, 1998 for the
purposes of the unaudited pro forma consolidated statements of operations.
2. UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL ADJUSTMENTS
The unaudited pro forma consolidated financial statements reflect a total
purchase price of $3.5 million, and the acquisition was recorded under the
purchase method of accounting. In connection with the acquisition, the Company
expensed $2.4 million of in-process technology in the quarter ended March 31,
1998. In addition, the Company recorded other intangibles of $587, which are
being amortized on a straight-line basis over six months to three years
following the acquisition. The determination of the acquired in-process
technology allocation was based upon recently issued guidance issued by the
Securities and Exchange Commission ("SEC") and considered such factors as degree
of completion, technological uncertainties, costs incurred and projected costs
to complete. In-process technology charges have not been reflected in the pro
forma consolidated financial statements of operations for the year ended
December 31, 1998 as they are considered a non-recurring charge.
3. UNAUDITED PRO FORMA CONSOLIDATED NET LOSS PER SHARE
The net loss per share and shares used in computing the net loss per share
for the year ended December 31, 1998 is based upon the historical weighted
average common shares outstanding. The Sagent Common Stock issuable upon the
exercise of the stock options and warrants have been excluded as the effect
would be antidilutive. In addition to the shares used in computing the net loss
per share above, pro forma net loss per share is calculated using the
Convertible Preferred Stock outstanding as if such shares were converted to
Common Stock at the time of issuance.
4. PURCHASE ADJUSTMENTS
Pro forma adjustments have been prepared to reflect the elimination of the
non-recurring one-time charge for acquired in-process technology and to reflect
the amortization of capitalized technology and other intangible assets.
F-35
SCHEDULE II
SAGENT TECHNOLOGY, INC.
VALUATION AND QUALIFYING ACCOUNTS
(IN THOUSANDS)
ADDITIONS
BALANCE AT (REDUCTIONS) BALANCE AT
BEGINNING IN COSTS END OF
OF PERIOD AND EXPENSES WRITE-OFFS PERIOD
---------- ------------ ---------- ----------
Allowance for doubtful accounts:
Year ended December 31,
1996.. $ -- $ -- $-- $ --
1997.. -- 450 -- 450
1998.. 450 58 -- 508
Valuation allowances for deferred
tax assets:
Year ended December 31,
1996.. $ -- $3,351 $-- $ 3,351
1997.. 3,351 2,739 -- 6,090
1998.. 6,090 5,899 -- 11,989
|
REPORT OF INDEPENDENT ACCOUNTS ON
FINANCIAL STATEMENT SCHEDULE
To the Stockholders and Board of Directors of
Sagent Technology, Inc.:
In connection with our audits of the consolidated financial statements of
Sagent Technology, Inc. as of December 31, 1997 and 1998, and for each of the
three years in the period ended December 31, 1998, which financial statements
are included in the Prospectus, we have also audited the financial statement
schedule listed in Item 16(b) herein. In our opinion, this financial statement
schedule, when considered in relation to the basic financial statements taken as
a whole, presents fairly, in all material respects, the information required to
be included therein.
/s/ PRICEWATERHOUSECOOPERS LLP
San Jose, California
January 27, 1999
|
F-37
, 1999
LOGO
SHARES OF COMMON STOCK
PROSPECTUS
DONALDSON, LUFKIN & JENRETTE
HAMBRECHT & QUIST
PIPER JAFFRAY INC.
DLJDIRECT INC.
WE HAVE NOT AUTHORIZED ANY DEALER, SALESPERSON OR OTHER PERSON TO GIVE YOU
WRITTEN INFORMATION OTHER THAN THIS PROSPECTUS OR TO MAKE REPRESENTATIONS AS TO
MATTERS NOT STATED IN THIS PROSPECTUS. YOU MUST NOT RELY ON UNAUTHORIZED
INFORMATION. THIS PROSPECTUS IS NOT AN OFFER TO SELL THESE SECURITIES OR OUR
SOLICITATION OF YOUR OFFER TO BUY THE SECURITIES IN ANY JURISDICTION WHERE THAT
WOULD NOT BE PERMITTED OR LEGAL. NEITHER THE DELIVERY OF THIS PROSPECTUS NOR ANY
SALES MADE HEREUNDER AFTER THE DATE OF THIS PROSPECTUS SHALL CREATE AN
IMPLICATION THAT THE INFORMATION CONTAINED HEREIN OR THE AFFAIRS OF THE COMPANY
HAVE NOT CHANGED SINCE THE DATE HEREOF.
UNTIL , 1999 (25 DAYS AFTER THE DATE OF THIS PROSPECTUS), ALL
DEALERS THAT EFFECT TRANSACTIONS IN THESE SHARES OF COMMON STOCK MAY BE REQUIRED
TO DELIVER A PROSPECTUS. THIS IS IN ADDITION TO THE DEALER'S OBLIGATION TO
DELIVER A PROSPECTUS WHEN ACTING AS AN UNDERWRITER AND WITH RESPECT TO THEIR
UNSOLD ALLOTMENTS OR SUBSCRIPTIONS.
PART II
INFORMATION NOT REQUIRED IN PROSPECTUS
ITEM 13. OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION
The following table sets forth the costs and expenses, other than
underwriting discounts and commissions, payable by the Registrant in connection
with the sale of Common Stock being registered. All amounts are estimates except
the registration fee and the NASD filing fee.
AMOUNT
TO BE
PAID
-------
Registration Fee............................................ $11,120
NASD Fee.................................................... 5,100
Nasdaq Listing Fee.......................................... *
Legal Fees and Expenses..................................... *
Accounting Fees and Expenses................................ *
Blue Sky Fees and Expenses.................................. *
Transfer Agent Fees......................................... *
Miscellaneous............................................... *
-------
Total............................................. $ *
=======
|
* To be filed by amendment.
ITEM 14. INDEMNIFICATION OF DIRECTORS AND OFFICERS
As permitted by Section 145 of the Delaware General Corporation Law, the
Registrant's Certificate of Incorporation includes a provision that eliminates
the personal liability of its directors for monetary damages for breach or
alleged breach of their duty of care. In addition, as permitted by Section 145
of the Delaware General Corporation Law, the Bylaws of the Registrant provide
that: (1) the Registrant is required to indemnify its directors and executive
officers and persons serving in such capacities in other business enterprises
(including, for example, subsidiaries of the Registrant) at the Registrant's
request to the fullest extent permitted by Delaware law, including in those
circumstances in which indemnification would otherwise be discretionary; (2) the
Registrant may, in its discretion, indemnify employees and agents in those
circumstances where indemnification is not required by law; (3) the Registrant
is required to advance expenses, as incurred, to its directors and executive
officers in connection with defending a proceeding (except that it is not
required to advance expenses to a person against whom the Registrant brings a
claim for breach of the duty of loyalty, failure to act in good faith,
intentional misconduct, knowing violation of law or deriving an improper
personal benefit; (4) the rights conferred in the Bylaws are not exclusive, and
the Registrant is authorized to enter into indemnification agreements with its
directors, executive officers and employees; and (5) the Registrant may not
retroactively amend the Bylaw provisions in a way that it adverse to such
directors, executive officers and employees in these matters.
The Registrant's policy is to enter into indemnification agreements with
each of its directors and executive officers that provide the maximum indemnity
allowed to directors and executive officers by Section 145 of the Delaware
General Corporation Law and the
II-1
Bylaws, as well as certain additional procedural protections. In addition, such
indemnification agreements provide that the Registrant directors and executive
officers will be indemnified to the fullest possible extent not prohibited by
law against all expenses (including attorney's fees) and settlement amounts paid
or incurred by them in any action or proceeding, including any derivative action
by or in the right of the Registrant, on account of their services as directors
or executive officers of the Registrant or as directors or officers of any other
company or enterprise when they are serving in such capacities at the request of
the Registrant. The Registrant will not be obligated pursuant to the
indemnification agreements to indemnify or advance expenses to an indemnified
party with respect to proceedings or claims initiated by the indemnified party
and not by way of defense, except with respect to proceedings specifically
authorized by the Company's Board of Directors (the "Board") or brought to
enforce a right to indemnification under the indemnification agreement, the
Registrant's Bylaws or any statute or law. Under the agreements, the Registrant
is not obligated to indemnify the indemnified party (1) for any expenses
incurred by the indemnified party with respect to any proceeding instituted by
the indemnified party to enforce or interpret the agreement, if a court of
competent jurisdiction determines that each of the material assertions made by
the indemnified party in such proceeding was not made in good faith or was
frivolous; (2) for any amounts paid in settlement of a proceedings unless the
Registrant consents to such settlement; (3) with respect to any proceeding
brought by the Registrant against the indemnified party for willful misconduct,
unless a court determines that each of such claims was not made in good faith or
was frivolous; (4) on account of any suit in which judgment is rendered against
the indemnified party for an accounting of profits made from the purchase or
sale by the indemnified party of securities of the Registrant pursuant to the
provisions of sec.16(b) of the Securities Exchange Act of 1934 and related laws;
(5) on account of conduct by the indemnified party that is finally adjudged to
have been knowingly fraudulent or deliberately dishonest, or to constitute
willful misconduct or a knowing violation of the law; (6) on account of any
conduct from which the indemnified party derived an improper personal benefit;
(7) on account of conduct the indemnified party believed to be contrary to the
best interests of the Registrant or its stockholders; (8) on account of conduct
that constituted a breach of the indemnified party's duty of loyalty to the
Registrant or its stockholders; or (9) if a final decision by a court having
jurisdiction in the matter determines that such indemnification is not lawful.
The indemnification provision in the Bylaws and the indemnification
agreements entered into between the Registrant and its directors and executive
officers may be sufficiently broad to permit indemnification of the Registrant's
officers and directors for liabilities arising under the Securities Act of 1933
(the "Securities Act").
II-2
Reference is made to the following documents filed as exhibits to this
Registration Statement regarding relevant indemnification provisions described
above and elsewhere herein:
EXHIBIT
DOCUMENT NUMBER
-------- -------
Form of Underwriting Agreement.............................. 1.1
Certificate of Incorporation of Registrant, as amended...... 3.1
Form of Amended and Restated Certificate of Incorporation of
Registrant, to be filed prior to closing of the
offering.................................................. 3.2
Bylaws of Registrant........................................ 3.3
Form of Indemnification Agreement entered into by the
Registrant with each of its directors and executive
officers.................................................. 10.1
|
ITEM 15. RECENT SALES OF UNREGISTERED SECURITIES
Since January 1, 1996, the Registrant has issued and sold the following
securities:
(a) From January 1, 1996 to December 31, 1998, the Registrant sold in the
aggregate of 1,444,443 shares of unregistered Common Stock to 55 directors,
officers, employees, former employees and consultants at prices ranging from
$0.045 to $5.50 per share, for aggregate cash consideration of $805,831.
Such shares were sold pursuant to the exercise of options granted by the
Board. As to each director, officer, employee, former employee and
consultant of the Registrant who was issued such securities, the Registrant
relied upon Rule 701 of the Securities Act. Each such person purchased
securities of the Registrant pursuant to a written contract between such
person and the Registrant. In addition, the Registrant met the conditions
imposed under Rule 701(b).
(b) On January 17, 1996 and February 25, 1997, the Registrant sold in the
aggregate 92,500 shares of unregistered Common Stock at a price per share of
$0.09 to a director and a price per share of $0.25 to a group of investors,
respectively, for aggregate cash consideration of $21,125. These shares were
sold pursuant to restricted stock purchase agreements between the Registrant
and the director and such stockholders. As to each person issued such
securities, the Registrant relied upon Section 4(2) of the Securities Act.
(c) In July, August and September 1996, the Registrant sold in the aggregate
2,615,680 shares of unregistered Series C Preferred Stock at a price per
share of $2.50 to certain investors for aggregate cash consideration of
$6,539,200. The Registrant relied upon Section 4(2) of the Securities Act
and Regulation D, Rule 506, thereunder in connection with the sale of these
shares. The sale of Series C Preferred Stock was made in compliance with all
of the terms of Rules 501 and 502 of Regulation D, there were no more than
35 investors (as calculated pursuant to Rule 501(e) of Regulation D), and
each investor who was not an accredited investor represented to the
Registrant that he or she had such knowledge and experience in financial and
business matters that he or she was capable of evaluating the merits and
risks of the investment.
(d) On March 17, 1997, the Registrant issued and sold in the aggregate 40,000
shares of unregistered Series C Preferred Stock at a price per share of
$2.50 to a director for aggregate cash consideration of $100,000. These
shares were sold pursuant to a
II-3
Series C Preferred Stock Purchase Agreement between the Registrant and the
director. Such issuance was made in reliance upon Section 4(2) of the
Securities Act. The Registrant repurchased the shares at a price per share
of $2.50 in April 1998.
(e) On June 16, 1997, the Registrant issued and sold in the aggregate 39,178
shares of unregistered Series C Preferred Stock at a price per share of
$2.50 to a consultant for aggregate cash consideration of $97,945. These
shares were sold pursuant to a Series C Preferred Stock Purchase Agreement
between the Registrant and the consultant. Such issuance was made in
reliance upon Section 4(2) of the Securities Act.
(f) In August and September 1997, the Registrant sold in the aggregate 1,572,327
shares of unregistered Series D Preferred Stock at a price per share of
$3.18 to certain investors for aggregate cash consideration of $5,000,000.
The Registrant relied upon Section 4(2) of the Securities Act and Regulation
D, Rule 506, thereunder in connection with the sale of these shares. The
sale of Series D Preferred Stock was made in compliance with all of the
terms of Rules 501 and 502 of Regulation D, there were no more than 35
investors (as calculated pursuant to Rule 501(e) of Regulation D), and each
investor who was not an accredited investor represented to the Registrant
that he or she had such knowledge and experience in financial and business
matters that he or she was capable of evaluating the merits and risks of the
investment.
(g) In January 1998, the Registrant sold in the aggregate 45,785 shares of
unregistered Series D Preferred Stock at a price per share of $3.18 to an
officer of the Registrant for aggregate cash consideration of $145,596.
These shares were sold pursuant to a Series D Preferred Stock Purchase
Agreement between the Registrant and the officer. Such issuance was made in
reliance upon Section 4(2) of the Securities Act.
(h) In February and March 1998, the Registrant sold in the aggregate 1,895,370
shares of unregistered Series E Preferred Stock at a price per share of
$5.40 to certain investors for aggregate cash consideration of $10,234,998.
The Registrant relied upon Section 4(2) of the 1933 act and Regulation D,
Rule 506, thereunder in connection with the sale of these shares. The sale
of Series E Preferred Stock was made in compliance with all of the terms of
Rules 501 and 502 of Regulation D, there were no more than 35 investors (as
calculated pursuant to Rule 501(e) of Regulation D), and each investor who
was not an accredited investor represented to the Registrant that he or she
had such knowledge and experience in financial and business matters that he
or she was capable of evaluating the merits and risks of the investment.
(i) On May 21, 1998, the Registrant sold in the aggregate 28,000 shares of
unregistered Common Stock at a price per share of $4.32 to a distributor of
the Registrant's products for aggregate cash consideration of $120,960.
These shares were sold pursuant to a stock purchase agreement between the
Registrant and the distributor. Such issuance was made in reliance upon
Section 4(2) of the Securities Act.
(j) On September 14, 1998, the Registrant sold in the aggregate 10,000 shares of
unregistered Common Stock at a price per share of $5.50 to a consultant for
aggregate cash consideration of $55,000. These shares were sold pursuant to
a stock purchase agreement between the Registrant and the consultant. Such
issuance was made in reliance upon Section 4(2) of the Securities Act.
II-4
Appropriate legends were affixed to the share certificates issued in the
transactions described above. All recipients had adequate access, through their
relationships with the Registrant, to information about the Registrant.
ITEM 16. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
(a) EXHIBITS
EXHIBIT
NUMBER DESCRIPTION
------- -----------
1.1 Form of Underwriting Agreement.
3.1 Certificate of Incorporation of Registrant.
3.2* Form of Amended and Restated Certificate of Incorporation of
Registrant to be filed prior to the closing of the offering
made under the Registration Statement.
3.3 Bylaws of Registrant.
4.1* Form of Registrant's Common Stock Certificate.
4.2 Sixth Amended and Restated Registration Rights Agreement,
dated as of February 24, 1998, between the Registrant and
the parties named therein.
4.3 Common Stock Registration Rights Agreement, dated as of
September 14, 1998, between the Registrant and Robert Hawk.
5.1* Opinion of Wilson Sonsini Goodrich & Rosati, Professional
Corporation.
10.1 Form of Indemnification Agreement entered into by Registrant
with each of its directors and executive officers.
10.2 Amended and Restated 1995 Stock Plan and related agreements.
10.3 1998 Stock Plan and related agreements.
10.4 1999 Employee Stock Purchase Plan and related agreements.
10.5 1999 Director Option Plan and related agreements.
10.6 Master Equipment Lease Agreement, dated August 7, 1995,
between the Registrant and Lighthouse Capital Partners, L.P.
10.7 Master Lease Agreement, dated as of September 26, 1998,
between the Registrant and Dell Financial Services L.P.
10.8 Loan and Security Agreement, dated as of July 16, 1997,
between the Registrant and Venture Banking Group, a division
of Cupertino National Bank, and amendments thereto.
10.9 Standard Office Lease, dated June 1, 1998, by and between
the Registrant and Asset Growth Partners, Ltd., and the
First Amendment thereto.
10.10** Development and Licensing Agreement, dated January 22, 1997,
between the Registrant and Abacus Concepts, Inc.
10.11** Microsoft License and Distribution Agreement, dated August
23, 1996, between the Registrant and Microsoft Corporation.
10.12** Value-Added Reseller Agreement, effective June 26, 1997,
between the Registrant and Automatic Data Processing, Inc.
10.13** Sagent KK Non-Exclusive Japanese Distribution Agreement,
dated as of December 17, 1997, between Sagent KK Japan and
Kawasaki Steel Systems R&D Corporation.
10.14** Exclusive Distribution Agreement, effective as of January 1,
1998, by and between the Registrant and Sagent U.K. Ltd.
10.15** Joint Venture Agreement, entered into as of April 8, 1998,
between the Registrant and ISAR-Vermogensverwaltung GbR mbH
and related agreements.
|
II-5
EXHIBIT
NUMBER DESCRIPTION
------- -----------
10.16** Exclusive Concession Agreement, effective as of November 21,
1997, by and between the Registrant and Sagent France S.A.
10.17** Value-Added Reseller/OEM Agreement, effective December 30,
1997, between the Registrant and Advent Software, Inc.
10.18 Form of Sagent Technology, Inc. End User Software License
Agreement.
10.19** OEM Software License Agreement, effective March 31, 1998,
between the Registrant and Siebel Systems, Inc.
10.20 Form of Sagent Technology, Inc. Software Maintenance and
Technical Support Agreement.
10.21 Form of Sagent Technology, Inc. Agreement for Consulting
Services.
10.22 Form of Sagent Technology, Inc. Agreement for Subcontractor
Consulting Services.
10.23 Form of Evaluation Agreement.
10.24 Note, dated February 1, 1998, of W. Virginia Walker.
10.25 Note, dated February 1, 1998, of W. Virginia Walker.
10.26** Solution Provider Agreement, effective June 27, 1997,
between the Registrant and Unisys Corporation.
10.27 Consulting Agreement, dated as of April 7, 1997, between the
Registrant and Ralph Kimball.
10.28 Executive Change of Control Policy.
10.29 Agreement and Plan of Reorganization, dated as of February
27, 1998, by and among Sagent Technology, Inc., Talus
Acquisition Corp., Talus, Incorporated and Certain
Shareholders of Talus, Inc.
10.30 Employment and Non-Competition Agreement, dated as of
February 27, 1998, between the Registrant and Michael P.
Venerable.
10.31** Software License and Services Agreement, dated March 31,
1998, between the Registrant and Siebel Systems, Inc.
21.1 Subsidiaries of the Registrant.
23.1* Consent of Wilson Sonsini Goodrich & Rosati, Professional
Corporation (included in Exhibit 5.1).
23.2 Consent of PricewaterhouseCoopers LLP, Independent
Accountants.
23.3 Consent of PricewaterhouseCoopers LLP, Independent
Accountants.
23.4* Consent of Klaus S. Luft.
24.1 Power of Attorney (See page II-8).
27.1 Financial Data Schedule (available in EDGAR format only).
|
* To be supplied by amendment.
** Confidential treatment has been requested with respect to certain portions of
this exhibit. Omitted portions have been filed separately with the Securities
and Exchange Commission.
(b) FINANCIAL STATEMENT SCHEDULES
Schedule II. Valuation and Qualifying Accounts
Schedules not listed above have been omitted because the information
required to be set forth therein is not applicable or is shown in the financial
statements or notes thereto.
II-6
ITEM 17. UNDERTAKINGS
The undersigned hereby undertakes to provide to the Underwriters at the
closing specified in the Underwriting Agreement, certificates in such
denominations and registered in such names as required by the Underwriters to
permit prompt delivery to each purchaser.
Insofar as indemnification for liabilities arising under the Securities Act
may be permitted to directors, officers and controlling persons of the
Registrant pursuant to the provisions referenced in Item 14 of this Registration
Statement or otherwise, the Registrant has been advised that in the opinion of
the Securities and Exchange Commission such indemnification is against public
policy as expressed in the Securities Act, and is, therefore, unenforceable. In
the event that a claim for indemnification against such liabilities (other than
the payment by the Registrant of expenses incurred or paid by a director,
officer, or controlling person of the Registrant in the successful defense of
any action, suit or proceeding) is asserted by such director, officer or
controlling person in connection with the securities being registered hereunder,
the Registrant will, unless in the opinion of its counsel the matter has been
settled by controlling precedent, submit to a court of appropriate jurisdiction
the question whether such indemnification by it is against public policy as
expressed in the Securities Act and will be governed by the final adjudication
of such issue.
The undersigned Registrant hereby undertakes that:
(1) For purposes of determining any liability under the Securities
Act, the information omitted from the form of prospectus filed as part of
this Registration Statement in reliance upon Rule 430A and contained in a
form of prospectus filed by the Registrant pursuant to Rule 424(b)(1) or
(4) or 497(h) under the Securities Act shall be deemed to be part of this
Registration Statement as of the time it was declared effective.
(2) For the purpose of determining any liability under the Securities
Act, each post-effective amendment that contains a form of prospectus shall
be deemed to be a new Registration Statement relating to the securities
offered therein, and the offering of such securities at that time shall be
deemed to be the initial bona fide offering thereof.
II-7
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the Registrant
has duly caused this registration statement on Form S-1 to be signed on its
behalf by the undersigned, thereunto duly authorized, in the City of Mountain
View, State of California, on this 28th day of January 1999.
SAGENT TECHNOLOGY, INC.
By: /s/ KENNETH C. GARDNER
-----------------------------------
Kenneth C. Gardner
President and Chief Executive
Officer
|
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS that each person whose signature appears
below constitutes and appoints, jointly and severally, Kenneth C. Gardner and W.
Virginia Walker and each one of them, his true and lawful attorney-in-fact and
agents, each with full power of substitution, for him and in his name, place and
stead, in any and all capacities, to sign any and all amendments (including
post-effective amendments) to this registration statement, and any registration
statement related to the offering contemplated by this registration statement
that is to be effective upon filing pursuant to Rule 462(b) under the Securities
Act of 1933 and to file the same, with all exhibits thereto and all other
documents in connection therewith, with the Securities and Exchange Commission,
granting unto said attorneys-in-fact and agents, and each of them, full power
and authority to do and perform each and every act and thing requisite and
necessary to be done in and about the premises, as fully to all intents and
purposes as he might or could do in person, hereby ratifying and confirming all
that each of said attorneys-in-fact and agents or any of them, or his or their
substitute or substitutes, may lawfully do or cause to be done or by virtue
hereof.
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons in the
capacities and on the dates indicated.
SIGNATURES TITLE DATE
---------- ----- ----
/s/ KENNETH C. GARDNER President and Chief January 28, 1999
--------------------------------------------- Executive Officer (Principal
Kenneth C. Gardner Executive Officer)
/s/ W. VIRGINIA WALKER Vice President of Finance January 28, 1999
--------------------------------------------- and Administration, Chief
W. Virginia Walker Financial Officer (Principal
Financial and Accounting
Officer)
/s/ JOHN E. ZICKER Director January 28, 1999
---------------------------------------------
John E. Zicker
/s/ SHANDA BAHLES Director January 28, 1999
---------------------------------------------
Shanda Bahles
|
II-8
SIGNATURES TITLE DATE
---------- ----- ----
/s/ RICHARD W. SHAPERO Director January 28, 1999
---------------------------------------------
Richard W. Shapero
/s/ JEFFREY T. WEBBER Director January 28, 1999
---------------------------------------------
Jeffrey T. Webber
|
II-9
EXHIBIT INDEX
EXHIBIT
NUMBER DESCRIPTION
------- -----------
1.1 Form of Underwriting Agreement.
3.1 Certificate of Incorporation of Registrant.
3.2* Form of Amended and Restated Certificate of Incorporation of
Registrant to be filed upon the closing of the offering made
under the Registration Statement.
3.3 Bylaws of Registrant.
4.1* Form of Registrant's Common Stock Certificate.
4.2 Sixth Amended and Restated Registration Rights Agreement,
dated as of February 24, 1998, between the Registrant and
the parties named therein.
4.3 Common Stock Registration Rights Agreement, dated as of
September 14, 1998, between the Registrant and Robert Hawk.
5.1* Opinion of Wilson Sonsini Goodrich & Rosati, Professional
Corporation.
10.1 Form of Indemnification Agreement entered into by Registrant
with each of its directors and executive officers.
10.2 Amended and Restated 1995 Stock Plan and related agreements.
10.3 1998 Stock Plan and related agreements.
10.4 1999 Employee Stock Purchase Plan and related agreements.
10.5 1999 Director Option Plan and related agreements.
10.6 Master Equipment Lease Agreement, dated August 7, 1995,
between the Registrant and Lighthouse Capital Partners, L.P.
10.7 Master Lease Agreement, dated as of September 26, 1998,
between the Registrant and Dell Financial Services L.P.
10.8 Loan and Security Agreement, dated as of July 16, 1997,
between the Registrant and Venture Banking Group, a division
of Cupertino National Bank, and amendments thereto.
10.9 Standard Office Lease, dated June 1, 1998, by and between
the Registrant and Asset Growth Partners, Ltd., and the
First Amendment thereto.
10.10** Development and Licensing Agreement, dated January 22, 1997,
between the Registrant and Abacus Concepts, Inc.
10.11** Microsoft License and Distribution Agreement, dated August
23, 1996, between the Registrant and Microsoft Corporation.
10.12** Value-Added Reseller Agreement, effective June 26, 1997,
between the Registrant and Automatic Data Processing, Inc.
10.13** Sagent KK Non-Exclusive Japanese Distribution Agreement,
dated as of December 17, 1997, between Sagent KK Japan and
Kawasaki Steel Systems R&D Corporation.
10.14** Exclusive Distribution Agreement, effective as of January 1,
1998, by and between the Registrant and Sagent U.K. Ltd.
10.15** Joint Venture Agreement, entered into as of April 8, 1998,
between the Registrant and ISAR- Vermongensverwaltung GbR
mbH and related agreements.
10.16** Exclusive Concession Agreement, effective as of November 21,
1997, by and between the Registrant and Sagent France S.A.
10.17** Value-Added Reseller/OEM Agreement, effective December 30,
1997, between the Registrant and Advent Software, Inc.
10.18 Form of Sagent Technology, Inc. End User Software License
Agreement.
|
EXHIBIT
NUMBER DESCRIPTION
------- -----------
10.19** OEM Software License Agreement, effective March 31, 1998,
between the Registrant and Siebel Systems, Inc.
10.20 Form of Sagent Technology, Inc. Software Maintenance and
Technical Support Agreement.
10.21 Form of Sagent Technology, Inc. Agreement for Consulting
Services.
10.22 Form of Sagent Technology, Inc. Agreement for Subcontractor
Consulting Services.
10.23 Form of Evaluation Agreement.
10.24 Note, dated February 1, 1998, of W. Virginia Walker.
10.25 Note, dated February 1, 1998, of W. Virginia Walker.
10.26** Solution Provider Agreement, effective June 27, 1997,
between the Registrant and Unisys Corporation.
10.27 Consulting Agreement, dated as of April 7, 1997, between the
Registrant and Ralph Kimball.
10.28 Executive Change of Control Policy.
10.29 Agreement and Plan Reorganization, dated as of February 27,
1998, by and among Sagent Technology, Inc., Talus
Acquisition Corp., Talus, Incorporated and Certain
Shareholders of Talus, Inc.
10.30 Employment and Non-Competition Agreement, dated as of
February 27, 1998 between Registrant and Michael P.
Venerable.
10.31** Software License and Services Agreement, dated March 31,
1998, between Registrant and Siebel Systems, Inc.
21.1 Subsidiaries of the Registrant.
23.1* Consent of Wilson Sonsini Goodrich & Rosati, Professional
Corporation (included in Exhibit 5.1).
23.2 Consent of PricewaterhouseCoopers LLP, Independent
Accountants.
23.3 Consent of PricewaterhouseCoopers LLP, Independent
Accountants.
23.4* Consent of Klaus S. Luft.
24.1 Power of Attorney (See page II-8).
27.1 Financial Data Schedule (available in EDGAR format only).
|
* To be supplied by amendment.
** Confidential treatment has been requested with respect to certain portions of
this exhibit. Omitted portions have been filed separately with the Securities
and Exchange Commission.
EXHIBIT 1.1
__________ Shares
SAGENT TECHNOLOGY, INC.
Common Stock
UNDERWRITING AGREEMENT
__________, 1999
DONALDSON, LUFKIN & JENRETTE
SECURITIES CORPORATION
HAMBRECHT & QUIST LLC
PIPER JAFFRAY INC.
As representatives of the several Underwriters
named in Schedule I hereto
c/o Donaldson, Lufkin & Jenrette
Securities Corporation
277 Park Avenue
New York, New York 10172
Dear Sirs:
Sagent Technology, Inc., a Delaware corporation (the "COMPANY"),
proposes to issue and sell ____________ shares of its Common Stock, par value
$0.001 per share (the "FIRM SHARES"), to the several underwriters named in
Schedule I hereto (the "UNDERWRITERS"). The Company also proposes to issue and
sell to the several Underwriters not more than an additional _______ shares of
its Common Stock, par value $0.001 per share (the "ADDITIONAL SHARES"), if
requested by the Underwriters as provided in Section 2 hereof. The Firm Shares
and the Additional Shares are hereinafter referred to collectively as the
"SHARES." The shares of common stock of the Company to be outstanding after
giving effect to the sales contemplated hereby are hereinafter referred to as
the "COMMON STOCK."
SECTION 1. Registration Statement and Prospectus. The Company has
prepared and filed with the Securities and Exchange Commission (the
"COMMISSION") in accordance with the provisions of the Securities Act of 1933,
as amended, and the rules and regulations of the Commission thereunder
(collectively, the "ACT"), a registration statement on Form S-1, including a
prospectus, relating to the Shares. The registration statement, as amended at
the time it became effective, including the information (if any) deemed to be
part of the registration statement at the time of effectiveness pursuant to Rule
430A under the Act, is hereinafter referred to as the "REGISTRATION STATEMENT";
and the prospectus in the form first used to confirm sales of Shares is
hereinafter referred to as the "PROSPECTUS." If the Company has filed or is
required pursuant to the terms hereof to file a registration statement pursuant
to Rule 462(b) under the Act registering
additional shares of Common Stock (a "RULE 462(B) REGISTRATION STATEMENT"),
then, unless otherwise specified, any reference herein to the term "Registration
Statement" shall be deemed to include such Rule 462(b) Registration Statement.
SECTION 2. Agreements to Sell and Purchase and Lock-Up
Agreements. On the basis of the representations and warranties contained in this
Agreement, and subject to its terms and conditions, the Company agrees to issue
and sell, and each Underwriter agrees, severally and not jointly, to purchase
from the Company at a price per Share of $______ (the "PURCHASE PRICE") the
number of Firm Shares set forth opposite the name of such Underwriter in
Schedule I hereto.
On the basis of the representations and warranties contained in
this Agreement, and subject to its terms and conditions, the Company agrees to
issue and sell the Additional Shares and the Underwriters shall have the right
to purchase, severally and not jointly, up to _______ Additional Shares from the
Company at the Purchase Price. Additional Shares may be purchased solely for the
purpose of covering over-allotments made in connection with the offering of the
Firm Shares. The Underwriters may exercise their right to purchase Additional
Shares in whole or in part from time to time by giving written notice thereof to
the Company within 30 days after the date of this Agreement. You shall give any
such notice on behalf of the Underwriters and such notice shall specify the
aggregate number of Additional Shares to be purchased pursuant to such exercise
and the date for payment and delivery thereof, which date shall be a business
day (i) no earlier than two business days after such notice has been given (and,
in any event, no earlier than the Closing Date (as hereinafter defined)) and
(ii) no later than ten business days after such notice has been given. If any
Additional Shares are to be purchased, each Underwriter, severally and not
jointly, agrees to purchase from the Company the number of Additional Shares
(subject to such adjustments to eliminate fractional shares as you may
determine) which bears the same proportion to the total number of Additional
Shares to be purchased from the Company as the number of Firm Shares set forth
opposite the name of such Underwriter in Schedule I bears to the total number of
Firm Shares.
The Company hereby agrees not to (i) offer, pledge, sell,
contract to sell, sell any option or contract to purchase, purchase any option
or contract to sell, grant any option, right or warrant to purchase, or
otherwise transfer or dispose of, directly or indirectly, any shares of Common
Stock or any securities convertible into or exercisable or exchangeable for
Common Stock or (ii) enter into any swap or other arrangement that transfers all
or a portion of the economic consequences associated with the ownership of any
Common Stock (regardless of whether any of the transactions described in clause
(i) or (ii) is to be settled by the delivery of Common Stock, or such other
securities, in cash or otherwise), except to the Underwriters pursuant to this
Agreement, for a period of 180 days after the date of the Prospectus without the
prior written consent of Donaldson, Lufkin & Jenrette Securities Corporation.
Notwithstanding the foregoing, during such period (i) the Company may grant
stock options pursuant to the Company's existing stock option plan and (ii) the
Company may issue shares of Common Stock upon the exercise of an option or
warrant or the conversion of a security outstanding on the date hereof. The
Company also agrees not to file any registration statement with respect to any
shares of Common Stock or any securities convertible into or exercisable or
exchangeable for Common Stock for a period of 180 days after the date of the
Prospectus without the prior written consent
2
of Donaldson, Lufkin & Jenrette Securities Corporation. The Company shall, prior
to or concurrently with the execution of this Agreement, deliver an agreement
executed by (i) each of the directors and officers of the Company and (ii) each
holder of greater than 0.5% of the Company's outstanding capital stock to the
effect that such person will not, during the period commencing on the date such
person signs such agreement and ending 180 days after the date of the
Prospectus, without the prior written consent of Donaldson, Lufkin & Jenrette
Securities Corporation, (A) engage in any of the transactions described in the
first sentence of this paragraph or (B) make any demand for, or exercise any
right with respect to, the registration of any shares of Common Stock or any
securities convertible into or exercisable or exchangeable for Common Stock.
SECTION 3. Terms of Public Offering. The Company is advised by
you that the Underwriters propose (i) to make a public offering of their
respective portions of the Shares as soon after the execution and delivery of
this Agreement as in your judgment is advisable and (ii) initially to offer the
Shares upon the terms set forth in the Prospectus.
SECTION 4. Delivery and Payment. The Shares shall be represented
by definitive certificates and shall be issued in such authorized denominations
and registered in such names as Donaldson, Lufkin & Jenrette Securities
Corporation shall request no later than two business days prior to the Closing
Date or the applicable Option Closing Date (as defined below), as the case may
be. The Company shall deliver the Shares, with any transfer taxes thereon duly
paid by the respective Sellers, to Donaldson, Lufkin & Jenrette Securities
Corporation through the facilities of The Depository Trust Company ("DTC"), for
the respective accounts of the several Underwriters, against payment to the
Company of the Purchase Price therefore by wire transfer of Federal or other
funds immediately available in New York City. The certificates representing the
Shares shall be made available for inspection not later than 9:30 A.M., New York
City time, on the business day prior to the Closing Date or the applicable
Option Closing Date, as the case may be, at the office of DTC or its designated
custodian (the "DESIGNATED OFFICE"). The time and date of delivery and payment
for the Firm Shares shall be 9:00 A.M., New York City time, on ________, 1999 or
such other time on the same or such other date as Donaldson, Lufkin & Jenrette
Securities Corporation and the Company shall agree in writing. The time and date
of delivery and payment for the Firm Shares are hereinafter referred to as the
"CLOSING DATE." The time and date of delivery and payment for any Additional
Shares to be purchased by the Underwriters shall be 9:00 A.M., New York City
time, on the date specified in the applicable exercise notice given by you
pursuant to Section 2 or such other time on the same or such other date as
Donaldson, Lufkin & Jenrette Securities Corporation and the Company shall agree
in writing. The time and date of delivery for any Additional Shares are
hereinafter referred to as the "OPTION CLOSING DATE."
The documents to be delivered on the Closing Date or any Option
Closing Date on behalf of the parties hereto pursuant to Section 8 of this
Agreement shall be delivered at the offices of Brobeck, Phleger & Harrison LLP,
Two Embarcadero Place, 2200 Geng Road, Palo Alto, CA 94303 and the Shares shall
be delivered at the Designated Office, all on the Closing Date or such Option
Closing Date, as the case may be.
SECTION 5. Agreements of the Company. The Company agrees with
you:
3
(a) To advise you promptly and, if requested by you, to
confirm such advice in writing, (i) of any request by the Commission for
amendments to the Registration Statement or amendments or supplements to the
Prospectus or for additional information, (ii) of the issuance by the Commission
of any stop order suspending the effectiveness of the Registration Statement or
of the suspension of qualification of the Shares for offering or sale in any
jurisdiction, or the initiation of any proceeding for such purposes, (iii) when
any amendment to the Registration Statement becomes effective, (iv) if the
Company is required to file a Rule 462(b) Registration Statement after the
effectiveness of this Agreement, when the Rule 462(b) Registration Statement has
become effective and (v) of the happening of any event during the period
referred to in Section 5(d) below which makes any statement of a material fact
made in the Registration Statement or the Prospectus untrue or which requires
any additions to or changes in the Registration Statement or the Prospectus in
order to make the statements therein not misleading. If at any time the
Commission shall issue any stop order suspending the effectiveness of the
Registration Statement, the Company will use its best efforts to obtain the
withdrawal or lifting of such order at the earliest possible time.
(b) To furnish to you four (4) signed copies of the
Registration Statement as first filed with the Commission and of each amendment
to it, including all exhibits, and to furnish to you and each Underwriter
designated by you such number of conformed copies of the Registration Statement
as so filed and of each amendment to it, without exhibits, as you may reasonably
request.
(c) To prepare the Prospectus, the form and substance of
which shall be satisfactory to you, and to file the Prospectus in such form with
the Commission within the applicable period specified in Rule 424(b) under the
Act; during the period specified in Section 5(d) below, not to file any further
amendment to the Registration Statement and not to make any amendment or
supplement to the Prospectus of which you shall not previously have been advised
or to which you shall reasonably object after being so advised; and, during such
period, to prepare and file with the Commission, promptly upon your reasonable
request, any amendment to the Registration Statement or amendment or supplement
to the Prospectus which may be necessary or advisable in connection with the
distribution of the Shares by you, and to use its best efforts to cause any such
amendment to the Registration Statement to become promptly effective.
(d) Prior to 10:00 A.M., New York City time, on the first
business day after the date of this Agreement and from time to time thereafter
for such period as in the opinion of counsel for the Underwriters a prospectus
is required by law to be delivered in connection with sales by an Underwriter or
a dealer, to furnish in New York City to each Underwriter and any dealer as many
copies of the Prospectus (and of any amendment or supplement to the Prospectus)
as such Underwriter or dealer may reasonably request.
(e) If during the period specified in Section 5(d), any event
shall occur or condition shall exist as a result of which, in the opinion of
counsel for the Underwriters, it becomes necessary to amend or supplement the
Prospectus in order to make the statements therein, in the light of the
circumstances when the Prospectus is delivered to a purchaser, not misleading,
or if, in the opinion of counsel for the Underwriters, it is necessary to amend
or
4
supplement the Prospectus to comply with applicable law, forthwith to prepare
and file with the Commission an appropriate amendment or supplement to the
Prospectus so that the statements in the Prospectus, as so amended or
supplemented, will not in the light of the circumstances when it is so
delivered, be misleading, or so that the Prospectus will comply with applicable
law, and to furnish to each Underwriter and to any dealer as many copies thereof
as such Underwriter or dealer may reasonably request.
(f) Prior to any public offering of the Shares, to cooperate
with you and counsel for the Underwriters in connection with the registration or
qualification of the Shares for offer and sale by the several Underwriters and
by dealers under the state securities or Blue Sky laws of such jurisdictions as
you may request, to continue such registration or qualification in effect so
long as required for distribution of the Shares and to file such consents to
service of process or other documents as may be necessary in order to effect
such registration or qualification; provided, however, that the Company shall
not be required in connection therewith to qualify as a foreign corporation in
any jurisdiction in which it is not now so qualified or to take any action that
would subject it to general consent to service of process or taxation other than
as to matters and transactions relating to the Prospectus, the Registration
Statement, any preliminary prospectus or the offering or sale of the Shares, in
any jurisdiction in which it is not now so subject.
(g) To mail and make generally available to its stockholders
as soon as practicable an earnings statement covering the twelve-month period
ending [INSERT DATE ONE YEAR AFTER THE END OF THE COMPANY'S FISCAL QUARTER IN
WHICH THE CLOSING WILL OCCUR] __________, 2000 that shall satisfy the provisions
of Section 11(a) of the Act, and to advise you in writing when such statement
has been so made available.
(h) During the period of three (3) years after the date of
this Agreement, to furnish to you as soon as available copies of all reports or
other communications furnished to the record holders of Common Stock or
furnished to or filed with the Commission or any national securities exchange on
which any class of securities of the Company is listed and such other publicly
available information concerning the Company and its subsidiaries as you may
reasonably request.
(i) Whether or not the transactions contemplated in this
Agreement are consummated or this Agreement is terminated, to pay or cause to be
paid all expenses incident to the performance of its obligations under this
Agreement, including: (i) the fees, disbursements and expenses of the Company's
counsel and the Company's accountants in connection with the registration and
delivery of the Shares under the Act and all other fees and expenses in
connection with the preparation, printing, filing and distribution of the
Registration Statement (including financial statements and exhibits), any
preliminary prospectus, the Prospectus and all amendments and supplements to any
of the foregoing, including the mailing and delivering of copies thereof to the
Underwriters and dealers in the quantities specified herein, (ii) all costs and
expenses related to the transfer and delivery of the Shares to the Underwriters,
including any transfer or other taxes payable thereon, (iii) all costs of
printing or producing this Agreement and any other agreements or documents in
connection with the offering, purchase, sale or delivery of the Shares, (iv) all
expenses in connection with the registration or qualification
5
of the Shares for offer and sale under the securities or Blue Sky laws of the
several states and all costs of printing or producing any Preliminary and
Supplemental Blue Sky Memoranda in connection therewith (including the filing
fees and fees and disbursements of counsel for the Underwriters in connection
with such registration or qualification and memoranda relating thereto), (v) the
filing fees and disbursements of counsel for the Underwriters in connection with
the review and clearance of the offering of the Shares by the National
Association of Securities Dealers, Inc., (vi) all fees and expenses in
connection with the preparation and filing of the Registration Statement on Form
8-A relating to the Common Stock and all costs and expenses incident to the
listing of the Shares on the Nasdaq National Market, (vii) the cost of printing
certificates representing the Shares, (viii) the costs and charges of any
transfer agent, registrar and/or depositary, and (ix) all other costs and
expenses incident to the performance of the obligations of the Company hereunder
for which provision is not otherwise made in this Section.
(j) To use its best efforts to list for quotation the Shares
on the Nasdaq National Market and to maintain the listing of the Shares on the
Nasdaq National Market for a period of three (3) years after the date of this
Agreement.
(k) To use its best efforts to do and perform all things
required or necessary to be done and performed under this Agreement by the
Company prior to the Closing Date or any Option Closing Date, as the case may
be, and to satisfy all conditions precedent to the delivery of the Shares.
(l) If the Registration Statement at the time of the
effectiveness of this Agreement does not cover all of the Shares, to file a Rule
462(b) Registration Statement with the Commission registering the Shares not so
covered in compliance with Rule 462(b) by 10:00 P.M., New York City time, on the
date of this Agreement and to pay to the Commission the filing fee for such Rule
462(b) Registration Statement at the time of the filing thereof or to give
irrevocable instructions for the payment of such fee pursuant to Rule 111(b)
under the Act.
SECTION 6. Representations and Warranties of the Company. The
Company represents and warrants to each Underwriter that:
(a) The Registration Statement has become effective (other
than any Rule 462(b) Registration Statement to be filed by the Company after the
effectiveness of this Agreement); any Rule 462(b) Registration Statement filed
after the effectiveness of this Agreement will become effective no later than
10:00 P.M., New York City time, on the date of this Agreement; and no stop order
suspending the effectiveness of the Registration Statement is in effect, and no
proceedings for such purpose are pending before or threatened by the Commission.
(b) (i) The Registration Statement (other than any Rule
462(b) Registration Statement to be filed by the Company after the effectiveness
of this Agreement), when it became effective, did not contain and, as amended,
if applicable, will not contain any untrue statement of a material fact or omit
to state a material fact required to be stated therein or necessary to make the
statements therein not misleading, (ii) the Registration Statement (other than
any Rule 462(b) Registration Statement to be filed by the Company after the
effectiveness
6
of this Agreement) and the Prospectus comply and, as amended or supplemented, if
applicable, will comply in all material respects with the Act, (iii) if the
Company is required to file a Rule 462(b) Registration Statement after the
effectiveness of this Agreement, such Rule 462(b) Registration Statement and any
amendments thereto, when they become effective (A) will not contain any untrue
statement of a material fact or omit to state a material fact required to be
stated therein or necessary to make the statements therein not misleading and
(B) will comply in all material respects with the Act and (iv) the Prospectus
does not contain and, as amended or supplemented, if applicable, will not
contain any untrue statement of a material fact or omit to state a material fact
necessary to make the statements therein, in the light of the circumstances
under which they were made, not misleading, except that the representations and
warranties set forth in this paragraph do not apply to statements or omissions
in the Registration Statement or the Prospectus based upon information relating
to any Underwriter furnished to the Company in writing by such Underwriter
through you expressly for use therein.
(c) Each preliminary prospectus filed as part of the
Registration Statement as originally filed or as part of any amendment thereto,
or filed pursuant to Rule 424 under the Act, complied when so filed in all
material respects with the Act, and did not contain an untrue statement of a
material fact or omit to state a material fact required to be stated therein or
necessary to make the statements therein, in the light of the circumstances
under which they were made, not misleading, except that the representations and
warranties set forth in this paragraph do not apply to statements or omissions
in any preliminary prospectus based upon information relating to any Underwriter
furnished to the Company in writing by such Underwriter through you expressly
for use therein.
(d) Each of the Company and its subsidiaries has been duly
incorporated, is validly existing as a corporation in good standing under the
laws of its jurisdiction of incorporation and has the corporate power and
authority to carry on its business as described in the Prospectus and to own,
lease and operate its properties, and each is duly qualified and is in good
standing as a foreign corporation authorized to do business in each jurisdiction
in which the nature of its business or its ownership or leasing of property
requires such qualification, except where the failure to be so qualified would
not have a material adverse effect on the business, prospects, financial
condition or results of operations of the Company and its subsidiaries, taken as
a whole.
(e) There are no outstanding subscriptions, rights, warrants,
options, calls, convertible securities, commitments of sale or liens granted or
issued by the Company or any of its subsidiaries relating to or entitling any
person to purchase or otherwise to acquire any shares of the capital stock of
the Company or any of its subsidiaries, except as otherwise disclosed in the
Registration Statement.
(f) All the outstanding shares of capital stock of the
Company have been duly authorized and validly issued and are fully paid,
non-assessable and not subject to any preemptive or similar rights; and the
Shares have been duly authorized and, when issued and delivered to the
Underwriters against payment therefor as provided by this Agreement, will be
validly issued, fully paid and non-assessable, and the issuance of such Shares
will not be subject to any preemptive or similar rights.
7
(g) All of the outstanding shares of capital stock of each of
the Company's subsidiaries have been duly authorized and validly issued and are
fully paid and non-assessable, and are owned by the Company, directly or
indirectly through one or more subsidiaries, free and clear of any security
interest, claim, lien, encumbrance or adverse interest of any nature.
(h) The authorized capital stock of the Company conforms as
to legal matters to the description thereof contained in the Prospectus.
(i) Neither the Company nor any of its subsidiaries is in
violation of its respective charter or by-laws or in default in the performance
of any obligation, agreement, covenant or condition contained in any indenture,
loan agreement, mortgage, lease or other agreement or instrument that is
material to the Company and its subsidiaries, taken as a whole, to which the
Company or any of its subsidiaries is a party or by which the Company or any of
its subsidiaries or their respective property is bound.
(j) This Agreement has been duly authorized, executed and
delivered by the Company.
(k) The execution, delivery and performance of this Agreement
by the Company, the compliance by the Company with all the provisions hereof and
the consummation of the transactions contemplated hereby will not (i) require
any consent, approval, authorization or other order of, or qualification with,
any court or governmental body or agency (except such as may be required under
the securities or Blue Sky laws of the various states), (ii) conflict with or
constitute a breach of any of the terms or provisions of, or a default under,
the charter or by-laws of the Company or any of its subsidiaries or any
indenture, loan agreement, mortgage, lease or other agreement or instrument that
is material to the Company and its subsidiaries, taken as a whole, to which the
Company or any of its subsidiaries is a party or by which the Company or any of
its subsidiaries or their respective property is bound, (iii) violate or
conflict with any applicable law or any rule, regulation, judgment, order or
decree of any court or any governmental body or agency having jurisdiction over
the Company, any of its subsidiaries or their respective property or (iv) result
in the suspension, termination or revocation of any Authorization (as defined
below) of the Company or any of its subsidiaries or any other impairment of the
rights of the holder of any such Authorization.
(l) The Company and its subsidiaries own or possess, or can
acquire on reasonable terms, all patents, patent rights, licenses, inventions,
copyrights, trademarks, service marks, trade names, mask work rights, technology
and know-how (including trade secrets and other unpatented and/or unpatentable
proprietary or confidential information, systems or procedures) ("INTELLECTUAL
PROPERTY") necessary to conduct the business now or as proposed to be conducted
by the Company as described in the Registration Statement. Neither the Company
nor any of its subsidiaries has received any notice of infringement of or
conflict with (or knows of such infringement of or conflict with) asserted
rights of others with respect to any of such intellectual property which, singly
or in the aggregate, if the subject of any unfavorable decision, ruling or
finding, would have a material adverse effect on the business, prospects,
financial condition or results of operations of the Company and its
subsidiaries, taken as a whole. To the
8
Company's knowledge, the discoveries, inventions, products or processes of the
Company referred to in the Registration Statement do not infringe or conflict
with any right or patent of any third party, or any discovery, invention,
product or process which is the subject of a patent application filed by any
third party.
(m) There are no legal or governmental proceedings pending or
threatened to which the Company or any of its subsidiaries is or could be a
party or to which any of their respective property is or could be subject that
are required to be described in the Registration Statement or the Prospectus and
are not so described; nor are there any statutes, regulations, contracts or
other documents that are required to be described in the Registration Statement
or the Prospectus or to be filed as exhibits to the Registration Statement that
are not so described or filed as required.
(n) No relationship, direct or indirect, exists between or
among the Company or any of its subsidiaries on the one hand, and the directors,
officers, stockholders, customers or suppliers of the Company or any of its
subsidiaries on the other hand, which is required by the Act to be described in
the Registration Statement or the Prospectus which is not so described. (o) Each
of the Company and its subsidiaries has such permits, licenses, consents,
exemptions, franchises, authorizations and other approvals (each, an
"AUTHORIZATION") of, and has made all filings with and notices to, all
governmental or regulatory authorities and self-regulatory organizations and all
courts and other tribunals, including, without limitation, under any applicable
Environmental Laws (as defined below), as are necessary to own, lease, license
and operate its respective properties and to conduct its respective business,
except where the failure to have any such Authorization or to make any such
filing or notice would not, singly or in the aggregate, have a material adverse
effect on the business, prospects, financial condition or results of operations
of the Company and its subsidiaries, taken as a whole. Each such Authorization
is valid and in full force and effect and each of the Company and its
subsidiaries is in compliance with all the terms and conditions thereof and with
the rules and regulations of the authorities and governing bodies having
jurisdiction with respect thereto; and no event has occurred (including, without
limitation, the receipt of any notice from any authority or governing body)
which allows or, after notice or lapse of time or both, would allow, revocation,
suspension or termination of any such Authorization or results or, after notice
or lapse of time or both, would result in any other impairment of the rights of
the holder of any such Authorization; and such Authorizations contain no
restrictions that are burdensome to the Company or any of its subsidiaries;
except where such failure to be valid and in full force and effect or to be in
compliance, the occurrence of any such event or the presence of any such
restriction would not, singly or in the aggregate, have a material adverse
effect on the business, prospects, financial condition or results of operations
of the Company and its subsidiaries, taken as a whole.
(p) Neither the Company nor any of its subsidiaries has
violated any foreign, federal, state or local law or regulation relating to the
protection of human health and safety, the environment or hazardous or toxic
substances or wastes, pollutants or contaminants ("ENVIRONMENTAL LAWS"), any
provisions of the Employee Retirement Income Security Act of
9
1974, as amended, or any provisions of the Foreign Corrupt Practices Act, or the
rules and regulations promulgated thereunder, except for such violations which,
singly or in the aggregate, would not have a material adverse effect on the
business, prospects, financial condition or results of operation of the Company
and its subsidiaries, taken as a whole.
(q) There are no costs or liabilities associated with
Environmental Laws (including, without limitation, any capital or operating
expenditures required for clean-up, closure of properties or compliance with
Environmental Laws or any Authorization, any related constraints on operating
activities and any potential liabilities to third parties) which would, singly
or in the aggregate, have a material adverse effect on the business, prospects,
financial condition or results of operations of the Company and its
subsidiaries, taken as a whole.
(r) PricewaterhouseCoopers LLP are independent public
accountants with respect to the Company and its subsidiaries as required by the
Act.
(s) The consolidated financial statements included in the
Registration Statement and the Prospectus (and any amendment or supplement
thereto), together with related schedules and notes, present fairly the
consolidated financial position, results of operations and changes in financial
position of the Company and its subsidiaries on the basis stated therein at the
respective dates or for the respective periods to which they apply; such
statements and related schedules and notes have been prepared in accordance with
generally accepted accounting principles consistently applied throughout the
periods involved, except as disclosed therein; the supporting schedules, if any,
included in the Registration Statement present fairly in accordance with
generally accepted accounting principles the information required to be stated
therein; and the other financial and statistical information and data set forth
in the Registration Statement and the Prospectus (and any amendment or
supplement thereto) are, in all material respects, accurately presented and
prepared on a basis consistent with such financial statements and the books and
records of the Company.
(t) The Company and each of its subsidiaries maintains a
system of internal accounting controls sufficient to provide reasonable
assurance that (i) transactions are executed in accordance with management's
general or specific authorizations; (ii) transactions are recorded as necessary
to permit preparation of financial statements in conformity with general
accepted accounting principles and to maintain asset accountability; (iii)
access to assets is permitted only in accordance with management's general or
specific authorization; and (iv) the recorded accountability for assets is
compared with the existing assets at reasonable intervals and appropriate action
is taken with respect to any differences.
(u) All material tax returns required to be filed by the
Company and each of its subsidiaries in any jurisdiction have been filed, other
than those filings being contested in good faith, and all material taxes,
including withholding taxes, penalties and interest, assessments, fees and other
charges due pursuant to such returns or pursuant to any assessment received by
the Company or any of its subsidiaries have been paid, other than those being
contested in good faith and for which adequate reserves have been provided.
10
(v) The Company is not and, after giving effect to the
offering and sale of the Shares and the application of the proceeds thereof as
described in the Prospectus, will not be, an "investment company" as such term
is defined in the Investment Company Act of 1940, as amended.
(w) There are no contracts, agreements or understandings
between the Company and any person granting such person the right to require the
Company to file a registration statement under the Act with respect to any
securities of the Company or to require the Company to include such securities
with the Shares registered pursuant to the Registration Statement.
(x) Since the respective dates as of which information is
given in the Prospectus and other than as set forth in the Prospectus (exclusive
of any amendments or supplements thereto subsequent to the date of this
Agreement), (i) there has not occurred any material adverse change or any
development involving a prospective material adverse change in the condition,
financial or otherwise, or the earnings, business, prospects, management or
operations of the Company and its subsidiaries, taken as a whole, (ii) there has
not been any material adverse change or any development involving a prospective
material adverse change in the capital stock or in the long-term debt of the
Company or any of its subsidiaries and (iii) neither the Company nor any of its
subsidiaries has incurred any material liability or obligation, direct or
contingent.
(y) The Company and its subsidiaries have good and marketable
title in fee simple to all real property and good and marketable title to all
personal property owned by them which is material to the business of the Company
and its subsidiaries, in each case free and clear of all liens, encumbrances and
defects except such as are described in the Prospectus or such as do not
materially affect the value of such property and do not interfere with the use
made and proposed to be made of such property by the Company and its
subsidiaries; and any real property and buildings held under lease by the
Company and its subsidiaries are held by them under valid, subsisting and
enforceable leases with such exceptions as are not material and do not interfere
with the use made and proposed to be made of such property and buildings by the
Company and its subsidiaries, in each case except as described in the
Prospectus.
(z) The Company and each of its subsidiaries are insured by
insurers of recognized financial responsibility against such losses and risks
and in such amounts as are prudent and customary in the businesses in which they
are engaged; and neither the Company nor any of its subsidiaries (i) has
received notice from any insurer or agent of such insurer that substantial
capital improvements or other material expenditures will have to be made in
order to continue such insurance or (ii) has any reason to believe that it will
not be able to renew its existing insurance coverage as and when such coverage
expires or to obtain similar coverage from similar insurers at a cost that would
not have a material adverse effect on the business, prospects, financial
conditions or results of the Company and its subsidiaries, taken as a whole.
(aa) There is no (i) significant unfair labor practice
complaint, grievance or arbitration proceeding pending or threatened against the
Company or any of its subsidiaries before the National Labor Relations Board or
any state or local labor relations board,
11
(ii) strike, labor dispute, slowdown or stoppage pending or threatened against
the Company or any of its subsidiaries or (iii) union representation question
existing with respect to the employees of the Company and its subsidiaries,
except for such actions specified in clause (i), (ii) or (iii) above, which,
singly or in the aggregate, would not have a material adverse effect on the
business, prospects, financial condition or results of operations of the Company
and its subsidiaries, taken as a whole. To the best of the Company's knowledge,
no collective bargaining organizing activities are taking place with respect to
the Company or any of its subsidiaries.
(bb) (i) To the Company's knowledge, none of the computer
software, computer firmware, computer hardware (whether general or special
purpose) or other similar or related items of automated, computerized or
software systems that are used or relied on by the Company or sub-licensed to
the Company in the conduct of its business will malfunction, will cease to
function, will generate incorrect data or will produce incorrect results when
processing, providing or receiving (i) date-related data from, into and between
the Twentieth (20th) and Twenty-First (21st) centuries or (ii) date-related data
in connection with any valid date in the Twentieth (20th) and Twenty-First
(21st) centuries, causing a material adverse effect on the Company.
(ii) None of the products and services sold, licensed,
rendered, or otherwise provided by the Company in the conduct of its business
will malfunction, will cease to function, will generate incorrect data or will
produce incorrect results when processing, providing or receiving (i)
date-related data from, into and between the Twentieth (20th) and Twenty-First
(21st) centuries or (ii) date-related data in connection with any valid date in
the Twentieth (20th) and Twenty-First (21st) centuries, causing a material
adverse effect on the Company.
(iii) The Company has not made any representations or
warranties relating to the ability of any product or service sold, licensed,
rendered, or otherwise provided by the Company in the conduct of its business to
operate without malfunction, to operate without ceasing to function, to generate
correct data or to produce correct results when processing, providing or
receiving (i) date-related data from, into and between the Twentieth (20th) and
Twenty-First (21st) centuries and (ii) date-related data in connection with any
valid date in the Twentieth (20th) and Twenty-First (21st) centuries.
(cc) Each product manufactured, sold, licensed, leased, or
delivered by the Company has been in conformity with all applicable contractual
commitments and all express and implied warranties except where the failure to
be in such conformity would not have a material and adverse effect on the
Company. The Company has no liability, and to the Company's knowledge, there is
no current reasonable basis for any action, suit, proceeding, hearing,
investigation, charge, complaint, claim, or demand giving rise to any liability,
for replacement or repair thereof or other damages in connection therewith. No
product manufactured, sold, licensed, leased or delivered by the Company is
subject to any guaranty, lease or warranty beyond that implied or imposed by
applicable law. Schedule 6(cc) includes a copy of the Company's standard terms
and conditions of sale, license and lease.
12
(dd) Each certificate signed by any officer of the Company and
delivered to the Underwriters or counsel for the Underwriters shall be deemed to
be a representation and warranty by the Company to the Underwriters as to the
matters covered thereby.
SECTION 7. Indemnification. (a) The Company agrees to indemnify
and hold harmless each Underwriter, its directors, its officers and each person,
if any, who controls any Underwriter within the meaning of Section 15 of the Act
or Section 20 of the Securities Exchange Act of 1934, as amended (the "EXCHANGE
ACT"), from and against any and all losses, claims, damages, liabilities and
judgments (including, without limitation, any legal or other expenses incurred
in connection with investigating or defending any matter, including any action,
that could give rise to any such losses, claims, damages, liabilities or
judgments) caused by any untrue statement or alleged untrue statement of a
material fact contained in the Registration Statement (or any amendment
thereto), the Prospectus (or any amendment or supplement thereto) or any
preliminary prospectus, or caused by any omission or alleged omission to state
therein a material fact required to be stated therein or necessary to make the
statements therein not misleading, except insofar as such losses, claims,
damages, liabilities or judgments are caused by any such untrue statement or
omission or alleged untrue statement or omission based upon information relating
to any Underwriter furnished in writing to the Company by such Underwriter
through you expressly for use therein; provided, however, that the foregoing
indemnity agreement with respect to any preliminary prospectus shall not inure
to the benefit of any Underwriter who failed to deliver a Prospectus, as then
amended or supplemented (so long as the Prospectus and any amendments or
supplements thereto was provided by the Company to the several Underwriters in
the requisite quantity and on a timely basis to permit proper delivery on or
prior to the Closing Date), to the person asserting any losses, claims, damages,
liabilities or judgments caused by any untrue statement or alleged untrue
statement of a material fact contained in such preliminary prospectus, or caused
by any omission or alleged omission to state therein a material fact required to
be stated therein or necessary to make the statements therein not misleading, if
such material misstatement or omission or alleged material misstatement or
omission was cured in the Prospectus, as so amended or supplemented, and such
Prospectus was required by law to be delivered at or prior to the written
confirmation of sale to such person.
(b) Each Underwriter agrees, severally and not jointly, to
indemnify and hold harmless the Company, its directors, its officers who sign
the Registration Statement and each person, if any, who controls the Company
within the meaning of Section 15 of the Act or Section 20 of the Exchange Act,
to the same extent as the foregoing indemnity from the Company to such
Underwriter but only with reference to information relating to such Underwriter
furnished in writing to the Company by such Underwriter through you expressly
for use in the Registration Statement (or any amendment thereto), the Prospectus
(or any amendment or supplement thereto) or any preliminary prospectus.
(c) In case any action shall be commenced involving any person in
respect of which indemnity may be sought pursuant to Section 7(a) or 7(b) (the
"INDEMNIFIED PARTY"), the indemnified party shall promptly notify the person
against whom such indemnity may be sought (the "INDEMNIFYING PARTY") in writing
and the indemnifying party shall assume the defense of such action, including
the employment of counsel reasonably satisfactory to the
13
indemnified party and the payment of all fees and expenses of such counsel, as
incurred (except that in the case of any action in respect of which indemnity
may be sought pursuant to both Sections 7(a) and 7(b), the Underwriter shall not
be required to assume the defense of such action pursuant to this Section 7(c),
but may employ separate counsel and participate in the defense thereof, but the
fees and expenses of such counsel, except as provided below, shall be at the
expense of such Underwriter). Any indemnified party shall have the right to
employ separate counsel in any such action and participate in the defense
thereof, but the fees and expenses of such counsel shall be at the expense of
the indemnified party unless (i) the employment of such counsel shall have been
specifically authorized in writing by the indemnifying party, (ii) the
indemnifying party shall have failed to assume the defense of such action or
employ counsel reasonably satisfactory to the indemnified party or (iii) the
named parties to any such action (including any impleaded parties) include both
the indemnified party and the indemnifying party, and the indemnified party
shall have been advised by such counsel that there may be one or more legal
defenses available to it which are different from or additional to those
available to the indemnifying party (in which case the indemnifying party shall
not have the right to assume the defense of such action on behalf of the
indemnified party). In any such case, the indemnifying party shall not, in
connection with any one action or separate but substantially similar or related
actions in the same jurisdiction arising out of the same general allegations or
circumstances, be liable for (i) the fees and expenses of more than one separate
firm of attorneys (in addition to any local counsel) for all Underwriters, their
officers and directors and all persons, if any, who control any Underwriter
within the meaning of either Section 15 of the Act or Section 20 of the Exchange
Act and (ii) the fees and expenses of more than one separate firm of attorneys
(in addition to any local counsel) for the Company, its directors, its officers
who sign the Registration Statement and all persons, if any, who control the
Company within the meaning of either such Section, and all such fees and
expenses shall be reimbursed as they are incurred. In the case of any such
separate firm for the Underwriters, their officers and directors and such
control persons of any Underwriters, such firm shall be designated in writing by
Donaldson, Lufkin & Jenrette Securities Corporation. In the case of any such
separate firm for the Company and such directors, officers and control persons
of the Company, such firm shall be designated in writing by the Company. The
indemnifying party shall indemnify and hold harmless the indemnified party from
and against any and all losses, claims, damages, liabilities and judgments by
reason of any settlement of any action (i) effected with its written consent or
(ii) effected without its written consent if the settlement is entered into more
than twenty business days after the indemnifying party shall have received a
request from the indemnified party for reimbursement for the fees and expenses
of counsel (in any case where such fees and expenses are at the expense of the
indemnifying party) and, prior to the date of such settlement, the indemnifying
party shall have failed to comply with such reimbursement request. No
indemnifying party shall, without the prior written consent of the indemnified
party, effect any settlement or compromise of, or consent to the entry of
judgment with respect to, any pending or threatened action in respect of which
the indemnified party is or could have been a party and indemnity or
contribution may be or could have been sought hereunder by the indemnified
party, unless such settlement, compromise or judgment (i) includes an
unconditional release of the indemnified party from all liability on claims that
are or could have been the subject matter of such action and (ii) does not
include a statement as to or an admission of fault, culpability or a failure to
act, by or on behalf of the indemnified party.
14
(d) To the extent the indemnification provided for in this
Section 7 is unavailable to an indemnified party or insufficient in respect of
any losses, claims, damages, liabilities or judgments referred to therein, then
each indemnifying party, in lieu of indemnifying such indemnified party, shall
contribute to the amount paid or payable by such indemnified party as a result
of such losses, claims, damages, liabilities and judgments (i) in such
proportion as is appropriate to reflect the relative benefits received by the
Company on the one hand and the Underwriters on the other hand from the offering
of the Shares or (ii) if the allocation provided by clause 7(d)(i) above is not
permitted by applicable law, in such proportion as is appropriate to reflect not
only the relative benefits referred to in clause 7(d)(i) above but also the
relative fault of the Company on the one hand and the Underwriters on the other
hand in connection with the statements or omissions which resulted in such
losses, claims, damages, liabilities or judgments, as well as any other relevant
equitable considerations. The relative benefits received by the Company on the
one hand and the Underwriters on the other hand shall be deemed to be in the
same proportion as the total net proceeds from the offering (after deducting
underwriting discounts and commissions, but before deducting expenses) received
by the Company, and the total underwriting discounts and commissions received by
the Underwriters, bear to the total price to the public of the Shares, in each
case as set forth in the table on the cover page of the Prospectus. The relative
fault of the Company on the one hand and the Underwriters on the other hand
shall be determined by reference to, among other things, whether the untrue or
alleged untrue statement of a material fact or the omission or alleged omission
to state a material fact relates to information supplied by the Company or the
Underwriters and the parties' relative intent, knowledge, access to information
and opportunity to correct or prevent such statement or omission.
The Company and the Underwriters agree that it would not be just
and equitable if contribution pursuant to this Section 7(d) were determined by
pro rata allocation (even if the Underwriters were treated as one entity for
such purpose) or by any other method of allocation which does not take account
of the equitable considerations referred to in the immediately preceding
paragraph. The amount paid or payable by an indemnified party as a result of the
losses, claims, damages, liabilities or judgments referred to in the immediately
preceding paragraph shall be deemed to include, subject to the limitations set
forth above, any legal or other expenses incurred by such indemnified party in
connection with investigating or defending any matter, including any action,
that could have given rise to such losses, claims, damages, liabilities or
judgments. Notwithstanding the provisions of this Section 7, no Underwriter
shall be required to contribute any amount in excess of the amount by which the
total price at which the Shares underwritten by it and distributed to the public
were offered to the public exceeds the amount of any damages which such
Underwriter has otherwise been required to pay by reason of such untrue or
alleged untrue statement or omission or alleged omission. No person guilty of
fraudulent misrepresentation (within the meaning of Section 11(f) of the Act)
shall be entitled to contribution from any person who was not guilty of such
fraudulent misrepresentation. The Underwriters' obligations to contribute
pursuant to this Section 7(d) are several in proportion to the respective number
of Shares purchased by each of the Underwriters hereunder and not joint.
15
(e) The remedies provided for in this Section 7 are not exclusive
and shall not limit any rights or remedies which may otherwise be available to
any indemnified party at law or in equity.
SECTION 8. Conditions of Underwriters' Obligations. The several
obligations of the Underwriters to purchase the Firm Shares under this Agreement
are subject to the satisfaction of each of the following conditions:
(a) All the representations and warranties of the Company
contained in this Agreement shall be true and correct on the Closing Date with
the same force and effect as if made on and as of the Closing Date.
(b) If the Company is required to file a Rule 462(b) Registration
Statement after the effectiveness of this Agreement, such Rule 462(b)
Registration Statement shall have become effective by 10:00 P.M., New York City
time, on the date of this Agreement; and no stop order suspending the
effectiveness of the Registration Statement shall have been issued and no
proceedings for that purpose shall have been commenced or shall be pending
before or contemplated by the Commission.
(c) You shall have received on the Closing Date a certificate
dated the Closing Date, signed by Ken Gardner and Virginia Walker, in their
capacities as the President and Chief Executive Officer, and Chief Financial
Officer, respectively, of the Company, confirming the matters set forth in
Sections 6(x), 8(a) and 8(b) and that the Company has complied with all of the
agreements and satisfied all of the conditions herein contained and required to
be complied with or satisfied by the Company on or prior to the Closing Date.
(d) Since the respective dates as of which information is given
in the Prospectus other than as set forth in the Prospectus (exclusive of any
amendments or supplements thereto subsequent to the date of this Agreement), (i)
there shall not have occurred any change or any development involving a
prospective change in the condition, financial or otherwise, or the earnings,
business, management or operations of the Company and its subsidiaries, taken as
a whole, (ii) there shall not have been any change or any development involving
a prospective change in the capital stock or in the long-term debt of the
Company or any of its subsidiaries and (iii) neither the Company nor any of its
subsidiaries shall have incurred any liability or obligation, direct or
contingent, the effect of which, in any such case described in clause 8(d)(i),
8(d)(ii) or 8(d)(iii), in your judgment, is material and adverse and, in your
judgment, makes it impracticable to market the Shares on the terms and in the
manner contemplated in the Prospectus.
(e) You shall have received on the Closing Date an opinion
(satisfactory to you and counsel for the Underwriters), dated the Closing Date,
of Wilson Sonsini Goodrich & Rosati, a Professional Corporation ("WSGR"),
counsel for the Company, to the effect that:
(i) each of the Company and its subsidiaries has been duly
incorporated, is validly existing as a corporation in good standing under the
laws of its
16
jurisdiction of incorporation and has the corporate power and authority to carry
on its business as described in the Prospectus and to own, lease and operate its
properties;
(ii) each of the Company and its subsidiaries is duly
qualified and is in good standing as a foreign corporation authorized to do
business in each jurisdiction in which the nature of its business or its
ownership or leasing of property requires such qualification, except where the
failure to be so qualified would not have a material adverse effect on the
business, prospects, financial condition or results of operations of the Company
and its subsidiaries, taken as a whole;
(iii) all the outstanding shares of capital stock of the
Company have been duly authorized and validly issued and are fully paid,
non-assessable and not subject to any preemptive or similar rights;
(iv) the Shares have been duly authorized and, when issued
and delivered to the Underwriters against payment therefor as provided by this
Agreement, will be validly issued, fully paid and non-assessable, and the
issuance of such Shares will not be subject to any preemptive or similar rights;
(v) all of the outstanding shares of capital stock of each
of the Company's subsidiaries have been duly authorized and validly issued and
are fully paid and non-assessable, and are owned by the Company, directly or
indirectly through one or more subsidiaries, free and clear of any security
interest, claim, lien, encumbrance or adverse interest of any nature;
(vi) this Agreement has been duly authorized, executed and
delivered by the Company;
(vii) the authorized capital stock of the Company conforms
as to legal matters to the description thereof contained in the Prospectus;
(viii) the Registration Statement has become effective
under the Act, no stop order suspending its effectiveness has been issued and no
proceedings for that purpose are, to the best of such counsel's knowledge after
due inquiry, pending before or contemplated by the Commission;
(ix) the statements under the captions "Risk
Factors--Risks Associated with Intellectual Property," "Risk Factors--Risks
Related to Third Party Technology," "Business--Legal Proceedings,"
"Business--Intellectual Property," "Management--Limitation on Liability and
Indemnification Matters," "Management--Employee Benefit Plans," "Certain
Transactions," "Description of Capital Stock" and "Underwriting" in the
Prospectus and Items 14 and 15 of Part II of the Registration Statement, insofar
as such statements constitute a summary of the legal matters, documents or
proceedings referred to therein, fairly present the information called for with
respect to such legal matters, documents and proceedings;
17
(x) neither the Company nor any of its subsidiaries is in
violation of its respective charter or by-laws and, to the best of such
counsel's knowledge after due inquiry, neither the Company nor any of its
subsidiaries is in default in the performance of any obligation, agreement,
covenant or condition contained in any indenture, loan agreement, mortgage,
lease or other agreement or instrument that is material to the Company and its
subsidiaries, taken as a whole, to which the Company or any of its subsidiaries
is a party or by which the Company or any of its subsidiaries or their
respective property is bound;
(xi) the execution, delivery and performance of this
Agreement by the Company, the compliance by the Company with all the provisions
hereof and the consummation of the transactions contemplated hereby will not (A)
require any consent, approval, authorization or other order of, or qualification
with, any court or governmental body or agency (except such as may be required
under the securities or Blue Sky laws of the various states), (B) conflict with
or constitute a breach of any of the terms or provisions of, or a default under,
the charter or by-laws of the Company or any of its subsidiaries or any
indenture, loan agreement, mortgage, lease or other agreement or instrument that
is material to the Company and its subsidiaries, taken as a whole, to which the
Company or any of its subsidiaries is a party or by which the Company or any of
its subsidiaries or their respective property is bound, (C) violate or conflict
with any applicable law or any rule, regulation, judgment, order or decree of
any court or any governmental body or agency having jurisdiction over the
Company, any of its subsidiaries or their respective property or (D) result in
the suspension, termination or revocation of any Authorization of the Company or
any of its subsidiaries or any other impairment of the rights of the holder of
any such Authorization;
(xii) after due inquiry, such counsel does not know of any
legal or governmental proceedings pending or threatened to which the Company or
any of its subsidiaries is or could be a party or to which any of their
respective property is or could be subject that are required to be described in
the Registration Statement or the Prospectus and are not so described, or of any
statutes, regulations, contracts or other documents that are required to be
described in the Registration Statement or the Prospectus or to be filed as
exhibits to the Registration Statement that are not so described or filed as
required;
(xiii) neither the Company nor any of its subsidiaries has
violated any Environmental Law, any provisions of the Employee Retirement Income
Security Act of 1974, as amended, or any provisions of the Foreign Corrupt
Practices Act, or the rules and regulations promulgated thereunder, except for
such violations which, singly or in the aggregate, would not have a material
adverse effect on the business, prospects, financial condition or results of
operation of the Company and its subsidiaries, taken as a whole;
(xiv) each of the Company and its subsidiaries has such
Authorizations of, and has made all filings with and notices to, all
governmental or regulatory authorities and self-regulatory organizations and all
courts and other tribunals, including, without limitation, under any applicable
Environmental Laws, as are necessary to own, lease, license and operate its
respective properties and to conduct its business, except where the failure to
have any such Authorization or to make any such filing or notice would not,
singly or in the aggregate, have a material adverse effect on the business,
prospects, financial condition or results of
18
operations of the Company and its subsidiaries, taken as a whole; each such
Authorization is valid and in full force and effect and each of the Company and
its subsidiaries is in compliance with all the terms and conditions thereof and
with the rules and regulations of the authorities and governing bodies having
jurisdiction with respect thereto; and no event has occurred (including, without
limitation, the receipt of any notice from any authority or governing body)
which allows or, after notice or lapse of time or both, would allow, revocation,
suspension or termination of any such Authorization or results or, after notice
or lapse of time or both, would result in any other impairment of the rights of
the holder of any such Authorization; and such Authorizations contain no
restrictions that are burdensome to the Company or any of its subsidiaries;
except where such failure to be valid and in full force and effect or to be in
compliance, the occurrence of any such event or the presence of any such
restriction would not, singly or in the aggregate, have a material adverse
effect on the business, prospects, financial condition or results of operations
of the Company and its subsidiaries, taken as a whole;
(xv) the Company is not and, after giving effect to the
offering and sale of the Shares and the application of the proceeds thereof as
described in the Prospectus, will not be, an "investment company" as such term
is defined in the Investment Company Act of 1940, as amended;
(xvi) to the best of such counsel's knowledge after due
inquiry, there are no contracts, agreements or understandings between the
Company and any person granting such person the right to require the Company to
file a registration statement under the Act with respect to any securities of
the Company or to require the Company to include such securities with the Shares
registered pursuant to the Registration Statement; and
(xvii) The Company and its subsidiaries have good and
marketable title in fee simple to all real property and good and marketable
title to all personal property owned by them which is material to the business
of the Company and its subsidiaries, in each case free and clear of all liens,
encumbrances and defects except such as are described in the Prospectus or such
as do not materially affect the value of such property and do not interfere with
the use made and proposed to be made of such property by the Company and its
subsidiaries; and any real property and buildings held under lease by the
Company and its subsidiaries are held by them under valid, subsisting and
enforceable leases with such exceptions as are not material and do not interfere
with the use made and proposed to be made of such property and buildings by the
Company and its subsidiaries, in each case except as described in the
Prospectus.
(xviii) The Company and its subsidiaries own or possess,
or can acquire on reasonable terms, all patents, patent rights, licenses,
inventions, copyrights, trademarks, service marks, trade names, mask work
rights, technology and know-how (including trade secrets and other unpatented
and/or unpatentable proprietary or confidential information, systems or
procedures), ("INTELLECTUAL PROPERTY") necessary to conduct the business now or
as proposed to be conducted by the Company as described in the Registration
Statement. To the best of such counsel's knowledge after due inquiry, neither
the Company nor any of its subsidiaries has received any notice of infringement
of or conflict with (or knows of such infringement of or conflict with) asserted
rights of others with respect to any of such intellectual property which, singly
or in the aggregate, if the subject of an unfavorable decision, ruling or
19
finding, would have a material adverse effect on the business, prospects,
financial condition or results of operations of the Company and its
subsidiaries, taken as a whole. To the best of such counsel's knowledge after
due inquiry, the discoveries, inventions, products or processes of the Company
referred to in the Registration Statement do not infringe or conflict with any
right or patent of any third party, or any discovery, invention, product or
process which is the subject of a patent application filed by any third party.
(xix) (A) the Registration Statement and the Prospectus
and any supplement or amendment thereto (except for the financial statements and
other financial data included therein as to which no opinion need be expressed)
comply as to form with the Act, (B) such counsel has no reason to believe that
at the time the Registration Statement became effective or on the date of this
Agreement, the Registration Statement and the prospectus included therein
(except for the financial statements and other financial data as to which such
counsel need not express any belief) contained any untrue statement of a
material fact or omitted to state a material fact required to be stated therein
or necessary to make the statements therein not misleading and (C) such counsel
has no reason to believe that the Prospectus, as amended or supplemented, if
applicable (except for the financial statements and other financial data, as
aforesaid) contains any untrue statement of a material fact or omits to state a
material fact necessary in order to make the statements therein, in the light of
the circumstances under which they were made, not misleading.
The opinion of WSGR described in this Section 8(e) shall be rendered
to you at the request of the Company and shall so state therein.
(f) You shall have received on the Closing Date an opinion, dated
the Closing Date, of Brobeck, Phleger & Harrison LLP ("BPH"), counsel for the
Underwriters, as to the matters referred to in Sections 8(e)(iv), 8(e)(vi),
8(e)(ix) (but only with respect to the statements under the caption "Description
of Capital Stock" and "Underwriting") and 8(e)(xix).
In giving such opinions with respect to the matters covered by
Section 8(e)(xix), WSGR and BPH may state that their opinion and belief are
based upon their participation in the preparation of the Registration Statement
and Prospectus and any amendments or supplements thereto and review and
discussion of the contents thereof, but are without independent check or
verification except as specified.
(g) You shall have received, on each of the date hereof and the
Closing Date, a letter dated the date hereof or the Closing Date, as the case
may be, in form and substance satisfactory to you, from PricewaterhouseCoopers
LLP, independent public accountants, containing the information and statements
of the type ordinarily included in accountants' "comfort letters" to
Underwriters with respect to the financial statements and certain financial
information contained in the Registration Statement and the Prospectus.
(h) The Company shall have delivered to you the agreements
specified in Section 2 hereof which agreements shall be in full force and effect
on the Closing Date.
20
(i) The Shares shall have been duly listed for quotation on the
Nasdaq National Market.
(j) The Company shall not have failed on or prior to the Closing
Date to perform or comply with any of the agreements herein contained and
required to be performed or complied with by the Company on or prior to the
Closing Date.
The several obligations of the Underwriters to purchase any Additional
Shares hereunder are subject to the delivery to you on the applicable Option
Closing Date of such documents as you may reasonably request with respect to the
good standing of the Company, the due authorization and issuance of such
Additional Shares and other matters related to the issuance of such Additional
Shares.
SECTION 9. Effectiveness of Agreement and Termination. This Agreement
shall become effective upon the execution and delivery of this Agreement by the
parties hereto.
This Agreement may be terminated at any time on or prior to the Closing
Date by you by written notice to the Company if any of the following has
occurred: (i) any outbreak or escalation of hostilities or other national or
international calamity or crisis or change in economic conditions or in the
financial markets of the United States or elsewhere that, in your judgment, is
material and adverse and, in your judgment, makes it impracticable to market the
Shares on the terms and in the manner contemplated in the Prospectus, (ii) the
suspension or material limitation of trading in securities or other instruments
on the New York Stock Exchange, the American Stock Exchange, the Chicago Board
of Options Exchange, the Chicago Mercantile Exchange, the Chicago Board of Trade
or the Nasdaq National Market or limitation on prices for securities or other
instruments on any such exchange or the Nasdaq National Market, (iii) the
suspension of trading of any securities of the Company on any exchange or in the
over-the-counter market, (iv) the enactment, publication, decree or other
promulgation of any federal or state statute, regulation, rule or order of any
court or other governmental authority which in your opinion materially and
adversely affects, or will materially and adversely affect, the business,
prospects, financial condition or results of operations of the Company and its
subsidiaries, taken as a whole, (v) the declaration of a banking moratorium by
either federal or New York State authorities or (vi) the taking of any action by
any federal, state or local government or agency in respect of its monetary or
fiscal affairs which in your opinion has a material adverse effect on the
financial markets in the United States.
If on the Closing Date or on an Option Closing Date, as the case may be,
any one or more of the Underwriters shall fail or refuse to purchase the Firm
Shares or Additional Shares, as the case may be, which it has or they have
agreed to purchase hereunder on such date and the aggregate number of Firm
Shares or Additional Shares, as the case may be, which such defaulting
Underwriter or Underwriters agreed but failed or refused to purchase is not more
than one-tenth of the total number of Firm Shares or Additional Shares, as the
case may be, to be purchased on such date by all Underwriters, each
non-defaulting Underwriter shall be obligated severally, in the proportion which
the number of Firm Shares set forth opposite its name in Schedule I bears to the
total number of Firm Shares which all the non-defaulting Underwriters have
agreed to purchase, or in such other proportion as you may specify, to purchase
the Firm
21
Shares or Additional Shares, as the case may be, which such defaulting
Underwriter or Underwriters agreed but failed or refused to purchase on such
date; provided that in no event shall the number of Firm Shares or Additional
Shares, as the case may be, which any Underwriter has agreed to purchase
pursuant to Section 2 hereof be increased pursuant to this Section 9 by an
amount in excess of one-ninth of such number of Firm Shares or Additional
Shares, as the case may be, without the written consent of such Underwriter. If
on the Closing Date any Underwriter or Underwriters shall fail or refuse to
purchase Firm Shares and the aggregate number of Firm Shares with respect to
which such default occurs is more than one-tenth of the aggregate number of Firm
Shares to be purchased by all Underwriters and arrangements satisfactory to you
and the Company for purchase of such Firm Shares are not made within 48 hours
after such default, this Agreement will terminate without liability on the part
of any non-defaulting Underwriter and the Company. In any such case which does
not result in termination of this Agreement, either you or the Company shall
have the right to postpone the Closing Date, but in no event for longer than
seven days, in order that the required changes, if any, in the Registration
Statement and the Prospectus or any other documents or arrangements may be
effected. If, on an Option Closing Date, any Underwriter or Underwriters shall
fail or refuse to purchase Additional Shares and the aggregate number of
Additional Shares with respect to which such default occurs is more than
one-tenth of the aggregate number of Additional Shares to be purchased on such
date, the non-defaulting Underwriters shall have the option to (i) terminate
their obligation hereunder to purchase such Additional Shares or (ii) purchase
not less than the number of Additional Shares that such non-defaulting
Underwriters would have been obligated to purchase on such date in the absence
of such default. Any action taken under this paragraph shall not relieve any
defaulting Underwriter from liability in respect of any default of any such
Underwriter under this Agreement.
SECTION 10. Miscellaneous. Notices given pursuant to any provision of
this Agreement shall be addressed as follows: (i) if to the Company, to Sagent
Technology, Inc., 800 W. El Camino Real, Suite 300, Mountain View, CA 94040 and
(ii) if to any Underwriter or to you, to you c/o Donaldson, Lufkin & Jenrette
Securities Corporation, 277 Park Avenue, New York, New York 10172, Attention:
Syndicate Department, or in any case to such other address as the person to be
notified may have requested in writing.
The respective indemnities, contribution agreements, representations,
warranties and other statements of the Company and the several Underwriters set
forth in or made pursuant to this Agreement shall remain operative and in full
force and effect, and will survive delivery of and payment for the Shares,
regardless of (i) any investigation, or statement as to the results thereof,
made by or on behalf of any Underwriter, the officers or directors of any
Underwriter, any person controlling any Underwriter, the Company, the officers
or directors of the Company or any person controlling the Company, (ii)
acceptance of the Shares and payment for them hereunder and (iii) termination of
this Agreement.
If for any reason the Shares are not delivered by or on behalf of the
Company as provided herein (other than as a result of any termination of this
Agreement pursuant to Section 9), the Company agrees to reimburse the several
Underwriters for all out-of-pocket expenses (including the fees and
disbursements of counsel) incurred by them. Notwithstanding any termination of
this Agreement, the Company shall be liable for all expenses which it has agreed
22
to pay pursuant to Section 5(i) hereof. The Company also agrees to reimburse the
several Underwriters, their directors and officers and any persons controlling
any of the Underwriters for any and all fees and expenses (including, without
limitation, the fees disbursements of counsel) incurred by them in connection
with enforcing their rights hereunder (including, without limitation, pursuant
to Section 7 hereof).
Except as otherwise provided, this Agreement has been and is made solely
for the benefit of and shall be binding upon the Company, the Underwriters, the
Underwriters' directors and officers, any controlling persons referred to
herein, the Company's directors and the Company's officers who sign the
Registration Statement and their respective successors and assigns, all as and
to the extent provided in this Agreement, and no other person shall acquire or
have any right under or by virtue of this Agreement. The term "successors and
assigns" shall not include a purchaser of any of the Shares from any of the
several Underwriters merely because of such purchase.
This Agreement shall be governed and construed in accordance with the
laws of the State of New York.
This Agreement may be signed in various counterparts which together
shall constitute one and the same instrument.
23
Please confirm that the foregoing correctly sets forth the agreement
between the Company and the several Underwriters.
Very truly yours,
SAGENT TECHNOLOGY, INC.
By:
Name:
Title:
DONALDSON, LUFKIN & JENRETTE
SECURITIES CORPORATION
HAMBRECHT & QUIST LLC
PIPER JAFFRAY, INC.
Acting severally on behalf of
themselves and the several
Underwriters named in
Schedule I hereto
By: DONALDSON, LUFKIN & JENRETTE
SECURITIES CORPORATION
By:
Name:
Title:
24
SCHEDULE I
Number of Firm Shares
Underwriters to be Purchased
------------ ---------------
Donaldson, Lufkin & Jenrette Securities
Corporation
Hambrecht & Quist LLC
Piper Jaffray, Inc.
[Names of other Underwriters]
---------------
Total
|
Annex I
[Insert names of stockholders of the Company who will be required to sign lock
ups]
2
EXHIBIT 3.1
CERTIFICATE OF INCORPORATION
OF
SAGENT TECHNOLOGY, INC.
ARTICLE I
The name of this Corporation is Sagent Technology, Inc. (the
"Corporation").
ARTICLE II
The address of the Corporation's registered office in the State of
Delaware is 1209 Orange Street, City of Wilmington, County of New Castle,
Delaware 19801. The name of its registered agent at such address is The
Corporation Trust Company.
ARTICLE III
The purpose of this Corporation is to engage in any lawful act or
activity for which a corporation may be organized under the General Corporation
Law of Delaware other than the banking business, the trust company business or
the practice of a profession permitted to be incorporated by the General
Corporation Law of Delaware.
ARTICLE IV
This Corporation is authorized to issue two classes of stock,
designated Common Stock, par value $0.001 per share ("Common Stock") and
Preferred Stock, par value $0.001 per share ("Preferred Stock"). The number of
shares of Common Stock which this Corporation is authorized to issue is
25,000,000. The number of shares of Preferred Stock which this Corporation is
authorized to issue is 15,555,555, 2,800,000 of which shall be designated
"Series A Preferred," 5,655,555 of which shall be designated "Series B
Preferred", 2,800,000 of which shall be designated "Series C Preferred",
1,800,000 of which shall be designated "Series D Preferred", and 2,500,000 of
which shall be designated "Series E Preferred" (Series A Preferred, Series B
Preferred, Series C Preferred, Series D Preferred and Series E Preferred are
referred to collectively as the "Preferred Stock").
The Corporation shall from time to time in accordance with the laws of
the State of Delaware increase the authorized amount of its Common Stock if at
any time the number of shares of Common Stock remaining unissued and available
for issuance shall not be sufficient to permit conversion of the Preferred
Stock.
The relative rights, preferences, privileges and restrictions granted
to or imposed upon the respective classes of Common Stock and Preferred Stock or
the holders thereof are as follows:
SECTION 1. DIVIDENDS.
The holders of the outstanding Preferred Stock shall be entitled to
receive, when and as declared by the Board of Directors, out of funds legally
available therefor, dividends at the rate of $0.036 per share of Series A
Preferred per annum, $0.072 per share of Series B Preferred per annum, $0.20 per
share of Series C Preferred per annum, $0.25 per share of Series D Preferred per
annum, and $0.43 per share of Series E Preferred per annum, payable in
preference and priority to any payment of any dividend on Common Stock of the
Corporation. Such dividends shall not be cumulative, and no right to such
dividends shall accrue to holders of Preferred Stock or to the holders of Common
Stock unless declared by the Board of Directors. No dividends or other
distributions shall be made with respect to the Common Stock in any fiscal year,
other than dividends payable solely in Common Stock, until a dividend has been
paid to or declared and set apart upon all shares of Preferred Stock at the
annual rates set forth above during that fiscal year. After the holders of the
Preferred Stock have received their dividend preference as set forth above, any
dividends declared by the Board of Directors out of funds legally available
therefor shall be shared equally among all outstanding shares on an as-converted
basis.
(a) For purposes of this Section 1, unless the context
otherwise requires, a "distribution" shall mean the transfer of cash or other
property without consideration whether by way of dividend or otherwise, payable
other than in Common Stock, or the purchase or redemption of shares of the
Corporation (other than repurchases of Common Stock issued to or held by
employees, officers, directors or consultants of the Corporation or its
subsidiaries upon termination of their employment or services pursuant to
agreements providing for the right of said repurchase) for cash or property.
(b) As authorized by Section 402.5(c) of the California
Corporations Code, the provisions of Sections 502 and 503 of the California
Corporations Code shall not apply with respect to repurchases by the Corporation
of shares of Common Stock issued to or held by employees, officers, directors or
consultants of the Corporation or its subsidiaries upon termination of their
employment or services pursuant to agreements providing for the right of said
repurchase.
SECTION 2. LIQUIDATION PREFERENCE.
In the event of any liquidation, dissolution, or winding up of the
Corporation, either voluntary or involuntary, distributions to the shareholders
of the Corporation shall be made in the following manner:
(a) The holders of the Series A Preferred shall be entitled to
receive, prior and in preference to any distribution of any of the assets or
surplus funds of the Corporation to the holders of the Common Stock by reason of
their ownership of such stock, the amount of $0.45 per share for each share of
Series A Preferred then held by them (adjusted for any subdivisions,
combinations, consoli dations, or stock distributions or stock dividends with
respect to such shares effected after the date these Amended and Restated
Articles were filed with the Secretary of State) plus an amount equal to all
-2-
declared but unpaid dividends on the Series A Preferred held by them, the
holders of the Series B Preferred shall be entitled to receive, prior and in
preference to any distribution of any of the assets or surplus funds of the
Corporation to the holders of Common Stock by reason of their ownership of such
stock, the amount of $0.90 per share for each share of Series B Preferred then
held by them(adjusted for any subdivisions, combinations, consolidations or
stock distributions or stock dividends with respect to such shares effected
after the date these Amended and Restated Articles were filed with the Secretary
of State) plus an amount equal to all declared and unpaid dividends on the
Series B Preferred shares then held by them, the holders of the Series C
Preferred shall be entitled to receive, prior and in preference to any
distribution of any of the assets or surplus funds of the Corporation to the
holders of Common Stock by reason of their ownership of such stock, the amount
of $2.50 per share for each share of Series C Preferred then held by them
(adjusted for any subdivisions, combinations, consolidations or stock
distributions or stock dividends with respect to such shares effected after the
date these Amended and Restated Articles were filed with the Secretary of State)
plus an amount equal to all declared and unpaid dividends on the Series C
Preferred shares then held by them, and the holders of the Series D Preferred
shall be entitled to receive, prior and in preference to any distribution of any
of the assets or surplus funds of the Corporation to the holders of Common Stock
by reason of their ownership of such stock, the amount of $3.18 per share for
each share of Series D Preferred then held by them (adjusted for any
subdivisions, combinations, consolidations or stock distributions or stock
dividends with respect to such shares effected after the date these Amended and
Restated Articles were filed with the Secretary of State) plus an amount equal
to all declared and unpaid dividends on the Series D Preferred shares then held
by them. The holders of the Series E Preferred shall be entitled to receive,
prior and in preference to any distribution of any of the assets or surplus
funds of the Corporation to the holders of Common Stock by reason of their
ownership of such stock, the amount of $5.40 per share for each share of Series
E Preferred then held by them (adjusted for any subdivisions, combinations,
consolidations or stock distributions or stock dividends with respect to such
shares effected after the date these Amended and Restated Articles were filed
with the Secretary of State) plus an amount equal to all declared and unpaid
dividends on the Series E Preferred shares then held by them. If the assets and
funds thus distri buted among the holders of the Preferred Stock shall be
insufficient to permit the payment to such holders of the full aforesaid
preferential amount, then the entire assets and funds of the Corporation legally
available for distribution shall be distributed ratably among the holders of the
Preferred Stock in proportion to the full aforesaid preferential amounts to
which each such holder is entitled.
(b) After payment has been made to the holders of the
Preferred Stock of the full amounts to which they shall be entitled as set forth
in Section 2(a) above, then the entire remaining assets and funds of the
Corporation legally available for distribution, if any, shall be distributed
ratably among the holders of the Common Stock in a manner such that the amount
distributed to each holder of Common Stock shall equal the amount obtained by
multiplying the entire remaining assets and funds of the Corporation legally
available for distribution hereunder by a fraction, the numerator of which shall
be the number of shares of Common Stock then held by such holder, and the
denominator of which shall be the total number of shares of Common Stock then
outstanding.
(c) For purposes of this Section 2, a merger or consolidation
of the Corporation with or into any other corporation or corporations, or a
merger of any other corporation or corporations into the Corporation, unless the
shareholders of the Corporation immediately following such transaction
-3-
directly or indirectly own greater than fifty percent (50%) of the total voting
power of the surviving or acquiring corporation or corporations, or a sale of
all or substantially all of the assets of the Corporation, shall be treated as a
liquidation, dissolution or winding up of the Corporation.
(d) Notwithstanding Sections 2(a) and 2(b) hereof, the
Corporation may at any time, out of funds legally available therefor, repurchase
shares of Common Stock of the Corporation issued to or held by employees,
officers, directors or consultants of the Corporation or its subsidiaries upon
termination of their employment or services, pursuant to any agreement providing
for such right of repurchase.
SECTION 3. CONVERSION.
The holders of the Preferred Stock shall have conversion rights as
follows (the "CONVERSION RIGHTS"):
(a) Right to Convert. Each share of Series A Preferred shall
be convertible, at the option of the holder thereof, at any time after the date
of issuance of such share, at the office of the Corporation or any transfer
agent for the Series A Preferred, into such number of fully paid and non
assessable shares of Common Stock as is determined by dividing $0.45 by the
applicable Conversion Price, determined as hereinafter provided, in effect at
the time of conversion. Each share of Series B Preferred shall be convertible,
at the option of the holder thereof, at any time after the date of issuance of
such share, at the office of the Corporation or any transfer agent for the
Series B Preferred, into such number of fully paid and nonassessable shares of
Common Stock as is determined by dividing $0.90 by the applicable Conversion
Price, determined as hereinafter provided, in effect at the time of conversion.
Each share of Series C Preferred shall be convertible, at the option of the
holder thereof, at any time after the date of issuance of such share, at the
office of the Corporation or any transfer agent for the Series C Preferred, into
such number of fully paid and nonassessable shares of Common Stock as is
determined by dividing $2.50 by the applicable Conversion Price, determined as
hereinafter provided, in effect at the time of conversion. Each share of Series
D Preferred shall be convertible, at the option of the holder thereof, at any
time after the date of issuance of such share, at the office of the Corporation
or any transfer agent for the Series D Preferred, into such number of fully paid
and nonassessable shares of Common Stock as is determined by dividing $3.18 by
the applicable Conversion Price, determined as hereinafter provided, in effect
at the time of conversion. Each share of Series E Preferred shall be
convertible, at the option of the holder thereof, at any time after the date of
issuance of such share, at the office of the Corporation or any transfer agent
for the Series E Preferred, into such number of fully paid and nonassessable
shares of Common Stock as is determined by dividing $5.40 by the applicable
Conversion Price, determined as hereinafter provided, in effect at the time of
conversion. The price at which shares of Common Stock shall be deliverable upon
conversion of shares of Preferred Stock (the "Conversion Price") shall initially
be $0.45 with respect to the Series A Preferred, $0.90 with respect to the
Series B Preferred, $2.50 with respect to the Series C Preferred, $3.18 with
respect to the Series D Preferred, and $5.40 with respect to the Series E
Preferred per share of Common Stock. Such initial Conversion Price shall be
subject to adjustment as hereinafter provided.
-4-
Upon conversion, all declared and unpaid dividends on the Preferred
Stock shall be paid either in cash or in shares of Common Stock of the
Corporation, at the election of the Company, wherein the shares of Common Stock
shall be valued at the fair market value at the time of such conversion, as
determined by the Board of Directors of the Corporation.
(b) Automatic Conversion. Each share of Preferred Stock shall
automatically be converted into shares of Common Stock at the then effective
applicable Conversion Price upon either (i) the closing of a firm commitment
underwritten public offering pursuant to an effective registration statement
under the Securities Act of 1933, as amended, covering the offer and sale of
Common Stock for the account of the Corporation to the public with gross
proceeds to the Company (prior to underwriter commissions and offering expenses)
of not less than $10 million, or (ii) the receipt by the Corporation of the
affirmative vote at a duly noticed shareholders meeting or pursuant to a duly
solicited written consent of the holders of more than sixty-six and two-thirds
percent (66 2/3%) of the then out standing shares of Preferred Stock in favor of
the conversion of all of the shares of Preferred Stock. In the event of the
automatic conversion of the Preferred Stock upon a public offering as set forth
in subsection (i) hereof, the person(s) entitled to receive the Common Stock
issuable upon such conversion of Preferred Stock shall not be deemed to have
converted such Preferred Stock until immediately prior to the closing of such
sale of securities.
(c) Mechanics of Conversion. No fractional shares of Common
Stock shall be issued upon conversion of Preferred Stock. In lieu of any
fractional shares to which the holder would otherwise be entitled, the
Corporation shall (after aggregating all shares into which shares of Preferred
Stock held by each holder could be converted) pay cash equal to such fraction
multiplied by the then-effective Conversion Price. Before any holder of
Preferred Stock shall be entitled to convert the same into full shares of Common
Stock and to receive certificates therefor, he shall surrender the certificate
or certificates therefor, duly endorsed, at the office of the Corporation or of
any transfer agent for the Preferred Stock, and shall give written notice to the
Corporation at such office that he elects to convert the same; provided,
however, that in the event of an automatic conversion pursuant to Section 3(b),
the outstanding shares of Preferred Stock shall be converted automatically
without any further action by the holders of such shares and whether or not the
certificates representing such shares are surrendered to the Corporation or its
transfer agent, and provided further that the Corporation shall not be obligated
to issue certificates evidencing the shares of Common Stock issuable upon such
automatic conversion unless the certificates evidencing such shares of Preferred
Stock are either delivered to the Corporation or its transfer agent as provided
above, or the holder notifies the Corporation or its transfer agent that such
certificates have been lost, stolen or destroyed and executes an agreement
satisfactory to the Corporation to indemnify the Corporation from any loss
incurred by it in connection with such certificates. The Corporation shall, as
soon as practicable after such delivery, or such agreement and indemnification
in the case of a lost certificate, issue and deliver at such office to such
holder of Preferred Stock, a certificate or certificates for the number of
shares of Common Stock to which he shall be entitled as aforesaid and a check
payable to the holder in the amount of any cash amounts payable as the result of
a conversion into fractional shares of Common Stock. Such conversion shall be
deemed to have been made immediately prior to the close of business on the date
of such surrender of the shares of Preferred Stock to be converted, or in the
case of automatic conversion immediately prior to the closing of the offering or
on the effective date of such written consent, and the person or persons
entitled to receive
-5-
the shares of Common Stock issuable upon such conversion shall be treated for
all purposes as the record holder or holders of such shares of Common Stock on
such date.
(d) Adjustments to Conversion Price.
(i) Adjustments for Subdivisions, Stock
Dividends, Combinations or Consolidations of Common Stock. In the event the
Corporation effects a subdivision or combination of its outstanding shares of
Common Stock into a greater or smaller number of shares without a proportionate
and corresponding subdivision or combination of its outstanding shares of
Preferred Stock, then and in each such event the Conversion Price shall be
proportionally decreased or increased, respectively.
(ii) Adjustments for Other Dividends and
Distributions. In the event the Corporation at any time or from time to time
makes, or fixes a record date for the determination of holders of Common Stock
entitled to receive, any distribution payable in securities of the Corporation
other than shares of Common Stock and other than as otherwise adjusted in this
Section 3, then and in each such event provision shall be made so that the
holders of Preferred Stock shall receive upon conversion thereof, in addition to
the number of shares of Common Stock receivable thereupon, the amount of
securities of the Corporation which they would have received had their shares of
Preferred Stock been converted into Common Stock on the date of such event and
had they thereafter, during the period from the date of such event to and
including the date of conversion, retained such securities receivable by them as
aforesaid during such period, subject to all other adjustments called for during
such period under this Section 3 with respect to the rights of the holders of
the Preferred Stock.
(iii) Adjustments for Reclassification, Exchange
and Substitution. If the Common Stock issuable upon conversion of the Preferred
Stock shall be changed into the same or a different number of shares of any
other class or classes of stock or other securities or property, whether by
capital reorganization, reclassification or otherwise, the Conversion Price then
in effect shall, concurrently with the effectiveness of such reorganization or
reclassification, be proportionately adjusted such that the Preferred Stock
shall be convertible into, in lieu of the number of shares of Common Stock which
the holders would otherwise have been entitled to receive, a number of shares of
such other class or classes of stock or other securities or property equivalent
to the number of shares of Common Stock that would have been subject to receipt
by the holders upon conversion of the Preferred Stock immediately before that
change and, in any such case, appropriate adjustment (as determined by the
Board) shall be made in the application of the provisions herein set forth with
respect to the rights and interest thereafter of the holders of the Preferred
Stock, to the end that the provisions set forth herein (including provisions
with respect to change in and other adjustments of the Conversion Price) shall
thereafter be applicable, as nearly as reasonably may be, in relation to any
shares of stock or other property thereafter deliverable upon the conversion of
the Preferred Stock.
(e) No Impairment. Except as provided in Section 5, the
Corporation will not, by amendment of its Articles of Incorporation or through
any reorganization, transfer of assets, consolidation, merger, dissolution,
issue or sale of securities or any other voluntary action, avoid or seek to
avoid the observance or performance of any of the terms to be observed or
performed hereunder by
-6-
the Corporation but will at all times in good faith assist in the carrying out
of all the provisions of this Section 3 and in the taking of all such action as
may be necessary or appropriate in order to protect the Conversion Rights of the
holders of the Preferred Stock against impairment.
(f) Certificate as to Adjustments. Upon the occurrence of each
adjustment or readjustment of the Conversion Price pursuant to this Section 3,
the Corporation at its expense shall promptly compute such adjustment or
readjustment in accordance with the terms hereof and furnish to each holder of
Preferred Stock a certificate setting forth such adjustment or readjustment and
showing in detail the facts upon which such adjustment or readjustment is based.
The Corporation shall, upon the written request at any time of any holder of
Preferred Stock, furnish or cause to be furnished to such holder a like
certificate setting forth (i) such adjustments and readjustments, (ii) the
Conversion Price at the time in effect, and (iii) the number of shares of Common
Stock and the amount, if any, of other property which at the time would be
received upon the conversion of Preferred Stock.
(g) Notices of Record Date. In the event that this Corporation
shall propose at any time:
(i) to declare any dividend or distribution upon
its Common Stock, whether in cash, property, stock or other securities, whether
or not a regular cash dividend and whether or not out of earnings or earned
surplus;
(ii) to offer for subscription pro rata to the
holders of any class or series of its stock any additional shares of stock of
any class or series or other rights;
(iii) to effect any reclassification or
recapitalization of its Common Stock outstanding involving a change in the
Common Stock; or
(iv) to merge or consolidate with or into any
other corporation, or sell, lease or convey all or substantially all its
property or business, or to liquidate, dissolve or wind up; then, in connection
with each such event, this Corporation shall send to the holders of the
Preferred Stock:
(1) at least 20 days' prior written notice
of the date on which a record shall be taken for such dividend, distribution or
subscription rights (and specifying the date on which the holders of Common
Stock shall be entitled thereto) or for determining rights to vote in respect of
the matters referred to in (iii) and (iv) above; and
(2) in the case of the matters referred to
in (iii) and (iv) above, at least 20 days' prior written notice of the date when
the same shall take place (and specifying the date on which the holders of
Common Stock shall be entitled to exchange their Common Stock for securities or
other property deliverable upon the occurrence of such event).
-7-
Each such written notice shall be delivered personally or by messenger
or given by express or first class mail, postage prepaid, addressed to the
holders of Preferred Stock at the address for each such holder as shown on the
books of this Corporation.
SECTION 4. VOTING RIGHTS.
Except as otherwise required by law or by Section 5 hereof, the holder
of each share of Common Stock issued and outstanding shall have one vote with
respect to such share and the holder of each share of Preferred Stock shall be
entitled with respect to such share to a number of votes equal to the number of
shares of Common Stock into which such share of Preferred Stock could be
converted at the record date for determination of the shareholders entitled to
vote on such matters, or, if no such record date is established, at the date
such vote is taken or any written consent of shareholders is solicited, such
votes to be counted together with all other shares of stock of the Company
having general voting power and not separately as a class. Holders of Common
Stock and Preferred Stock shall be entitled to notice of any shareholders'
meeting in accordance with the Bylaws of the Corporation. Fractional votes by
the holders of Preferred Stock shall not, however, be permitted and any
fractional voting rights shall (after aggregating all shares into which shares
of Preferred Stock held by each holder could be converted) be rounded to the
nearest whole number.
SECTION 5. COVENANTS.
In addition to any other rights provided by law, so long as any
Preferred Stock shall be outstanding, this Corporation shall not, without first
obtaining the affirmative vote or written consent of the holders of not less
than a majority of such outstanding shares of Preferred Stock, voting together
as a single class:
(a) amend or repeal any provision of, or add any provision to,
this Corporation's Amended and Restated Articles of Incorporation if such action
would materially and adversely alter or change the preferences, rights,
privileges or powers of, or the restrictions provided for the benefit of, any
Preferred Stock;
(b) authorize, issue or obligate itself to issue shares of any
class of stock or any other security convertible into or exchangeable for shares
of any class of stock having any preference or priority as to dividends or
assets superior to or on a parity with any such preference or priority of any
Preferred Stock;
(c) reclassify any Common Stock or any other shares of this
Corporation other than the Preferred Stock into shares having any preference or
priority as to dividends or assets superior to or on a parity with any such
preference or priority of the Preferred Stock;
(d) increase the authorized number of shares of Preferred
Stock; or
-8-
(e) authorize a liquidation, dissolution, recapitalization or
reorganization of the Corporation, or a sale or transfer of all or substantially
all of the assets of the Corporation or a merger or consolidation of the
Corporation if, as a result of such merger or consolidation, the shareholders of
the Corporation shall own less than 50% of the voting securities of the
surviving corporation.
SECTION 6. NO REISSUANCE OF PREFERRED STOCK.
No share or shares of Preferred Stock acquired by this Corporation by
reason of redemption, purchase, conversion or otherwise shall be reissued, and
all such shares shall be canceled, retired and eliminated from the shares which
the Corporation shall be authorized to issue.
ARTICLE V
SECTION 1. LIMITATION OF DIRECTOR'S LIABILITY.
The liability of the directors of this Corporation for monetary
damages shall be eliminated to the fullest extent permissible under California
law.
SECTION 2. INDEMNIFICATION OF CORPORATE AGENTS.
This Corporation is authorized to provide indemnification of agents
(as defined in Section 317 of the California Corporations Code) through Bylaw
provisions, agreements with agents, vote of shareholders or disinterested
directors, or otherwise, to the fullest extent permissible under California law.
SECTION 3. REPEAL OR MODIFICATION.
Any amendment, repeal or modification of the foregoing provisions of
this Article IV shall not adversely affect any right of indemnification or
limitation of liability of an agent of this Corporation relating to acts or
omissions occurring prior to such amendment, repeal or modification.
ARTICLE VI
The name and mailing address of the incorporator are as follows:
Deborah Chang
650 Page Mill Road
Palo Alto, CA 94303-1050
The undersigned incorporator hereby acknowledges that the above
Certificate of Incorporation of Sagent Technology, Inc. is her act and deed and
that the facts stated therein are true.
Dated: September 4, 1998 /s/ Deborah Chang
---------------------
Deborah Chang
|
-9-
EXHIBIT 3.3
BYLAWS
OF
SAGENT TECHNOLOGY, INC
(a Delaware Corporation)
TABLE OF CONTENTS
Page
----
ARTICLE I - CORPORATE OFFICES........................................................................................1
1.1 REGISTERED OFFICE.................................................................................1
1.2 OTHER OFFICES.....................................................................................1
ARTICLE II - MEETINGS OF STOCKHOLDERS................................................................................1
2.1 PLACE OF MEETINGS.................................................................................1
2.2 ANNUAL MEETING....................................................................................1
2.3 SPECIAL MEETING...................................................................................2
2.4 NOTICE OF STOCKHOLDERS' MEETINGS..................................................................2
2.5 ADVANCE NOTICE OF STOCKHOLDER NOMINEES AND STOCKHOLDER
BUSINESS..........................................................................................2
2.6 MANNER OF GIVING NOTICE; AFFIDAVIT OF NOTICE......................................................3
2.7 QUORUM............................................................................................4
2.8 ADJOURNED MEETING; NOTICE.........................................................................4
2.9 VOTING............................................................................................4
2.10 WAIVER OF NOTICE..................................................................................5
2.11 RECORD DATE FOR STOCKHOLDER NOTICE; VOTING........................................................5
2.12 PROXIES...........................................................................................5
2.13 ORGANIZATION......................................................................................6
2.14 LIST OF STOCKHOLDERS ENTITLED TO VOTE.............................................................6
ARTICLE III - DIRECTORS..............................................................................................6
3.1 POWERS............................................................................................6
3.2 NUMBER OF DIRECTORS...............................................................................6
3.3 ELECTION AND TERM OF OFFICE OF DIRECTORS..........................................................7
3.4 RESIGNATION AND VACANCIES.........................................................................7
3.5 PLACE OF MEETINGS; MEETINGS BY TELEPHONE..........................................................7
3.6 REGULAR MEETINGS..................................................................................7
3.7 SPECIAL MEETINGS; NOTICE..........................................................................8
3.8 QUORUM............................................................................................8
3.9 WAIVER OF NOTICE..................................................................................8
3.10 ADJOURNMENT.......................................................................................8
|
-i-
TABLE OF CONTENTS
(Continued)
Page
----
3.11 NOTICE OF ADJOURNMENT.............................................................................9
3.12 BOARD ACTION BY WRITTEN CONSENT WITHOUT A MEETING.................................................9
3.13 FEES AND COMPENSATION OF DIRECTORS................................................................9
3.14 APPROVAL OF LOANS TO OFFICERS.....................................................................9
ARTICLE IV - COMMITTEES.............................................................................................10
4.1 COMMITTEES OF DIRECTORS..........................................................................10
4.2 MEETINGS AND ACTION OF COMMITTEES................................................................10
4.3 COMMITTEE MINUTES................................................................................11
ARTICLE V - OFFICERS................................................................................................11
5.1 OFFICERS.........................................................................................11
5.2 ELECTION OF OFFICERS.............................................................................11
5.3 SUBORDINATE OFFICERS.............................................................................11
5.4 REMOVAL AND RESIGNATION OF OFFICERS..............................................................12
5.5 VACANCIES IN OFFICES.............................................................................12
5.6 CHAIRMAN OF THE BOARD............................................................................12
5.7 PRESIDENT........................................................................................12
5.8 VICE PRESIDENTS..................................................................................12
5.9 SECRETARY........................................................................................13
5.10 CHIEF FINANCIAL OFFICER..........................................................................13
ARTICLE VI - INDEMNIFICATION OF DIRECTORS, OFFICERS, EMPLOYEES, AND
OTHER AGENTS...............................................................................................14
6.1 INDEMNIFICATION OF DIRECTORS AND OFFICERS........................................................14
6.2 INDEMNIFICATION OF OTHERS........................................................................15
6.3 INSURANCE........................................................................................15
ARTICLE VII - RECORDS AND REPORTS...................................................................................15
7.1 MAINTENANCE AND INSPECTION OF RECORDS............................................................15
7.2 INSPECTION BY DIRECTORS..........................................................................16
7.3 ANNUAL STATEMENT TO STOCKHOLDERS.................................................................16
7.4 REPRESENTATION OF SHARES OF OTHER CORPORATIONS...................................................16
7.5 CERTIFICATION AND INSPECTION OF BYLAWS...........................................................16
|
-ii-
TABLE OF CONTENTS
(Continued)
Page
----
ARTICLE VIII - GENERAL MATTERS......................................................................................16
8.1 RECORD DATE FOR PURPOSES OTHER THAN NOTICE AND VOTING............................................16
8.2 CHECKS; DRAFTS; EVIDENCES OF INDEBTEDNESS........................................................17
8.3 CORPORATE CONTRACTS AND INSTRUMENTS: HOW EXECUTED...............................................17
8.4 STOCK CERTIFICATES; TRANSFER; PARTLY PAID SHARES.................................................17
8.5 SPECIAL DESIGNATION ON CERTIFICATES..............................................................18
8.6 LOST CERTIFICATES................................................................................18
8.7 TRANSFER AGENTS AND REGISTRARS...................................................................19
8.8 CONSTRUCTION; DEFINITIONS........................................................................19
ARTICLE IX - AMENDMENTS.............................................................................................19
9.1 AMENDMENTS BY STOCKHOLDERS AND DIRECTORS.........................................................19
9.2 SUPERMAJORITY VOTE...............................................................................19
|
-iii-
BYLAWS
OF
SAGENT TECHNOLOGY, INC.
(a Delaware Corporation)
ARTICLE I
CORPORATE OFFICES
1.1 REGISTERED OFFICE
The registered office of the corporation shall be fixed in the
certificate of incorporation of the corporation.
1.2 OTHER OFFICES
The board of directors may at any time establish branch or subordinate
offices at any place or places where the corporation is qualified to do
business.
ARTICLE II
MEETINGS OF STOCKHOLDERS
2.1 PLACE OF MEETINGS
Meetings of stockholders shall be held at any place within or outside
the State of Delaware designated by the board of directors. In the absence of
any such designation, stockholders' meetings shall be held at the principal
executive office of the corporation.
2.2 ANNUAL MEETING
The annual meeting of stockholders shall be held each year on a date
and at a time designated by the board of directors. In the absence of such
designation, the annual meeting of stockholders shall be held on the third
Tuesday of May in each year at 10:00 a.m. However, if such day falls on a legal
holiday, then the meeting shall be held at the same time and place on the next
succeeding full business day. At the meeting, directors shall be elected, and
any other proper business may be transacted.
2.3 SPECIAL MEETING
Except as otherwise required by law, a special meeting of the
stockholders may be called only by the Board of Directors, the Chairman of the
Board, or the President; provided however, that if at any time no directors
remain in office, then a special meeting for the purpose of electing directors
may be called in accordance with the procedure set forth in the Bylaws. No
business may be transacted at such special meeting otherwise than as specified
in the notice of such meeting.
2.4 NOTICE OF STOCKHOLDERS' MEETINGS
All notices of meetings of stockholders shall be sent or otherwise
given in accordance with Section 2.6 of these bylaws not less than ten (10) nor
more than sixty (60) days before the date of the meeting. The notice shall
specify the place, date and hour of the meeting and (i) in the case of a special
meeting, the purpose or purposes for which the meeting is called (no business
other than that specified in the notice may be transacted) or (ii) in the case
of the annual meeting, those matters which the board of directors, at the time
of giving the notice, intends to present for action by the stockholders (but any
proper matter may be presented at the meeting for such action). The notice of
any meeting at which directors are to be elected shall include the name of any
nominee or nominees who, at the time of the notice, the board intends to present
for election.
2.5 ADVANCE NOTICE OF STOCKHOLDER NOMINEES AND STOCKHOLDER
BUSINESS
Subject to the rights of holders of any class or series of stock having
a preference over the Common Stock as to dividends or upon liquidation,
(a) nominations for the election of directors, and
(b) business proposed to be brought before any
stockholder meeting
may be made by the board of directors or proxy committee appointed by the board
of directors or by any stockholder entitled to vote in the election of directors
generally if such nomination or business proposed is otherwise proper business
before such meeting. However, any such stockholder may nominate one or more
persons for election as directors at a meeting or propose business to be brought
before a meeting, or both, only if such stockholder has given timely notice to
the secretary of the corporation in proper written form of their intent to make
such nomination or nominations or to propose such business. To be timely, such
stockholder's notice must be delivered to or mailed and received at the
principal executive offices of the corporation not less than one hundred twenty
(120) calendar days in advance of the date of the corporation's proxy statement
released to stockholders in connection with the previous year's annual meeting
of stockholders; provided, however, that in the event that no annual meeting was
held in the previous year or the date of the annual meeting has been changed by
more than thirty (30) days from the date contemplated at the time of the
previous year's proxy statement, notice by the stockholder to be timely must be
so received a reasonable time
-2-
before the solicitation is made. To be in proper form, a stockholder's notice to
the secretary shall set forth:
(i) the name and address of the stockholder who
intends to make the nominations or propose the business and, as the case may be,
of the person or persons to be nominated or of the business to be proposed;
(ii) a representation that the stockholder is a
holder of record of stock of the corporation entitled to vote at such meeting
and, if applicable, intends to appear in person or by proxy at the meeting to
nominate the person or persons specified in the notice;
(iii) if applicable, a description of all
arrangements or understandings between the stockholder and each nominee and any
other person or persons (naming such person or persons) pursuant to which the
nomination or nominations are to be made by the stockholder;
(iv) such other information regarding each
nominee or each matter of business to be proposed by such stockholder as would
be required to be included in a proxy statement filed pursuant to the proxy
rules of the Securities and Exchange Commission had the nominee been nominated,
or intended to be nominated, or the matter been proposed, or intended to be
proposed by the board of directors; and
(v) if applicable, the consent of each nominee
to serve as director of the corporation if so elected.
The chairman of the meeting shall refuse to acknowledge the nomination
of any person or the proposal of any business not made in compliance with the
foregoing procedure.
2.6 MANNER OF GIVING NOTICE; AFFIDAVIT OF NOTICE
Written notice of any meeting of stockholders shall be given either
personally or by first-class mail or by telegraphic or other written
communication. Notices not personally delivered shall be sent charges prepaid
and shall be addressed to the stockholder at the address of that stockholder
appearing on the books of the corporation or given by the stockholder to the
corporation for the purpose of notice. Notice shall be deemed to have been given
at the time when delivered personally or deposited in the mail or sent by
telegram or other means of written communication.
An affidavit of the mailing or other means of giving any notice of any
stockholders' meeting, executed by the secretary, assistant secretary or any
transfer agent of the corporation giving the notice, shall be prima facie
evidence of the giving of such notice.
-3-
2.7 QUORUM
The holders of a majority in voting power of the stock issued and
outstanding and entitled to vote thereat, present in person or represented by
proxy, shall constitute a quorum at all meetings of the stockholders for the
transaction of business except as otherwise provided by statute or by the
certificate of incorporation. If, however, such quorum is not present or
represented at any meeting of the stockholders, then either (i) the chairman of
the meeting or (ii) the stockholders entitled to vote thereat, present in person
or represented by proxy, shall have power to adjourn the meeting in accordance
with Section 2.7 of these bylaws.
When a quorum is present at any meeting, the vote of the holders of a
majority of the stock having voting power present in person or represented by
proxy shall decide any question brought before such meeting, unless the question
is one upon which, by express provision of the laws of the State of Delaware or
of the certificate of incorporation or these bylaws, a different vote is
required, in which case such express provision shall govern and control the
decision of the question.
If a quorum be initially present, the stockholders may continue to
transact business until adjournment, notwithstanding the withdrawal of enough
stockholders to leave less than a quorum, if any action taken is approved by a
majority of the stockholders initially constituting the quorum.
2.8 ADJOURNED MEETING; NOTICE
When a meeting is adjourned to another time and place, unless these
bylaws otherwise require, notice need not be given of the adjourned meeting if
the time and place thereof are announced at the meeting at which the adjournment
is taken. At the adjourned meeting the corporation may transact any business
that might have been transacted at the original meeting. If the adjournment is
for more than thirty (30) days, or if after the adjournment a new record date is
fixed for the adjourned meeting, a notice of the adjourned meeting shall be
given to each stockholder of record entitled to vote at the meeting.
2.9 VOTING
The stockholders entitled to vote at any meeting of stockholders shall
be determined in accordance with the provisions of Section 2.11 of these bylaws,
subject to the provisions of Sections 217 and 218 of the General Corporation Law
of Delaware (relating to voting rights of fiduciaries, pledgors and joint
owners, and to voting trusts and other voting agreements).
Except as may be otherwise provided in the certificate of incorporation
or these bylaws, each stockholder shall be entitled to one vote for each share
of capital stock held by such stockholder with respect to any matter submitted
to a vote of the stockholders and stockholders shall not be entitled to cumulate
their votes in the election of directors.
-4-
2.10 WAIVER OF NOTICE
Whenever notice is required to be given under any provision of the
General Corporation Law of Delaware or of the certificate of incorporation or
these bylaws, a written waiver thereof, signed by the person entitled to notice,
whether before or after the time stated therein, shall be deemed equivalent to
notice. Attendance of a person at a meeting shall constitute a waiver of notice
of such meeting, except when the person attends a meeting for the express
purpose of objecting, at the beginning of the meeting, to the transaction of any
business because the meeting is not lawfully called or convened. Neither the
business to be transacted at, nor the purpose of, any regular or special meeting
of the stockholders need be specified in any written waiver of notice unless so
required by the certificate of incorporation or these bylaws.
2.11 RECORD DATE FOR STOCKHOLDER NOTICE; VOTING
For purposes of determining the stockholders entitled to notice of any
meeting or to vote thereat, the board of directors may fix, in advance, a record
date, which shall not precede the date upon which the resolution fixing the
record date is adopted by the board of directors and which shall not be more
than sixty (60) days nor less than ten (10) days before the date of any such
meeting, and in such event only stockholders of record on the date so fixed are
entitled to notice and to vote, notwithstanding any transfer of any shares on
the books of the corporation after the record date.
If the board of directors does not so fix a record date, the record
date for determining stockholders entitled to notice of or to vote at a meeting
of stockholders shall be at the close of business on the business day next
preceding the day on which notice is given, or, if notice is waived, at the
close of business on the business day next preceding the day on which the
meeting is held.
A determination of stockholders of record entitled to notice of or to
vote at a meeting of stockholders shall apply to any adjournment of the meeting
unless the board of directors fixes a new record date for the adjourned meeting,
but the board of directors shall fix a new record date if the meeting is
adjourned for more than thirty (30) days from the date set for the original
meeting.
The record date for any other purpose shall be as provided in Section
8.1 of these bylaws.
2.12 PROXIES
Every person entitled to vote for directors, or on any other matter,
shall have the right to do so either in person or by one or more agents
authorized by a written proxy signed by the person and filed with the secretary
of the corporation, but no such proxy shall be voted or acted upon after three
(3) years from its date unless the proxy provides for a longer period. A proxy
shall be deemed signed if the stockholder's name is placed on the proxy (whether
by manual signature, typewriting, telegraphic transmission, telefacsimile or
otherwise) by the stockholder or the stockholder's attorney-in-fact. The
revocability of a proxy that states on its face that it is irrevocable shall be
governed by the provisions of Section 212(e) of the General Corporation Law of
Delaware.
-5-
2.13 OR |